<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome - Abdel-Latif, ME - 2024 | Cochrane Library</title> <meta content="Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome - Abdel-Latif, ME - 2024 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008309.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome - Abdel-Latif, ME - 2024 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008309.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD008309.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome" name="citation_title"/> <meta content="Mohamed E Abdel-Latif" name="citation_author"/> <meta content="abdel-latif.mohamed@act.gov.au" name="citation_author_email"/> <meta content="Elizabeth Walker" name="citation_author"/> <meta content="Canberra Health Services" name="citation_author_institution"/> <meta content="David A Osborn" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD008309.pub3" name="citation_doi"/> <meta content="2024" name="citation_date"/> <meta content="2024/01/25" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008309.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008309.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008309.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Bronchopulmonary Dysplasia [prevention &amp; control]; Cerebral Hemorrhage; Infant, Extremely Premature; *Laryngeal Masks; Morbidity; *Respiratory Distress Syndrome; *Respiratory Distress Syndrome, Newborn [prevention &amp; control]; Surface-Active Agents" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD008309.pub3&amp;doi=10.1002/14651858.CD008309.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="6nHUP32m";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD008309\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD008309\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ms","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD008309.pub3",title:"Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome",firstPublishedDate:"Jan 25, 2024 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008309.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008309.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD008309.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD008309.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008309.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD008309.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD008309.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD008309.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD008309.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD008309.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2263 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD008309.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-sec-0214"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-sec-0204"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/appendices#CD008309-sec-0219"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/supinfo/CD008309-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/supinfo/CD008309-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2024 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information#CD008309-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Mohamed E Abdel-Latif</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information#CD008309-cr-0005">Elizabeth Walker</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information#CD008309-cr-0006">David A Osborn</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information/en#CD008309-sec-0237">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 25 January 2024 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD008309.pub3">https://doi.org/10.1002/14651858.CD008309.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD008309-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008309-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD008309-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008309-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008309-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008309-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD008309-abs-0001" lang="en"> <section id="CD008309-sec-0001"> <h3 class="title" id="CD008309-sec-0001">Background</h3> <p>Laryngeal mask airway surfactant administration (S‐LMA) has the potential benefit of surfactant administration whilst avoiding endotracheal intubation and ventilation, ventilator‐induced lung injury and bronchopulmonary dysplasia (BPD). </p> </section> <section id="CD008309-sec-0002"> <h3 class="title" id="CD008309-sec-0002">Objectives</h3> <p>To evaluate the benefits and harms of S‐LMA either as prophylaxis or treatment (rescue) compared to placebo, no treatment, or intratracheal surfactant administration via an endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) or extubate at standard criteria (S‐ETT) or via other less‐invasive surfactant administration (LISA) methods on morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome (RDS). </p> </section> <section id="CD008309-sec-0003"> <h3 class="title" id="CD008309-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, CINAHL, and three trial registries in December 2022. </p> </section> <section id="CD008309-sec-0004"> <h3 class="title" id="CD008309-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs), cluster‐ or quasi‐RCTs of S‐LMA compared to placebo, no treatment, or other routes of administration (nebulised, pharyngeal instillation of surfactant before the first breath, thin endotracheal catheter surfactant administration or intratracheal surfactant instillation) on morbidity and mortality in preterm infants at risk of RDS. We considered published, unpublished and ongoing trials. </p> </section> <section id="CD008309-sec-0005"> <h3 class="title" id="CD008309-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed studies for inclusion and extracted data. We used GRADE to assess the certainty of the evidence. </p> </section> <section id="CD008309-sec-0006"> <h3 class="title" id="CD008309-sec-0006">Main results</h3> <p>We included eight trials (seven new to this update) recruiting 510 newborns. Five trials (333 infants) compared S‐LMA with surfactant administration via ETT with InSurE. One trial (48 infants) compared S‐LMA with surfactant administration via ETT with S‐ETT, and two trials (129 infants) compared S‐LMA with no surfactant administration. We found no studies comparing S‐LMA with LISA techniques or prophylactic or early S‐LMA. </p> <p><b>S‐LMA versus surfactant administration via InSurE</b> </p> <p>S‐LMA may have little or no effect on the composite outcome of death or BPD at 36 weeks' postmenstrual age (risk ratio (RR) 1.50, 95% confidence interval (CI) 0.27 to 8.34, I <sup>2</sup> = not applicable (NA) as 1 study had 0 events; risk difference (RD) 0.02, 95% CI −0.07 to 0.10; I <sup>2</sup> = 0%; 2 studies, 110 infants; low‐certainty evidence). There may be a reduction in the need for mechanical ventilation at any time (RR 0.53, 95% CI 0.36 to 0.78; I <sup>2</sup> = 27%; RD −0.14, 95% CI −0.22 to −0.06, I <sup>2</sup> = 89%; number needed to treat for an additional beneficial outcome (NNTB) 7, 95% CI 5 to 17; 5 studies, 333 infants; low‐certainty evidence). However, this was limited to four studies (236 infants) using analgesia or sedation for the InSurE group. There was little or no difference for air leak during first hospitalisation (RR 1.39, 95% CI 0.65 to 2.98; I <sup>2</sup> = 0%; 5 studies, 333 infants (based on 3 studies as 2 studies had 0 events); low‐certainty evidence); BPD among survivors to 36 weeks' PMA (RR 1.28, 95% CI 0.47 to 3.52; I <sup>2</sup> = 0%; 4 studies, 264 infants (based on 3 studies as 1 study had 0 events); low‐certainty evidence); or death (all causes) during the first hospitalisation (RR 0.28, 95% CI 0.01 to 6.60; I <sup>2</sup> = NA as 2 studies had 0 events; 3 studies, 203 infants; low‐certainty evidence). Neurosensory disability was not reported. Intraventricular haemorrhage <i>(</i> IVH) grades III and IV were reported among the study groups (1 study, 50 infants). </p> <p><b>S‐LMA versus surfactant administration via S‐ETT</b> </p> <p>No study reported death or BPD at 36 weeks' PMA. S‐LMA may reduce the use of mechanical ventilation at any time compared with S‐ETT (RR 0.47, 95% CI 0.31 to 0.71; RD −0.54, 95% CI −0.74 to −0.34; NNTB 2, 95% CI 2 to 3; 1 study, 48 infants; low‐certainty evidence). We are very uncertain whether S‐LMA compared with S‐ETT reduces air leak during first hospitalisation (RR 2.56, 95% CI 0.11 to 59.75), IVH grade III or IV (RR 2.56, 95% CI 0.11 to 59.75) and death (all causes) during the first hospitalisation (RR 0.17, 95% CI 0.01 to 3.37) (1 study, 48 infants; very low‐certainty evidence). No study reported BPD to 36 weeks' PMA or neurosensory disability. </p> <p><b>S‐LMA versus no surfactant administration</b> </p> <p>Rescue surfactant could be used in both groups. There may be little or no difference in death or BPD at 36 weeks (RR 1.65, 95% CI 0.85 to 3.22; I <sup>2</sup> = 58%; RD 0.08, 95% CI −0.03 to 0.19; I <sup>2</sup> = 0%; 2 studies, 129 infants; low‐certainty evidence). There was probably a reduction in the need for mechanical ventilation at any time with S‐LMA compared with nasal continuous positive airway pressure without surfactant (RR 0.57, 95% CI 0.38 to 0.85; I <sup>2</sup> = 0%; RD −0.24, 95% CI −0.40 to −0.08; I <sup>2</sup> = 0%; NNTB 4, 95% CI 3 to 13; 2 studies, 129 infants; moderate‐certainty evidence). There was little or no difference in air leak during first hospitalisation (RR 0.65, 95% CI 0.23 to 1.88; I <sup>2</sup> = 0%; 2 studies, 129 infants; low‐certainty evidence) or BPD to 36 weeks' PMA (RR 1.65, 95% CI 0.85 to 3.22; I <sup>2</sup> = 58%; 2 studies, 129 infants; low‐certainty evidence). There were no events in either group for death during the first hospitalisation (1 study, 103 infants) or IVH grade III and IV (1 study, 103 infants). No study reported neurosensory disability. </p> </section> <section id="CD008309-sec-0007"> <h3 class="title" id="CD008309-sec-0007">Authors' conclusions</h3> <p>In preterm infants less than 36 weeks' PMA, rescue S‐LMA may have little or no effect on the composite outcome of death or BPD at 36 weeks' PMA. However, it may reduce the need for mechanical ventilation at any time. This benefit is limited to trials reporting the use of analgesia or sedation in the InSurE and S‐ETT groups. There is low‐ to very‐low certainty evidence for no or little difference in neonatal morbidities and mortality. Long‐term outcomes are largely unreported. </p> <p>In preterm infants less than 32 weeks' PMA or less than 1500 g, there are insufficient data to support or refute the use of S‐LMA in clinical practice. Adequately powered trials are required to determine the effect of S‐LMA for prevention or early treatment of RDS in extremely preterm infants. S‐LMA use should be limited to clinical trials in this group of infants. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD008309-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD008309-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD008309-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD008309-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD008309-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD008309-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD008309-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD008309-abs-0012">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD008309-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD008309-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD008309-abs-0002" lang="en"> <h3>Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with, or at risk of, respiratory distress syndrome </h3> <p><b>Key messages</b> </p> <p>– Surfactant administration via laryngeal mask may reduce the need for mechanical ventilation at any time when compared to surfactant administration via endotracheal tube. </p> <p>– Surfactant administration via laryngeal mask probably reduces the need for mechanical ventilation at any time compared to no surfactant administration. </p> <p>– Further trials are needed.</p> <p><b>What is a surfactant?</b> </p> <p>Pulmonary surfactant is a natural substance that prevents the air sacs of the lungs (alveoli) from sticking together (collapsing) when the baby exhales (breathes out). Surfactant is often lacking in the lungs of newborn babies with respiratory distress syndrome. </p> <p><b>What is respiratory distress syndrome?</b> </p> <p>Respiratory distress syndrome is a breathing disorder that occurs mainly in infants born before their due date (37 weeks' gestation). It is caused by a lack of surfactant. </p> <p><b>How is respiratory distress treated?</b> </p> <p>The usual treatment involves providing breathing support and oxygen, and administering artificial surfactant directly into the newborn infant's lungs through the breathing pipe (trachea). This can be via a tube in the trachea (called an endotracheal tube) for infants on mechanical ventilation or via a thin tube or nebuliser (a machine that turns liquid medicine into a fine mist) for infants breathing for themselves whilst on pressure support to open the lungs (called continuous positive airway pressure (CPAP)). However, placing tubes in the infant's trachea is technically challenging and mechanical ventilation may damage the lungs. An alternative is to insert a tube called laryngeal mask airway into the infant's upper airway, which fits on the infant's larynx (the tube just above the trachea) and allows breathing support and administration of surfactant. This technique is thought to be less technically challenging. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to find out if surfactant administration via laryngeal mask airway compared to dummy treatment (placebo), no treatment, or surfactant administration via an endotracheal tube or other less‐invasive methods given to premature infants with or at risk of respiratory distress syndrome could improve survival. We also wanted to know if it reduced the risk of developing a chronic lung condition called bronchopulmonary dysplasia (BPD) or duration of mechanical ventilation and other outcomes, such as any harmful effects. </p> <p><b>What did we do?</b> </p> <p>We searched for studies that compared surfactant administration via laryngeal mask to no treatment, surfactant administration via an endotracheal tube or other less‐invasive methods in preterm infants with or at risk of respiratory distress syndrome. We compared and summarised the results of the included studies and rated our confidence in the evidence based on factors such as study methods and size. </p> <p><b>What did we find?</b> </p> <p>We identified eight studies that investigated this therapy in 510 premature infants. Surfactant administration via laryngeal mask may reduce the need for mechanical ventilation at any time when compared to surfactant administration via endotracheal tube. Furthermore, we found that surfactant administration via laryngeal mask probably reduces the need for mechanical ventilation at any time compared to no surfactant administration. Long‐term outcomes were not reported. No trial compared surfactant administered by laryngeal mask airway to surfactant administered by a thin catheter. Given the encouraging results from these trials, high‐quality trials of laryngeal mask airway surfactant administration in very preterm infants with or at risk of respiratory distress syndrome are justified. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We are not confident in the evidence because it was based on relatively few cases and few studies. </p> <p><b>How up to date is this evidence?</b> </p> <p>The evidence is up to date to 1 December 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD008309-sec-0214" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD008309-sec-0214"></div> <h3 class="title" id="CD008309-sec-0215">Implications for practice</h3> <section id="CD008309-sec-0215"> <p>In preterm infants of less than 36 weeks' gestation, rescue surfactant administration via laryngeal mask airway (S‐LMA) may have little or no effect on the composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks. However, it may reduce the need for mechanical ventilation at any time. This benefit is limited to trials reporting the use of analgesia or sedation in the INtubation‐SURfactant‐Extubation (InSurE) and surfactant administration via endotracheal (S‐ETT) groups. There is low‐ to very‐low certainty evidence for no or little difference in neonatal morbidities and mortality. Long‐term outcomes are largely unreported. </p> <p>In preterm infants at less than 32 weeks' gestation or less than 1500 g, there are insufficient data to support or refute the use of S‐LMA in clinical practice. Adequately powered trials are required to determine the effect of S‐LMA for prevention or early treatment of respiratory distress syndrome (RDS) in extremely preterm infants. S‐LMA use should be limited to clinical trials in this group of infants. </p> </section> <h3 class="title" id="CD008309-sec-0216">Implications for research</h3> <section id="CD008309-sec-0216"> <p>Adequately powered trials are required to determine the effect of S‐LMA for preventing or treating RDS in preterm and extremely preterm infants, particularly compared to other non‐invasive techniques, including thin catheter surfactant administration whilst on nasal intermittent positive pressure ventilation. Studies should measure short‐ and long‐term outcomes prespecified in this review. Given the evidence for prophylactic and early surfactant administration, trials should enrol infants early in the course of respiratory illness. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD008309-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD008309-sec-0008"></div> <div class="table" id="CD008309-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants with or at risk of respiratory distress syndrome<br/><b>Settings:</b> NICU<br/><b>Intervention:</b> S‐LMA<br/><b>Comparator:</b> InSurE </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With InSurE</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With S‐LMA</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or bronchopulmonary dysplasia</b> <br/>Follow‐up at 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>55 per 1000</b> <br/>(10 to 303) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.50</b> <br/>(0.27 to 8.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mechanical ventilation at any time</b> </p> <p>Any time to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>302 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>160 per 1000</b> <br/>(109 to 236) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.53</b> <br/>(0.36 to 0.78) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subgroup analyses: there may be a reduction for infants born at 28–36 weeks' gestation (RR 0.56, 95% CI 0.38 to 0.82; 3 studies, 213 participants; I <sup>2</sup> = 46%). </p> <p>Comparing S‐LMA without sedation or analgesia vs InSurE with analgesia or sedation, there may be a reduction in mechanical ventilation at any time (RR 0.53, 95% CI 0.36 to 0.78; 4 studies, 263 participants; I <sup>2</sup> = 27%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pulmonary air leak, any (during first hospitalisation)</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> <br/>(36 to 166) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.39</b> <br/>(0.65 to 2.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors</b> <br/>Follow‐up at 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 1000</b> <br/>(22 to 165) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.28</b> <br/>(0.47 to 3.52) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>264<br/>(4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraventricular haemorrhage grade III and IV</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death (all causes) during the first hospitalisation</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> <br/>(0 to 68) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.28</b> <br/>(0.01 to 6.60) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurosensory disability in survivors</b> <br/>Follow‐up: &gt; 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>NICU:</b> neonatal intensive care unit; <b>PMA:</b> postmenstrual age; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded two levels for severe imprecision (wide confidence intervals and few events).<br/><sup>b</sup> Downgraded one level for imprecision (wide confidence intervals) and one level for inconsistency (low heterogeneity).<br/><sup>c</sup> Downgraded one level for inconsistency (single small study so not able to be assessed) and two levels for severe imprecision (no events). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD008309-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants with or at risk of respiratory distress syndrome<br/><b>Settings:</b> NICU<br/><b>Intervention:</b> S‐LMA<br/><b>Comparator:</b> S‐ETT </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With S‐ETT</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With S‐LMA</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or bronchopulmonary dysplasia</b> <br/>Follow‐up to 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mechanical ventilation at any time</b> </p> <p>Any time to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1000 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>470 per 1000</b> <br/>(310 to 710) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.47</b> <br/>(0.31 to 0.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA without sedation or analgesia vs S‐ETT with sedation and analgesia may reduce the use of mechanical ventilation at any time. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pulmonary air leak, any (during first hospitalisation)</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.56</b> <br/>(0.11 to 59.75) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors</b> <br/>Follow‐up at 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraventricular haemorrhage grade III and IV</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.56</b> <br/>(0.11 to 59.75) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death (all causes) during the first hospitalisation</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>91 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/>(1 to 306) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.17</b> <br/>(0.01 to 3.37) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurosensory disability in survivors</b> <br/>Follow‐up at &gt; 1 year </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>NICU:</b> neonatal intensive care unit; <b>PMA:</b> postmenstrual age; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for inconsistency (single small study so not able to be assessed) and one level for imprecision (wide confidence intervals).<br/><sup>b</sup> Downgraded one level for inconsistency (single small study so not able to be assessed) and two levels for imprecision (wide confidence intervals and few events). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD008309-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants with or at risk of respiratory distress syndrome<br/><b>Settings:</b> NICU<br/><b>Intervention:</b> S‐LMA </p> <p><b>Comparator:</b> no surfactant administration </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With nCPAP and no surfactant administration</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With S‐LMA</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or bronchopulmonary dysplasia</b> <br/>Follow‐up at 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>200 per 1000</b> <br/>(103 to 390) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.65</b> <br/>(0.85 to 3.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mechanical ventilation at any time</b> </p> <p>At any time to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>561 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>320 per 1000</b> <br/>(213 to 477) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.57</b> <br/>(0.38 to 0.85) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pulmonary air leak, any (during first hospitalisation)</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b> <br/>(28 to 228) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.65</b> <br/>(0.23 to 1.88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors</b> <br/>Follow‐up: 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>200 per 1000</b> <br/>(103 to 390) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.65</b> <br/>(0.85 to 3.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraventricular haemorrhage grade III and IV</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death (all causes) during the first hospitalisation</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurosensory disability in survivors</b> <br/>Follow‐up at &gt; 1 year </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>nCPAP:</b> nasal continuous positive airway pressure; <b>NICU:</b> neonatal intensive care unit; <b>PMA:</b> postmenstrual age; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for inconsistency (moderate heterogeneity) and one level for imprecision (wide confidence intervals).<br/><sup>b</sup> Downgraded one level for imprecision (wide confidence intervals).<br/><sup>c</sup> Downgraded two levels for severe imprecision (wide confidence intervals and few events).<br/><sup>d</sup> Downgraded one level for inconsistency (single small study so not able to be assessed) and two levels for imprecision (wide confidence intervals and few events). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD008309-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD008309-sec-0009"></div> <section id="CD008309-sec-0010"> <h3 class="title" id="CD008309-sec-0010">Description of the condition</h3> <p>Respiratory distress syndrome (RDS) results from pulmonary surfactant deficiency and is an important cause of morbidity and mortality in preterm infants. Randomised controlled trials (RCTs) and meta‐analyses have demonstrated the efficacy of surfactant therapy in both prevention and treatment of RDS. A wide variety of surfactant preparations have been studied. These include synthetic surfactants ( <a href="./references#CD008309-bbs2-0083" title="SollRF . Synthetic surfactant for respiratory distress syndrome in preterm infants . Cochrane Database of Systematic Reviews2000 , Issue 2 . Art. No: CD001149. [DOI: 10.1002/14651858.CD001149 ] ">Soll 2000</a> ; <a href="./references#CD008309-bbs2-0086" title="SollR , ÖzekE . Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2010 , Issue 1 . Art. No: CD001079. [DOI: 10.1002/14651858.CD001079.pub2 ] ">Soll 2010</a> ), and surfactants derived from animal sources (natural surfactants) ( <a href="./references#CD008309-bbs2-0080" title="SegerN , SollR . Animal derived surfactant extract for treatment of respiratory distress syndrome . Cochrane Database of Systematic Reviews2009 , Issue 2 . Art. No: CD007836. [DOI: 10.1002/14651858.CD007836 ] ">Seger 2009</a> ; <a href="./references#CD008309-bbs2-0084" title="SollRF . Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2002 , Issue 1 . Art. No: CD000511. [DOI: 10.1002/14651858.CD000511 ] ">Soll 2002</a> ). Although both synthetic and animal‐derived surfactant preparations are effective ( <a href="./references#CD008309-bbs2-0080" title="SegerN , SollR . Animal derived surfactant extract for treatment of respiratory distress syndrome . Cochrane Database of Systematic Reviews2009 , Issue 2 . Art. No: CD007836. [DOI: 10.1002/14651858.CD007836 ] ">Seger 2009</a> ; <a href="./references#CD008309-bbs2-0083" title="SollRF . Synthetic surfactant for respiratory distress syndrome in preterm infants . Cochrane Database of Systematic Reviews2000 , Issue 2 . Art. No: CD001149. [DOI: 10.1002/14651858.CD001149 ] ">Soll 2000</a> ; <a href="./references#CD008309-bbs2-0084" title="SollRF . Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2002 , Issue 1 . Art. No: CD000511. [DOI: 10.1002/14651858.CD000511 ] ">Soll 2002</a> ; <a href="./references#CD008309-bbs2-0086" title="SollR , ÖzekE . Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2010 , Issue 1 . Art. No: CD001079. [DOI: 10.1002/14651858.CD001079.pub2 ] ">Soll 2010</a> ), clinical trials suggest that animal‐derived surfactants may be more effective ( <a href="./references#CD008309-bbs2-0031" title="ArdellS , PfisterRH , SollR . Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome . Cochrane Database of Systematic Reviews2015 , Issue 8 . Art. No: CD000144. [DOI: 10.1002/14651858.CD000144.pub3 ] ">Ardell 2015</a> ), than protein‐free synthetic surfactants ( <a href="./references#CD008309-bbs2-0088" title="TooleyWH , ClementsJA , MuramatsuK , BrownCL , SchlueterMA . Lung function in prematurely delivered rabbits treated with a synthetic surfactant . American Review of Respiratory Disease1987 ; 136 ( 3 ): 651-6 . [PMID: 3307569 ] ">Tooley 1987</a> ). Furthermore, clinical trials have shown that prophylactic surfactants ( <a href="./references#CD008309-bbs2-0083" title="SollRF . Synthetic surfactant for respiratory distress syndrome in preterm infants . Cochrane Database of Systematic Reviews2000 , Issue 2 . Art. No: CD001149. [DOI: 10.1002/14651858.CD001149 ] ">Soll 2000</a> ; <a href="./references#CD008309-bbs2-0084" title="SollRF . Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2002 , Issue 1 . Art. No: CD000511. [DOI: 10.1002/14651858.CD000511 ] ">Soll 2002</a> ; <a href="./references#CD008309-bbs2-0086" title="SollR , ÖzekE . Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2010 , Issue 1 . Art. No: CD001079. [DOI: 10.1002/14651858.CD001079.pub2 ] ">Soll 2010</a> ), and early surfactants ( <a href="./references#CD008309-bbs2-0087" title="StevensTP , BlennowM , MyersEW , SollR . Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome . Cochrane Database of Systematic Reviews2007 , Issue 4 . Art. No: CD003063. [DOI: 10.1002/14651858.CD003063.pub3 ] ">Stevens 2007</a> ), are superior to the selective use of surfactants in preventing morbidity and mortality in preterm infants. They also suggest that a multiple‐dose strategy is superior to a single‐dose strategy ( <a href="./references#CD008309-bbs2-0085" title="SollR , ÖzekE . Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome . Cochrane Database of Systematic Reviews2009 , Issue 1 . Art. No: CD000141. [DOI: 10.1002/14651858.CD000141.pub2 ] ">Soll 2009</a> ). Protein‐containing synthetic surfactants have also been successfully tested ( <a href="./references#CD008309-bbs2-0074" title="PfisterRH , SollR , WiswellTE . Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome . Cochrane Database of Systematic Reviews2007 , Issue 4 . Art. No: CD006069. [DOI: 10.1002/14651858.CD006069.pub3 ] ">Pfister 2007</a> ), although these preparations are not currently available for clinical use. </p> <p>However, despite the benefits of surfactants, many infants develop bronchopulmonary dysplasia (BPD) and chronic lung disease (CLD). Although the aetiology of CLD in preterm infants is multifactorial ( <a href="./references#CD008309-bbs2-0028" title="AllenJ , ZwerdlingR , GaultierC , GeggelR , GreenoughA , KleinmanR , et al, American Thoracic Society . Statement on the care of the child with chronic lung disease of infancy and childhood . American Journal of Respiratory and Critical Care Medicine2003 ; 168 ( 3 ): 356-96 . [PMID: 12888611 ] ">Allen 2003</a> ), ventilator‐induced lung injury (VILI) remains one of the main implicated risk factors ( <a href="./references#CD008309-bbs2-0038" title="ClarkRH , SlutskyAS , GerstmannDR . Lung protective strategies of ventilation in the neonate: what are they?Pediatrics2000 ; 105 ( 1 Pt 1 ): 112-4 . [PMID: 10617711 ] ">Clark 2000</a> ; <a href="./references#CD008309-bbs2-0039" title="CoalsonJJ , WinterVT , Siler-KhodrT , YoderBA . Neonatal chronic lung disease in extremely immature baboons . American Journal of Respiratory and Critical Care Medicine1999 ; 160 ( 4 ): 1333-6 . [PMID: 10508826 ] ">Coalson 1999</a> ). Only a few resuscitative positive pressure ventilation (PPV) breaths may result in VILI ( <a href="./references#CD008309-bbs2-0034" title="BjörklundLJ , IngimarssonJ , CurstedtT , JohnJ , RobertsonB , WernerO , et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs . Pediatric Research1997 ; 42 ( 3 ): 348-55 . [PMID: 9284276 ] ">Björklund 1997</a> ; <a href="./references#CD008309-bbs2-0047" title="FleckonoeSJ , CrossleyKJ , LaneMA , AllisonBJ , MorleyCJ , HooperSB . The effects of mechanical ventilation on airway epithelium in near term and very preterm sheep [Abstract] . Journal of Paediatrics and Child Health2008 ; 44 : A42.">Fleckonoe 2008</a> ; <a href="./references#CD008309-bbs2-0050" title="GrossmannG , NilssonR , RobertsonB . Scanning electron microscopy of epithelial lesions induced by artificial ventilation of the immature neonatal lung; the prophylactic effect of surfactant replacement . European Journal of Pediatrics1986 ; 145 ( 5 ): 361-7 . [PMID: 3641719 ] ">Grossmann 1986</a> ; <a href="./references#CD008309-bbs2-0070" title="O'ReillyM , HooperSB , AllisonBJ , SnibsonK , HardingR , SozoF . Airway remodelling and pulmonary inflammation in a model of ventilator-induced injury of the very preterm lung [Abstract] . Journal of Paediatrics and Child Health2008 ; 44 : A63.">O'Reilly 2008</a> ). </p> <p>Both surfactant prophylaxis and therapy require endotracheal intubation to facilitate surfactant administration. Although surfactant is an established effective intervention for either prevention or treatment of RDS ( <a href="./references#CD008309-bbs2-0080" title="SegerN , SollR . Animal derived surfactant extract for treatment of respiratory distress syndrome . Cochrane Database of Systematic Reviews2009 , Issue 2 . Art. No: CD007836. [DOI: 10.1002/14651858.CD007836 ] ">Seger 2009</a> ; <a href="./references#CD008309-bbs2-0084" title="SollRF . Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2002 , Issue 1 . Art. No: CD000511. [DOI: 10.1002/14651858.CD000511 ] ">Soll 2002</a> ; <a href="./references#CD008309-bbs2-0085" title="SollR , ÖzekE . Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome . Cochrane Database of Systematic Reviews2009 , Issue 1 . Art. No: CD000141. [DOI: 10.1002/14651858.CD000141.pub2 ] ">Soll 2009</a> ; <a href="./references#CD008309-bbs2-0086" title="SollR , ÖzekE . Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2010 , Issue 1 . Art. No: CD001079. [DOI: 10.1002/14651858.CD001079.pub2 ] ">Soll 2010</a> ; <a href="./references#CD008309-bbs2-0087" title="StevensTP , BlennowM , MyersEW , SollR . Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome . Cochrane Database of Systematic Reviews2007 , Issue 4 . Art. No: CD003063. [DOI: 10.1002/14651858.CD003063.pub3 ] ">Stevens 2007</a> ), endotracheal intubation and PPV, which follow, have adverse effects. </p> <p>Endotracheal intubation is a potentially traumatic procedure often performed without optimal pain management ( <a href="./references#CD008309-bbs2-0078" title="SarkarS , SchumacherRE , BaumgartS , DonnSM . Are newborns receiving premedication before elective intubation?Journal of Perinatology2006 ; 26 ( 5 ): 286-9 . [PMID: 16598295 ] ">Sarkar 2006</a> ). It may be accompanied by significant haemodynamic instability, including hypoxia, bradycardia, blood pressure fluctuations and increased intracranial pressure ( <a href="./references#CD008309-bbs2-0048" title="GhantaS , Abdel-LatifME , LuiK , RavindranathanH , AwadA , OeiJ . Propofol compared with the morphine, atropine, and suxamethonium regimen as induction agents for neonatal endotracheal intubation: a randomized, controlled trial . Pediatrics2007 ; 119 ( 6 ): e1248-55 . [PMID: 17485450 ] ">Ghanta 2007</a> ; <a href="./references#CD008309-bbs2-0068" title="MarshallT , DeederR , PaiS , BerkowitzGP , AustinTL . Physiologic changes associated with endotracheal intubation in preterm infants . Critical Care Medicine1984 ; 12 ( 6 ): 501-3 . [PMID: 6723333 ] ">Marshall 1984</a> ). Intubation is inevitably associated with colonisation of the trachea, retained secretions resulting in collapse, differential aeration and high airflow resistance resulting in increased work of breathing, potentially leading to nosocomial pneumonia and sepsis ( <a href="./references#CD008309-bbs2-0030" title="AlyH , BadawyM , El-KholyA , NabilR , MohamedA . Randomized, controlled trial on tracheal colonization of ventilated infants: can gravity prevent ventilator-associated pneumonia?Pediatrics2008 ; 122 ( 4 ): 770-4 . [PMID: 18829800 ] ">Aly 2008</a> ; <a href="./references#CD008309-bbs2-0097" title="YoungKC , Del MoralT , ClaureN , VanbuskirkS , BancalariE . The association between early tracheal colonization and bronchopulmonary dysplasia . Journal of Perinatology2005 ; 25 ( 6 ): 403-7 . [PMID: 15843814 ] ">Young 2005</a> ). Intubation is associated with an inflammatory process which can lead to lung injury and BPD ( <a href="./references#CD008309-bbs2-0097" title="YoungKC , Del MoralT , ClaureN , VanbuskirkS , BancalariE . The association between early tracheal colonization and bronchopulmonary dysplasia . Journal of Perinatology2005 ; 25 ( 6 ): 403-7 . [PMID: 15843814 ] ">Young 2005</a> ). Current evidence suggests that PPV of immature, surfactant‐deficient lungs is harmful and may increase the likelihood of the development of BPD ( <a href="./references#CD008309-bbs2-0034" title="BjörklundLJ , IngimarssonJ , CurstedtT , JohnJ , RobertsonB , WernerO , et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs . Pediatric Research1997 ; 42 ( 3 ): 348-55 . [PMID: 9284276 ] ">Björklund 1997</a> ; <a href="./references#CD008309-bbs2-0090" title="vanMarterLJ , AllredEN , PaganoM , SanockaU , ParadR , MooreM , et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network . Pediatrics2000 ; 105 ( 6 ): 1194-201 . [PMID: 10835057 ] ">van Marter 2000</a> ). Björklund demonstrated that resuscitation of surfactant‐deficient immature lambs with as few as six breaths damages the lungs and blunts the therapeutic effect of subsequent surfactant replacement ( <a href="./references#CD008309-bbs2-0034" title="BjörklundLJ , IngimarssonJ , CurstedtT , JohnJ , RobertsonB , WernerO , et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs . Pediatric Research1997 ; 42 ( 3 ): 348-55 . [PMID: 9284276 ] ">Björklund 1997</a> ). <a href="./references#CD008309-bbs2-0050" title="GrossmannG , NilssonR , RobertsonB . Scanning electron microscopy of epithelial lesions induced by artificial ventilation of the immature neonatal lung; the prophylactic effect of surfactant replacement . European Journal of Pediatrics1986 ; 145 ( 5 ): 361-7 . [PMID: 3641719 ] ">Grossmann 1986</a> showed similar results. <a href="./references#CD008309-bbs2-0047" title="FleckonoeSJ , CrossleyKJ , LaneMA , AllisonBJ , MorleyCJ , HooperSB . The effects of mechanical ventilation on airway epithelium in near term and very preterm sheep [Abstract] . Journal of Paediatrics and Child Health2008 ; 44 : A42.">Fleckonoe 2008</a> demonstrated that just six hours of ventilation is enough to cause marked airway epithelial injury in very preterm and near‐term foetal sheep. <a href="./references#CD008309-bbs2-0070" title="O'ReillyM , HooperSB , AllisonBJ , SnibsonK , HardingR , SozoF . Airway remodelling and pulmonary inflammation in a model of ventilator-induced injury of the very preterm lung [Abstract] . Journal of Paediatrics and Child Health2008 ; 44 : A63.">O'Reilly 2008</a> reported that ventilator‐induced injury extends to involve the conducting airways. </p> <p>One approach to surfactant administration is the InSurE (INtubation‐SURfactant‐Extubation) technique pioneered by Victorin ( <a href="./references#CD008309-bbs2-0093" title="VictorinLH , DeverajanLV , CurstedtT , RobertsonB . Surfactant replacement in spontaneously breathing babies with hyaline membrane disease–a pilot study . Biology of the Neonate1990 ; 58 ( 3 ): 121-6 . [PMID: 2279046 ] ">Victorin 1990</a> ), and Verder ( <a href="./references#CD008309-bbs2-0092" title="VerderH , RobertsonB , GreisenG , EbbesenF , AlbertsenP , LundstromK , et al, Danish-Swedish Multicenter Study Group . Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group . New England Journal of Medicine1994 ; 331 ( 16 ): 1051-5 . [PMID: 8090164 ] ">Verder 1994</a> ). Evidence showed that early surfactant replacement therapy with prompt extubation to nasal continuous positive airway pressure (nCPAP) is associated with less need for mechanical ventilation, lower incidence of BPD and fewer air leak syndromes when compared with later selective surfactant replacement and continued mechanical ventilation with extubation from low ventilator support ( <a href="./references#CD008309-bbs2-0087" title="StevensTP , BlennowM , MyersEW , SollR . Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome . Cochrane Database of Systematic Reviews2007 , Issue 4 . Art. No: CD003063. [DOI: 10.1002/14651858.CD003063.pub3 ] ">Stevens 2007</a> ). However, the limited data also showed the InSurE procedure to be associated with a trend for decreased cerebral oxygenation, higher cerebral oxygen extraction and decreased electrical brain activity ( <a href="./references#CD008309-bbs2-0052" title="Hellstrom-WestasL , BellAH , SkovL , GreisenG , SvenningsenNW . Cerebroelectrical depression following surfactant treatment in preterm neonates . Pediatrics1992 ; 89 ( 4 Pt 1 ): 643-7 . [PMID: 1557244 ] ">Hellstrom‐Westas 1992</a> ; <a href="./references#CD008309-bbs2-0089" title='vande BergE , LemmersPMA , ToetMC , KlaessensJ , Van BelF . The effect of the "InSurE" procedure on cerebral oxygenation and electrical brain activity of the preterm infant . Archives of Disease in Childhood Fetal and Neonatal Edition2010 ; 95 ( 1 ): F53-8 . [DOI: 10.1136/adc.2008.156414 ] [PMID: 19679893 ] '>van de Berg 2010</a> ). The InSurE procedure may need to be repeated if the first dose of surfactant was not sufficiently effective ( <a href="./references#CD008309-bbs2-0035" title="BohlinK , GudmundsdottirT , Katz-SalamonM , JonssonB , BlennowM . Implementation of surfactant treatment during continuous positive airway pressure . Journal of Perinatology2007 ; 27 ( 7 ): 422-7 . [PMID: 17476269 ] ">Bohlin 2007</a> ), leading to an additional risk of brain damage. </p> <p>The main strategy used to avoid endotracheal intubation and PPV in premature infants is the application of nCPAP, or continuous distending pressure (CDP), immediately following birth ( <a href="./references#CD008309-bbs2-0055" title="HoJJ , SubramaniamP , DavisPG . Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants . Cochrane Database of Systematic Reviews2020 , Issue 10 . Art. No: CD002271. [DOI: 10.1002/14651858.CD002271.pub3 ] ">Ho 2020a</a> ; <a href="./references#CD008309-bbs2-0056" title="HoJJ , SubramaniamP , SivakaanthanA , DavisPG . Early versus delayed continuous positive airway pressure (CPAP) for respiratory distress in preterm infants . Cochrane Database of Systematic Reviews2020 , Issue 10 . Art. No: CD002975. [DOI: 10.1002/14651858.CD002975.pub2 ] ">Ho 2020b</a> ; <a href="./references#CD008309-bbs2-0059" title="KamperJ . Early nasal continuous positive airway pressure and minimal handling in the treatment of very-low-birthweight infants . Biology of the Neonate1999 ; 76 ( Suppl 1 ): 22-8 . [PMID: 10393390 ] ">Kamper 1999</a> ). Studies have suggested that CDP may lead to less CLD when compared to elective intubation, surfactant and PPV ( <a href="./references#CD008309-bbs2-0029" title="AlyHZ . Nasal prongs continuous positive airway pressure: a simple yet powerful tool . Pediatrics2001 ; 108 ( 3 ): 759-61 . [PMID: 11533346 ] ">Aly 2001</a> ; <a href="./references#CD008309-bbs2-0041" title="De KlerkAM , De KlerkRK . Use of continuous positive airway pressure in preterm infants: comments and experience from New Zealand . Pediatrics2001 ; 108 ( 3 ): 761-2 . [PMID: 11533347 ] ">De Klerk 2001</a> ). Similarly, nasal intermittent positive pressure ventilation (nIPPV) has shown a decreased need for intubation and mechanical ventilation. It also reduces the frequency of apnoea and the incidence of CLD without an increase in adverse effects ( <a href="./references#CD008309-bbs2-0065" title="LemyreB , DavisPG , De PaoliAG . Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity . Cochrane Database of Systematic Reviews2002 , Issue 1 . Art. No: CD002272. [DOI: 10.1002/14651858.CD002272 ] ">Lemyre 2002</a> ; <a href="./references#CD008309-bbs2-0066" title="LemyreB , DavisPG , De PaoliAG , KirpalaniH . Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation . Cochrane Database of Systematic Reviews2017 , Issue 2 . Art. No: CD003212. [DOI: 10.1002/14651858.CD003212.pub3 ] ">Lemyre 2017</a> ). Although CDP and nIPPV strategies avoid endotracheal intubation and PPV, they preclude surfactant administration, a standard and proven treatment for RDS. Furthermore, CDP, nIPPV and InSurE may fail in 25% to 50% of preterm infants ( <a href="./references#CD008309-bbs2-0046" title="FinerNN , CarloWA , WalshMC , RichW , GantzMG , LaptookAR , et al, SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network . Early CPAP versus surfactant in extremely preterm infants . New England Journal of Medicine2010 ; 362 ( 21 ): 1970-9 . [PMID: 20472939 ] ">Finer 2010</a> ; <a href="./references#CD008309-bbs2-0064" title="KugelmanA , FeferkornI , RiskinA , ChistyakovI , KaufmanB , BaderD . Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study . Journal of Pediatrics2007 ; 150 ( 5 ): 521-6 . [PMID: 17452229 ] ">Kugelman 2007</a> ; <a href="./references#CD008309-bbs2-0069" title="MorleyCJ , DavisPG , DoyleLW , BrionLP , HascoetJM , CarlinJB , COIN Trial Investigators . Nasal CPAP or intubation at birth for very preterm infants . New England Journal of Medicine2008 ; 358 ( 7 ): 700-8 . [PMID: 18272893 ] ">Morley 2008</a> ; <a href="./references#CD008309-bbs2-0076" title="ReiningerA , KhalakR , KendigJW , RyanRM , StevensTP , ReubensL , et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial . Journal of Perinatology2005 ; 25 ( 11 ): 703-8 . [PMID: 16163369 ] ">Reininger 2005</a> ), resulting in late surfactant administration, a strategy proven to be inferior ( <a href="./references#CD008309-bbs2-0086" title="SollR , ÖzekE . Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants . Cochrane Database of Systematic Reviews2010 , Issue 1 . Art. No: CD001079. [DOI: 10.1002/14651858.CD001079.pub2 ] ">Soll 2010</a> ; <a href="./references#CD008309-bbs2-0087" title="StevensTP , BlennowM , MyersEW , SollR . Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome . Cochrane Database of Systematic Reviews2007 , Issue 4 . Art. No: CD003063. [DOI: 10.1002/14651858.CD003063.pub3 ] ">Stevens 2007</a> ). </p> </section> <section id="CD008309-sec-0011"> <h3 class="title" id="CD008309-sec-0011">Description of the intervention</h3> <p>Non‐invasive or minimally invasive methods of surfactant administration may potentially reduce the need for intubation and endotracheal surfactant administration. Possible strategies include: </p> <p> <ol id="CD008309-list-0001"> <li> <p>intra‐amniotic instillation ( <a href="./references#CD008309-bbs2-0023" title="Abdel-LatifME , OsbornDA , ChallisD . Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns . Cochrane Database of Systematic Reviews2010 , Issue 1 . Art. No: CD007916. [DOI: 10.1002/14651858.CD007916.pub2 ] ">Abdel‐Latif 2010</a> ; <a href="./references#CD008309-bbs2-0073" title="PetrikovskyBM , LysikiewiczA , MarkinLB , SlomkoZ . In utero surfactant administration to preterm human fetuses using endoscopy . Fetal Diagnosis and Therapy1995 ; 10 ( 2 ): 127-30 . [DOI: 10.1159/000264218 ] [PMID: 7794513 ] ">Petrikovsky 1995</a> ); </p> </li> <li> <p>pharyngeal instillation ( <a href="./references#CD008309-bbs2-0024" title="Abdel-LatifME , OsbornDA . Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome . Cochrane Database of Systematic Reviews2011 , Issue 3 . Art. No: CD008311. [DOI: 10.1002/14651858.CD008311.pub2 ] ">Abdel‐Latif 2011a</a> ; <a href="./references#CD008309-bbs2-0060" title="KattwinkelJ , RobinsonM , BloomB , DelmoreP , FergusonJE . Technique for intrapartum administration of surfactant without requirement for an endotracheal tube . Journal of Perinatology2004 ; 24 ( 6 ): 360–5 . [PMID: 15085166 ] ">Kattwinkel 2004</a> ); </p> </li> <li> <p>administration via a thin endotracheal catheter ( <a href="./references#CD008309-bbs2-0026" title="Abdel-LatifME , WheelerKI , DavisPG , De PaoliAG , DargavillePA . Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome . Cochrane Database of Systematic Reviews2021 , Issue 5 . Art. No: CD011672. [DOI: 10.1002/14651858.CD011672.pub2 ] ">Abdel‐Latif 2021</a> ; <a href="./references#CD008309-bbs2-0063" title="KribsA , PillekampF , HűsnelerC , VierzigA , RothB . Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age &lt;/=27 weeks) . Paediatric Anaesthesia2007 ; 17 ( 4 ): 364-9 . [PMID: 17359406 ] ">Kribs 2007</a> ); </p> </li> <li> <p>nebulised surfactant administration in spontaneously breathing infants ( <a href="./references#CD008309-bbs2-0025" title="Abdel-LatifME , OsbornDA . Nebulised surfactant in preterm infants with or at risk of respiratory distress syndrome . Cochrane Database of Systematic Reviews2012 , Issue 10 . Art. No: CD008310. [DOI: 10.1002/14651858.CD008310.pub2 ] ">Abdel‐Latif 2012</a> ; <a href="./references#CD008309-bbs2-0058" title="JorchG , HartlH , RothB , KribsA , GortnerL , SchaibleT , et al. Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants . Pediatric Pulmonology1997 ; 24 ( 3 ): 222-4 . [PMID: 9330420 ] ">Jorch 1997</a> ); </p> </li> <li> <p>administration via laryngeal mask airway (LMA) ( <a href="./references#CD008309-bbs2-0100" title="Abdel-LatifME , OsbornDA . Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome . Cochrane Database of Systematic Reviews2011 , Issue 7 . Art. No: CD008309. [DOI: 10.1002/14651858.CD008309.pub2 ] ">Abdel‐Latif 2011b</a> ; <a href="./references#CD008309-bbs2-0017" title="TrevisanutoD , GrazzinaN , FerrareseP , MicaglioM , VergheseC , ZanardoV . Laryngeal mask airway as a delivery channel for administration of surfactant in preterm infants with RDS . Biology of the Neonate2005 ; 87 ( 4 ): 217-20 . [DOI: 10.1159/000083370 ] [PMID: 15650304 ] TrevisanutoD , GrazzinaN , MicaglioM , FerrareseP , ZanardoV . Laryngeal mask airway as a delivery channel for administration of surfactant in preterm infants with RDS [Abstract 2920] . In: Proceedings of the American Pediatric Society / Society for Pediatric Research . 2004 . ">Trevisanuto 2005</a> ). </p> </li> </ol> </p> <p>One Cochrane review found that LMA can achieve adequate ventilation during neonatal resuscitation in a time frame consistent with current guidelines ( <a href="./references#CD008309-bbs2-0075" title="QureshiMJ , KumarM . Laryngeal mask airway versus bag-mask ventilation or endotracheal intubation for neonatal resuscitation . Cochrane Database of Systematic Reviews2018 , Issue 3 . Art. No: CD003314. [DOI: 10.1002/14651858.CD003314.pub3 ] ">Qureshi 2018</a> ), and one small RCT found no clinically significant difference between the LMA and endotracheal tube (ETT) when bag and mask ventilation was unsuccessful. </p> <p>This review focused on LMA surfactant administration (S‐LMA). An example of a protocol for S‐LMA involves positioning the LMA, followed by instilling the surfactant in two to four aliquots via the LMA ( <a href="./references#CD008309-bbs2-0017" title="TrevisanutoD , GrazzinaN , FerrareseP , MicaglioM , VergheseC , ZanardoV . Laryngeal mask airway as a delivery channel for administration of surfactant in preterm infants with RDS . Biology of the Neonate2005 ; 87 ( 4 ): 217-20 . [DOI: 10.1159/000083370 ] [PMID: 15650304 ] TrevisanutoD , GrazzinaN , MicaglioM , FerrareseP , ZanardoV . Laryngeal mask airway as a delivery channel for administration of surfactant in preterm infants with RDS [Abstract 2920] . In: Proceedings of the American Pediatric Society / Society for Pediatric Research . 2004 . ">Trevisanuto 2005</a> ). Each aliquot follows a brief PPV until the surfactant disappears from the LMA. Once the surfactant aliquots are complete, the LMA is removed, and the baby is placed on CDP and managed by standard protocol. S‐LMA is also known as surfactant administration through laryngeal or supraglottic airways (SALSA) ( <a href="./references#CD008309-bbs2-0019" title="ZapataHA , FortP , RobertsKD , KaluarachchiDC , GuthrieSO . Surfactant administration through laryngeal or supraglottic airways (SALSA): a viable method for low-income and middle-income countries . Frontiers in Pediatrics2022 ; 10 : 853831 . [DOI: 10.3389/fped.2022.853831 ] [PMID: 35372140 ] ">Zapata 2022</a> ), and Catheter and Laryngeal Mask Endotracheal Surfactant Therapy (CALMEST) ( <a href="./references#CD008309-bbs2-0091" title="VannozziI , CiantelliM , MoscuzzaF , ScaramuzzoRT , PanizzaD , SigaliE , et al. Catheter and laryngeal mask endotracheal surfactant therapy: the CALMEST approach as a novel MIST technique . Journal of Maternal-Fetal &amp; Neonatal Medicine2017 ; 30 ( 19 ): 2375-7 . [DOI: 10.1080/14767058.2016.1248938 ] [PMID: 27780385 ] ">Vannozzi 2017</a> ). </p> <p>The LMA is a supraglottic device consisting of a curved plastic tube with an elliptical inflatable mask inserted blindly into the patient's posterior pharynx. The mask may be inflated in the hypopharynx creating an airtight seal around the upper oesophagus. It offers the possibility of rapid establishment of adequate ventilation and access to the airway without tracheal intubation, even when performed by relatively inexperienced personnel. Different types of LMA are available (i‐Gel, ProSeal, PA <sub>x</sub> press, CobraPLA, classic, Supreme, Ultimate, PRO‐Breathe, Unique, air‐Qsp and AuroOnce). Possible adverse effects of S‐LMA include hypoxia and bradycardia during administration, laryngospasm and malposition of the LMA, with a potential impact on the newborn. </p> <p>The practice of awake LMA insertion without premedication use remains heterogeneous. One evidence‐based statement from the French Society of Neonatology (SFN) recommended atropine use before LMA insertion, except in an immediate life‐threatening situation ( <a href="./references#CD008309-bbs2-0044" title="DurrmeyerX , Walter-NicoletE , ChollatC , ChabernaudJL , BaroisJ , Chary TardyAC , et al. Premedication before laryngoscopy in neonates: evidence based statement from the French Society of Neonatology (SFN) . Frontiers in Pediatrics2023 ; 10 : 1075184 . [DOI: 10.3389/fped.2022.1075184 ] [PMID: 36683794 ] ">Durrmeyer 2023</a> ). There were no specific data regarding the use and types of premedication ( <a href="./references#CD008309-bbs2-0044" title="DurrmeyerX , Walter-NicoletE , ChollatC , ChabernaudJL , BaroisJ , Chary TardyAC , et al. Premedication before laryngoscopy in neonates: evidence based statement from the French Society of Neonatology (SFN) . Frontiers in Pediatrics2023 ; 10 : 1075184 . [DOI: 10.3389/fped.2022.1075184 ] [PMID: 36683794 ] ">Durrmeyer 2023</a> ). </p> </section> <section id="CD008309-sec-0012"> <h3 class="title" id="CD008309-sec-0012">How the intervention might work</h3> <p>S‐LMA is designed to avoid endotracheal intubation yet potentially offers the benefits of early surfactant administration. Combining this strategy with antenatal steroid administration and CDP may offer synergy to treat RDS, avoiding both endotracheal intubation and PPV associated with lung injury that may lead to BPD. In one small case series, delivering surfactant via LMA was feasible, with no complications reported ( <a href="./references#CD008309-bbs2-0011" title="BrimacombeJ , GandiniD , KellerC . The laryngeal mask airway for administration of surfactant in two neonates with respiratory distress syndrome . Paediatric Anaesthesia2004 ; 14 ( 2 ): 188-90 . [PMID: 14962337 ] ">Brimacombe 2004</a> ; <a href="./references#CD008309-bbs2-0017" title="TrevisanutoD , GrazzinaN , FerrareseP , MicaglioM , VergheseC , ZanardoV . Laryngeal mask airway as a delivery channel for administration of surfactant in preterm infants with RDS . Biology of the Neonate2005 ; 87 ( 4 ): 217-20 . [DOI: 10.1159/000083370 ] [PMID: 15650304 ] TrevisanutoD , GrazzinaN , MicaglioM , FerrareseP , ZanardoV . Laryngeal mask airway as a delivery channel for administration of surfactant in preterm infants with RDS [Abstract 2920] . In: Proceedings of the American Pediatric Society / Society for Pediatric Research . 2004 . ">Trevisanuto 2005</a> ). </p> </section> <section id="CD008309-sec-0013"> <h3 class="title" id="CD008309-sec-0013">Why it is important to do this review</h3> <p>Despite substantial advances in neonatal intensive care, CLD results in a significant health burden to infants born at less than 32 weeks' gestation who receive mechanical ventilation. CLD results in substantial neonatal and infant morbidities and health resource utilisation ( <a href="./references#CD008309-bbs2-0028" title="AllenJ , ZwerdlingR , GaultierC , GeggelR , GreenoughA , KleinmanR , et al, American Thoracic Society . Statement on the care of the child with chronic lung disease of infancy and childhood . American Journal of Respiratory and Critical Care Medicine2003 ; 168 ( 3 ): 356-96 . [PMID: 12888611 ] ">Allen 2003</a> ). CLD is associated with chronic respiratory difficulties ( <a href="./references#CD008309-bbs2-0043" title="DoyleLW , Victorian Infant Collaborative Study Group . Respiratory function at age 8–9 years in extremely low birthweight/very preterm children born in Victoria in 1991–1992 . Pediatric Pulmonology2006 ; 41 ( 6 ): 570-6 . [PMID: 16617453 ] ">Doyle 2006</a> ; <a href="./references#CD008309-bbs2-0061" title="KilbrideHW , GelattMC , SabathRJ . Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease . Journal of Pediatrics2003 ; 143 ( 4 ): 488-93 . [PMID: 14571227 ] ">Kilbride 2003</a> ); prolonged and recurrent hospitalisation ( <a href="./references#CD008309-bbs2-0037" title="ChyeJK , GrayPH . Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study . Journal of Paediatrics and Child Health1995 ; 31 ( 2 ): 105-11 . [PMID: 7794609 ] ">Chye 1995</a> ); neurodevelopmental disability including cerebral palsy, neurosensory and motor disability ( <a href="./references#CD008309-bbs2-0057" title="HughesCA , O'GormanLA , ShyrY , SchorkMA , BozynskiME , McCormickMC . Cognitive performance at school age of very low birth weight infants with bronchopulmonary dysplasia . Journal of Developmental and Behavioral Pediatrics1999 ; 20 ( 1 ): 1-8 . [PMID: 10071939 ] ">Hughes 1999</a> ; <a href="./references#CD008309-bbs2-0067" title="MajnemerA , RileyP , ShevellM , BirnbaumR , GreenstoneH , CoatesAL . Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors . Developmental Medicine and Child Neurology2000 ; 42 ( 1 ): 53-60 . [PMID: 10665976 ] ">Majnemer 2000</a> ; <a href="./references#CD008309-bbs2-0082" title="SkidmoreMD , RiversA , HackM . Increased risk of cerebral palsy among very low-birthweight infants with chronic lung disease . Developmental Medicine and Child Neurology1990 ; 32 ( 4 ): 325-32 . [PMID: 2332123 ] ">Skidmore 1990</a> ); and poor cognitive outcome ( <a href="./references#CD008309-bbs2-0057" title="HughesCA , O'GormanLA , ShyrY , SchorkMA , BozynskiME , McCormickMC . Cognitive performance at school age of very low birth weight infants with bronchopulmonary dysplasia . Journal of Developmental and Behavioral Pediatrics1999 ; 20 ( 1 ): 1-8 . [PMID: 10071939 ] ">Hughes 1999</a> ). CLD significantly impacts the daily life of families that persists beyond the neonatal period ( <a href="./references#CD008309-bbs2-0062" title="KorhonenP , KoivistoAM , IkonenS , LaippalaP , TammelaO . Very low birthweight, bronchopulmonary dysplasia and health in early childhood . Acta Paediatrica1999 ; 88 ( 12 ): 1385-91 . [PMID: 10626527 ] ">Korhonen 1999</a> ). S‐LMA has the potential benefit of avoiding VILI and BPD. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD008309-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD008309-sec-0014"></div> <p>To evaluate the benefits and harms of S‐LMA either as prophylaxis or treatment (rescue) compared to placebo, no treatment, or intratracheal surfactant administration via an endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) or extubate at standard criteria (S‐ETT) or via other less‐invasive surfactant administration (LISA) methods on morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome (RDS). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD008309-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD008309-sec-0015"></div> <section id="CD008309-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD008309-sec-0017"> <h4 class="title">Types of studies</h4> <p>We considered RCTs using randomisation or quasi‐randomisation of participants regardless of the allocation unit (individual or cluster) eligible for inclusion in this review. Published or unpublished studies were eligible for inclusion. </p> </section> <section id="CD008309-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included preterm infants (less than 37 weeks' gestation) with, or at risk for, RDS of any severity and any postnatal age. </p> </section> <section id="CD008309-sec-0019"> <h4 class="title">Types of interventions</h4> <section id="CD008309-sec-0020"> <h5 class="title">Intervention</h5> <p>Surfactant administration via laryngeal mask airway (S‐LMA) at any dose, using any surfactant (synthetic, animal‐derived or protein‐containing) and any type of LMA (Classic; ProSeal; i‐Gel; PA <sub>X</sub> press; CobraPLA) compared with placebo, no treatment, or intratracheally instilled surfactant via ETT or a minimally invasive method such as thin catheter surfactant. </p> <p>Where possible, we planned to perform separate comparisons for the following.</p> <p> <ol id="CD008309-list-0002"> <li> <p>Prophylactic surfactant defined as a treatment strategy in which the intent was to treat a preterm infant based on the risk of RDS (e.g. less than 27 weeks' gestational age (GA) or as defined by the study authors) within the first hour of life. </p> </li> <li> <p>Rescue surfactant defined as the treatment of an established disease (preterm infant less than 37 weeks' GA requiring respiratory support and having signs and symptoms of RDS). </p> </li> </ol> </p> </section> <section id="CD008309-sec-0021"> <h5 class="title">Comparisons</h5> <p>We categorised trials by intervention in the comparator (control) group as below.</p> <p> <ol id="CD008309-list-0003"> <li> <p>S‐LMA versus surfactant administration via invasive methods.</p> <ol id="CD008309-list-0004"> <li> <p>S‐LMA versus InSurE: for the controls, there was the intent to extubate soon after surfactant delivery ( <a href="./references#CD008309-bbs2-0051" title="HabermanB , ShankaranS , StevensonDK , PapileLA , StarkA , KoronesS , et al. Does surfactant and immediate extubation to nasal continuous positive airway pressure (CPAP) reduce use of mechanical ventilation?Pediatric Research2002 ; 51 ( 4 ): 349A4.">Haberman 2002</a> ), that is, the InSurE procedure ( <a href="./references#CD008309-bbs2-0076" title="ReiningerA , KhalakR , KendigJW , RyanRM , StevensTP , ReubensL , et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial . Journal of Perinatology2005 ; 25 ( 11 ): 703-8 . [PMID: 16163369 ] ">Reininger 2005</a> ; <a href="./references#CD008309-bbs2-0093" title="VictorinLH , DeverajanLV , CurstedtT , RobertsonB . Surfactant replacement in spontaneously breathing babies with hyaline membrane disease–a pilot study . Biology of the Neonate1990 ; 58 ( 3 ): 121-6 . [PMID: 2279046 ] ">Victorin 1990</a> ). </p> </li> <li> <p>S‐LMA versus S‐ETT: control infants remained intubated after surfactant delivery, with delayed extubation after a period of mechanical ventilation and after meeting standard extubation criteria. </p> </li> </ol> </li> <li> <p>S‐LMA versus LISA: infants in the control group received surfactant through less‐invasive methods such as thin catheter and continued on non‐invasive respiratory support (nCPAP, nIPPV, high flow (HF), variations thereof). </p> </li> <li> <p>S‐LMA versus no surfactant administration: infants in the control group continued non‐invasive respiratory support (nCPAP, nIPPV, HF, variations thereof) without surfactant administration. </p> </li> </ol> </p> </section> </section> <section id="CD008309-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We have underlined below the critical outcomes that we have graded and presented in the summary of findings tables. We included many outcomes to account for extremely preterm and borderline preterm infants. </p> <section id="CD008309-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008309-list-0005"> <li> <p>Death or bronchopulmonary dysplasia (BPD) (composite outcome), defined as the need for oxygen or respiratory support at 36 weeks' postmenstrual age (PMA) ( <a href="./references#CD008309-bbs2-0081" title="ShennanAT , DunnMS , OhlssonA , LennoxK , HoskinsEM . Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period . Pediatrics1988 ; 82 ( 4 ): 527-32 . [PMID: 3174313 ] ">Shennan 1988</a> ). </p> </li> </ol> </p> </section> <section id="CD008309-sec-0024"> <h5 class="title">Secondary outcomes</h5> <section id="CD008309-sec-0025"> <h6 class="title">Measures of the safety of the surfactant administration procedure</h6> <p> <ol id="CD008309-list-0006"> <li> <p>Failure to place laryngeal mask airway (LMA) or endotracheal tube (ETT) at the first attempt. </p> </li> <li> <p>Bradycardia during the intervention (heart rate less than 100 beats per minute (bpm) or as defined by study authors). </p> </li> <li> <p>Hypoxaemia during the intervention (oxygen saturation less than 80% or as defined by study authors). </p> </li> <li> <p>Apnoea (cessation of spontaneous breathing greater than 20 seconds) during the intervention.</p> </li> <li> <p>Surfactant reflux during the intervention.</p> </li> <li> <p>Postintervention gastric surfactant aspirated greater than 10% of surfactant dose.</p> </li> <li> <p>Postintervention intratracheal surfactant received.</p> </li> <li> <p>Number of doses of intratracheal surfactant received postintervention.</p> </li> </ol> </p> <section id="CD008309-sec-0026"> <p><b>For studies comparing laryngeal mask airway or other non‐invasive methods</b></p> <p> <ol id="CD008309-list-0007"> <li> <p>Need for positive pressure ventilation (PVV) during the intervention.</p> </li> <li> <p>Need for immediate intubation (within 15 minutes of intervention).</p> </li> </ol> </p> </section> </section> <section id="CD008309-sec-0027"> <h6 class="title">Measures of respiratory support</h6> <p> <ol id="CD008309-list-0008"> <li> <p>Mechanical ventilation within the first 72 hours of life.</p> </li> <li> <p>Mechanical ventilation within the first 72 hours or not ventilated but reached failure criteria. </p> </li> <li> <p>Mechanical ventilation at any time .</p> </li> <li> <p>Pulmonary air leak, any (during the first hospitalisation) .</p> </li> <li> <p>Pulmonary air leak requiring drainage (during the first hospitalisation).</p> </li> <li> <p>Duration of mechanical ventilation via an ETT (days; in survivors).</p> </li> <li> <p>Duration of any respiratory support (mechanical ventilation, nasal continuous positive airway pressure (nCPAP), high flow (HF)) (days; in survivors). </p> </li> <li> <p>Duration of oxygen therapy (days; in survivors).</p> </li> <li> <p>Postnatal systemic corticosteroid therapy for BPD prevention.</p> </li> </ol> </p> </section> <section id="CD008309-sec-0028"> <h6 class="title">Outcomes during hospitalisation</h6> <p> <ol id="CD008309-list-0009"> <li> <p>BPD (physiological definition), evaluated where necessary by a room‐air challenge at 36 weeks' PMA for infants with borderline oxygen requirements ( <a href="./references#CD008309-bbs2-0095" title="WalshMC , YaoQ , GettnerP , HaleE , CollinsM , HensmanA , et al, National Institute of Child Health and Human Development Neonatal Research Network . Impact of a physiologic definition on bronchopulmonary dysplasia rates . Pediatrics2004 ; 114 ( 5 ): 114 . [DOI: 10.1542/peds.2004-0204 ] [PMID: 15520112 ] ">Walsh 2004</a> ). </p> </li> <li> <p>BPD (clinical definition) among survivors to 36 weeks' PMA .</p> </li> <li> <p>Intraventricular haemorrhage (IVH), any grade ( <a href="./references#CD008309-bbs2-0071" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm . Journal of Pediatrics1978 ; 92 ( 4 ): 529-34 . [PMID: 305471 ] ">Papile 1978</a> ). </p> </li> <li> <p>IVH, grade III and IV ( <a href="./references#CD008309-bbs2-0071" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm . Journal of Pediatrics1978 ; 92 ( 4 ): 529-34 . [PMID: 305471 ] ">Papile 1978</a> ). </p> </li> <li> <p>Cystic periventricular leukomalacia (PVL).</p> </li> <li> <p>Patent ductus arteriosus (PDA) requiring medical therapy.</p> </li> <li> <p>Necrotising enterocolitis (NEC), modified Bell stage 2 or greater ( <a href="./references#CD008309-bbs2-0032" title="BellMJ , TernbergJL , FeiginRD , KeatingJP , MarshallR , BartonL , et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging . Annals of Surgery1978 ; 187 ( 1 ): 1-7 . [PMID: 413500 ] ">Bell 1978</a> ; <a href="./references#CD008309-bbs2-0094" title="WalshMC , KliegmanRM , FanaroffAA . Necrotizing enterocolitis: a practitioner's perspective . Pediatrics in Review1988 ; 9 ( 7 ): 219-26 . [PMID: 3141910 ] ">Walsh 1988</a> ). </p> </li> <li> <p>Spontaneous intestinal perforation.</p> </li> <li> <p>Retinopathy of prematurity (ROP), any grade.</p> </li> <li> <p>ROP, stage 3 or greater.</p> </li> <li> <p>Duration of hospitalisation (days).</p> </li> <li> <p>Neonatal death (all causes) during the first 28 days.</p> </li> <li> <p>Death (all causes) during the first hospitalisation .</p> </li> </ol> </p> </section> <section id="CD008309-sec-0029"> <h6 class="title">Postdischarge outcomes</h6> <p> <ol id="CD008309-list-0010"> <li> <p>Oxygen therapy at home.</p> </li> <li> <p>Number of hospital readmissions with respiratory illness in the first two years.</p> </li> <li> <p>Parent‐reported wheeze in the first two years.</p> </li> <li> <p>Bronchodilator use in the first two years.</p> </li> <li> <p>Neurosensory disability in survivors; measured beyond one‐year PMA and defined as any of </p> <ol id="CD008309-list-0011"> <li> <p>cerebral palsy by clinical examination or other means;</p> </li> <li> <p>developmental delay more than two standard deviations (SD) below the population mean on standardised testing; </p> </li> <li> <p>blindness (visual acuity less than 6/60);</p> </li> <li> <p>deafness (hearing impairment requiring amplification).</p> </li> </ol> </li> </ol> </p> </section> </section> </section> </section> <section id="CD008309-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD008309-sec-0031"> <h4 class="title">Electronic searches</h4> <p>Two review authors (AME and LB) searched the following databases on 1 December 2022 using the search strategies in the appendices. We applied no date or language limits. </p> <p> <ol id="CD008309-list-0012"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2022, Issue 11), in the Cochrane Library ( <a href="./appendices#CD008309-sec-0220">Appendix 1</a> ) </p> </li> <li> <p>Ovid MEDLINE(R) and Epub Ahead of Print, In‐Process, In‐Data‐Review &amp; Other Non‐Indexed Citations, Daily and Versions 1946 to 30 November 2022 ( <a href="./appendices#CD008309-sec-0221">Appendix 2</a> ) </p> </li> <li> <p>Embase via Ovid (from 1974) ( <a href="./appendices#CD008309-sec-0222">Appendix 3</a> ) </p> </li> <li> <p>CINAHL Plus EBSCOhost (from 1937) ( <a href="./appendices#CD008309-sec-0223">Appendix 4</a> ) </p> </li> <li> <p>Epistemonikos ( <a href="./appendices#CD008309-sec-0224">Appendix 5</a> ) </p> </li> <li> <p>Chinese language articles from <a href="http://caod.oriprobe.com" target="_blank">China/Asia On Demand (CAOD)</a> </p> </li> <li> <p>Trial registries ( <a href="./appendices#CD008309-sec-0225">Appendix 6</a> ) </p> <ol id="CD008309-list-0013"> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP, <a href="http://trialsearch.who.int/" target="_blank">trialsearch.who.int/</a> ). </p> </li> <li> <p>The US National Library of Medicine's ClinicalTrials.gov ( <a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a> ) </p> </li> <li> <p>ISRCTN Registry ( <a href="http://www.isrctn.com/" target="_blank">www.isrctn.com/</a> ) </p> </li> <li> <p>Australian New Zealand Clinical Trials Registry (ANZCTR; <a href="https://www.anzctr.org.au/" target="_blank">www.anzctr.org.au/</a> ) </p> </li> </ol> </li> </ol> </p> </section> <section id="CD008309-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We carried out additional searches as follows.</p> <p> <ol id="CD008309-list-0014"> <li> <p>Reference lists of articles selected for inclusion in this review to identify additional relevant articles. </p> </li> <li> <p>Abstracts of conferences from:</p> <ol id="CD008309-list-0015"> <li> <p>Proceedings of the Pediatric Academic Societies (American Pediatric Society, Society for Pediatric Research and European Society for Pediatric Research) from 1990 to 2022 from the journal <i>Pediatric Research</i> and Abstracts Online; </p> </li> <li> <p>Proceedings of the European Academy of Paediatric Societies (EAPS) (the European Society for Paediatric Research (ESPR), the European Academy of Paediatrics (EAP) and the European Society of Paediatric and Neonatal Intensive Care (ESPNIC)) from 2003 to 2022 from Abstracts Online; </p> </li> <li> <p>Proceedings of the Perinatal Society of Australia and New Zealand (PSANZ) from 1996 to 2022. </p> </li> </ol> </li> <li> <p>Personal communications with expert informants and authors of included studies.</p> </li> <li> <p>Pharmaceutical companies: we also contacted the companies that developed different types of surfactants for possible unpublished studies using their product. </p> </li> </ol> </p> </section> </section> <section id="CD008309-sec-0033"> <h3 class="title" id="CD008309-sec-0033">Data collection and analysis</h3> <p>We used the standardised review method of Cochrane Neonatal for conducting a systematic review ( <a href="http://neonatal.cochrane.org/en/index.html" target="_blank">neonatal.cochrane.org/en/index.html</a> ). We entered and cross‐checked data using Review Manager Web ( <a href="./references#CD008309-bbs2-0077" title="Review Manager Web (RevMan Web) . Version 4.12.0. The Cochrane Collaboration , 2022 . Available at revman.cochrane.org.">RevMan Web 2022</a> ). </p> <section id="CD008309-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MEA and DAO) independently reviewed the titles and abstracts of potentially relevant studies identified by the search strategy against the inclusion and exclusion criteria to assess eligibility for inclusion in this review. We used <a href="./references#CD008309-bbs2-0040" title="Covidence . Version accessed 3 December 2022 . Melbourne, Australia: Veritas Health Innovation , 2022 . Available at www.covidence.org.">Covidence 2022</a> to remove duplicates. At any point in the screening process, we resolved disagreements between review authors by discussion. We documented the reasons for excluding studies during the review of full‐texts in the <a href="./references#CD008309-sec-0244" title="">Characteristics of excluded studies</a> table. We collated multiple reports of the same study so that each study, rather than each report or reference, was the unit of interest in the review, and grouped related reports under a single study ID. We also provided any information we could obtain about ongoing studies in the <a href="./references#CD008309-sec-0245" title="">Characteristics of ongoing studies</a> table. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram ( <a href="#CD008309-fig-0001">Figure 1</a> ). </p> <div class="figure" id="CD008309-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram. Updated search December 2022." data-id="CD008309-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram. Updated search December 2022.</p> </div> </div> </div> </section> <section id="CD008309-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>One review author (MEA) extracted and entered the data into Review Manager Web ( <a href="./references#CD008309-bbs2-0077" title="Review Manager Web (RevMan Web) . Version 4.12.0. The Cochrane Collaboration , 2022 . Available at revman.cochrane.org.">RevMan Web 2022</a> ). A second review author (DAO) checked the data. We resolved disagreements through discussion. We contacted study investigators/authors for clarification in cases requiring additional data. </p> <p>We extracted the following characteristics from each included study in the <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> table and <a href="#CD008309-tbl-0004">Table 1</a> . </p> <div class="table" id="CD008309-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of characteristics of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Multicentre study/total number of infants recruited</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Country</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Birth weight (g) and gestational age (weeks)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Intervention group (LMA)</b><sup>a</sup> </p> <p><b>(LMA type and size)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Control group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Surfactant dose</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Sedation or analgesia</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Eligibility criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>S‐LMA group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control group</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 37 weeks' GA</p> <p>Birth weight ≥ 1200 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32.6 SD 2.3</p> <p>Mean 1970, SD 520 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32.4, SD 2.3</p> <p>Mean 1850, SD 496 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Classic</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>InSurE group single‐dose morphine 0.1 mg/kg.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Birth weight &gt; 1200 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA median 33+5/7 (IQR 31–34+6/7)</p> <p>Median 2001 (IQR 1670–2820) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA median 32 (IQR 31+3/7–35)</p> <p>Median 2130 (IQR 1799–2570) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>North America LMA</p> <p>Not stated.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nCPAP without surfactant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>nCPAP group no analgesia‐sedation.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28–35 weeks' GA</p> <p>Birth weight ≥ 1000 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 31 (range 28–34)</p> <p>Mean 1515 (range 1025–2295) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32 (range 28–35)</p> <p>Mean 1495 (range 1005–2515) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ProSeal</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ETT with extubation at standard criteria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>S‐ETT group remifentanil and midazolam bolus.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27–36 weeks' GA</p> <p>Birth weight &gt; 800 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA range 27–36</p> <p>Mean 1848 (range 810–3560) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA range 27–36</p> <p>Mean 1926 (range 1050–3288) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unique</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group atropine and no analgesia‐sedation.</p> <p>InSurE group atropine 0.01 mg/kg and remifentanil 2 μg/kg.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33–37 weeks' GA</p> <p>Birth weight ≥ 1200 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32.88, SD 1.32</p> <p>Mean 2078, SD 669 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 33.76, SD 2.12</p> <p>Mean 2198, SD 669 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hangzhou LMA</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>InSurE group fentanyl 1–2 µg/kg/dose.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29–36 weeks' GA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA &lt; 33 weeks (n = 11)</p> <p>GA ≥ 33 weeks (n = 19)</p> <p>Mean 2118 (range 1150–3984) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA &lt; 33 weeks (n = 18)</p> <p>GA ≥ 33 weeks (n = 12)</p> <p>Mean 1945 (range 1015–3700) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Classic</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group atropine 0.01 mg/kg and no analgesia‐sedation.</p> <p>InSurE group premedication with atropine 0.01 mg/kg plus morphine 0.1 mg/kg.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28–35 weeks' GA</p> <p>Birth weight ≥ 1250 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32+5/7, SD 1+6/7</p> <p>Mean 1968, SD 506 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32+5/7, SD 1+6/7</p> <p>Mean 1982, SD 492 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unique</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nCPAP without surfactant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group 24% oral sucrose solution and atropine 0.02 mg/kg.</p> <p>nCPAP group no analgesia‐sedation.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Birth weight ≥ 2000 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 34.9, SD 1.6</p> <p>Mean 2352, SD 318 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 35.07, SD 1.04</p> <p>Mean 2999, SD 523 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>i‐Gel SA</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>InSurE group no analgesia‐sedation.</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ETT: endotracheal tube; GA: gestational age; IQR: interquartile range; InSurE: intubate, surfactant and extubate; LMA: laryngeal mask airway; nCPAP: nasal continuous positive airway pressure; S‐LMA: surfactant administration via laryngeal mask airway; S‐ETT: surfactant administration via an endotracheal tube with extubation at standard criteria; SD: standard deviation. </p> <p><sup>a</sup> Manufacturer details: Classic LMA, Unique LMA and ProSeal LMA, Teleflex Medical, Wayne, Pennsylvania, USA; Hangzhou LMA, Hangzhou Shanyou Co Ltd, Hangzhou, Zhejiang, China; i‐Gel SA, Wokingham, Berkshire, UK; North America LMA, San Diego, California, USA. </p> </div> </div> <p> <ol id="CD008309-list-0016"> <li> <p>Administrative details: study author(s); published or unpublished; year of publication; year in which study was conducted; the presence of vested interest by study authors; details of other relevant papers cited. </p> </li> <li> <p>Study characteristics: study registration, study design type, study setting, number of study centres and location; informed consent; ethics approval, details of any 'run‐in' period (if applicable), completeness of follow‐up (e.g. greater than 80%); </p> </li> <li> <p>Participants: number randomised, number lost to follow‐up/withdrawn, number analysed, mean GA, GA age range, mean chronological age, chronological age range, sex, diagnostic criteria, inclusion criteria and exclusion criteria. </p> </li> <li> <p>Interventions: initiation, dose and duration of administration.</p> </li> <li> <p>Outcomes: as mentioned under <a href="#CD008309-sec-0022">Types of outcome measures</a> . </p> </li> </ol> </p> <p>We described ongoing studies identified by our search and documented available information such as the primary author, research question(s), methods, and outcome measures, together with an estimate of the anticipated reporting date in the <a href="./references#CD008309-sec-0245" title="">Characteristics of ongoing studies</a> table. We replaced any standard error of the mean (SEM) with the corresponding SD. </p> </section> <section id="CD008309-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (MEA and DAO) independently assessed the risk of bias (low, high or unclear) of all included trials using the Cochrane RoB 1 tool ( <a href="./references#CD008309-bbs2-0053" title="HigginsJP , AltmanDG , SterneJA , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 . Available from training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a> ), for the following domains. </p> <p> <ol id="CD008309-list-0017"> <li> <p>Sequence generation (selection bias)</p> </li> <li> <p>Allocation concealment (selection bias)</p> </li> <li> <p>Blinding of participants and personnel (performance bias)</p> </li> <li> <p>Blinding of outcome assessment (detection bias)</p> </li> <li> <p>Incomplete outcome data (attrition bias)</p> </li> <li> <p>Selective reporting (reporting bias)</p> </li> <li> <p>Any other bias</p> </li> </ol> </p> <p>We resolved any disagreements by discussion. See <a href="./appendices#CD008309-sec-0226">Appendix 7</a> for a more detailed description of the risk of bias for each domain. </p> </section> <section id="CD008309-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <section id="CD008309-sec-0038"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented the results using risk ratios (RR) and risk differences (RD) with 95% confidence intervals (CIs). We calculated the number needed to treat for an additional beneficial outcome (NNTB) or, where relevant, the number needed to treat for an additional harmful outcome (NNTH) with 95% CIs if there was a significant reduction or increase in RD. </p> </section> <section id="CD008309-sec-0039"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference (MD) when trials measured outcomes in the same way and standardised mean difference (SMD) when trials that measured the same outcome used different scales. Where trials reported continuous data as the median and interquartile range (IQR) and data passed the test of skewness, we converted the median to mean and estimated the SD as IQR/1.35. </p> </section> </section> <section id="CD008309-sec-0040"> <h4 class="title">Unit of analysis issues</h4> <p>We performed the primary analysis per individual randomised.</p> <p>We planned to abstract information on the study design and unit of analysis for each study, indicating whether the clustering of observations was present due to allocation to the intervention at the group level or clustering of individually randomised observations (e.g. people within the intensive care units). Available statistical information needed to account for the implications of clustering on the estimation of outcome variances was planned to be abstracted, such as design effects or intracluster correlations and whether the study adjusted results for the correlations in the data. In cases where the study did not account for clustering, we planned to ensure that appropriate adjustments were made to the effective sample size following Cochrane guidance ( <a href="./references#CD008309-bbs2-0054" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor( s) . Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 . Available from training.cochrane.org/handbook/archive/v6.3.">Higgins 2022</a> ). Where possible, we planned to derive the intracluster correlation coefficient (ICC) for these adjustments from the trial itself or a similar trial. If an appropriate ICC was unavailable, we planned to conduct a sensitivity analysis to investigate the potential effect of clustering by imputing a range of values of ICC. </p> <p>If any trials had multiple arms that were compared against the same control condition to be included in the same meta‐analysis, we planned to combine groups to create a single pair‐wise comparison, select one pair of interventions and exclude the others. In the meta‐analysis and data synthesis, we planned only to include the first phase data from cross‐over trials. </p> </section> <section id="CD008309-sec-0041"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the original investigators when we identified important missing data (in the outcomes) or unclear data. We planned to describe the number of participants with missing data in the <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> table and the <a href="./full#CD008309-sec-0048">Results</a> section. We planned to make explicit the assumptions of any methods used to deal with missing data. We planned to perform sensitivity analyses to assess how sensitive results were to reasonable changes in the undertaken assumptions. We planned to address the potential impact of missing data on the review's findings in the <a href="#CD008309-sec-0204">Discussion</a> section. </p> </section> <section id="CD008309-sec-0042"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used Review Manager Web to assess the heterogeneity of treatment effects between trials ( <a href="./references#CD008309-bbs2-0077" title="Review Manager Web (RevMan Web) . Version 4.12.0. The Cochrane Collaboration , 2022 . Available at revman.cochrane.org.">RevMan Web 2022</a> ). We used two formal statistical approaches. </p> <p> <ol id="CD008309-list-0018"> <li> <p>We assessed the presence of statistical heterogeneity using the Chi <sup>2</sup> test for homogeneity (P &lt; 0.1). Because this test has low power when the number of studies included in the meta‐analysis is small, we set the significance level at 10% probability ( <a href="./references#CD008309-bbs2-0054" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor( s) . Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 . Available from training.cochrane.org/handbook/archive/v6.3.">Higgins 2022</a> ). </p> </li> <li> <p>The I <sup>2</sup> statistic describes the percentage of total variation across studies due to heterogeneity rather than sampling error and is thus a measure of the validity of data pooling for meta‐analysis. We graded the degree of heterogeneity as follows: 24% or less, no heterogeneity; 25% to 49%, low heterogeneity; 50% to 74%, moderate heterogeneity; and 75% or greater, high heterogeneity. </p> </li> </ol> </p> <p>When we noted evidence of apparent or statistical heterogeneity, we assessed the source of the heterogeneity using sensitivity and subgroup analyses to look for evidence of bias or methodological differences between trials. </p> </section> <section id="CD008309-sec-0043"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to obtain the study protocols of all included studies and compare outcomes reported in the protocol versus those reported in the findings for each of the included studies. If we suspected reporting bias (see <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> table), we planned to contact the study authors to request further information. When this was not possible, and the missing data were thought to introduce serious bias, we planned to examine the impact of including/excluding such studies in the overall assessment of results by performing a sensitivity analysis. </p> <p>We planned to investigate non‐reporting (including publication) bias by assessing the funnel plot asymmetry visually and with Egger's test in meta‐analyses if data were available from at least 10 trials contributing events ( <a href="./references#CD008309-bbs2-0045" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test . BMJ1997 ; 315 ( 7109 ): 629-34 . [DOI: 10.1136/bmj.315.7109.629 ] [PMID: 9310563 ] ">Egger 1997</a> ). </p> </section> <section id="CD008309-sec-0044"> <h4 class="title">Data synthesis</h4> <p>We performed meta‐analyses using the standard methods of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> ( <a href="./references#CD008309-bbs2-0054" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor( s) . Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 . Available from training.cochrane.org/handbook/archive/v6.3.">Higgins 2022</a> ). We carried out the analysis on an intention‐to‐treat (ITT) basis for all included outcomes. We analysed all participants in the treatment group to which they were randomised, regardless of the actual treatment received. For categorical outcomes, we calculated typical estimates of RR and RD, each with 95% CI; for continuous outcomes, we calculated the MD if outcomes were measured in the same way between trials and SMD to combine trials that measured the same outcome, but used different scales. We used a fixed‐effect model to combine data where it was reasonable to assume that studies were estimating the same underlying treatment effect. We analysed and interpreted individual trials separately when we judged meta‐analysis as inappropriate. We explained clinical heterogeneity based on the different study characteristics and subgroup analyses where appropriate. </p> <p>Given the fundamental difference in the therapeutic approaches for control infants (InSurE, S‐ETT, LISA and no surfactant administration), we analysed data from trials within these categories separately and did not pool data in a meta‐analysis. </p> </section> <section id="CD008309-sec-0045"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We explored potential sources of clinical heterogeneity through the following subgroup analyses. </p> <p> <ol id="CD008309-list-0019"> <li> <p>Use of sedation and analgesia premedication (i.e. sedation and analgesia used versus none). </p> </li> <li> <p>GA (28 weeks or less (extremely preterm), 29 to 32 weeks (very preterm), 33 to 36 weeks (preterm)). </p> </li> <li> <p>Timing of surfactant administration (i.e. prophylaxis versus rescue). Here we defined prophylaxis trials as those in which surfactant treatment was administered soon after birth to infants at risk of RDS and rescue trials as those that used treatment with surfactant selectively in infants demonstrating features of RDS. </p> </li> </ol> </p> <p>Of these, we could not do a subgroup analysis concerning the timing of surfactant administration (i.e. prophylaxis versus rescue) as all included studies used rescue surfactant. </p> </section> <section id="CD008309-sec-0046"> <h4 class="title">Sensitivity analysis</h4> <p>We explored methodological heterogeneity using sensitivity analyses. We performed sensitivity analyses by excluding trials of lower quality based on a lack of any of the following: adequate randomisation, allocation concealment and less than 10% loss to follow‐up. As the intervention is unlikely to be adequately blinded, we did not include blinding as a criterion in the sensitivity analyses. </p> </section> <section id="CD008309-sec-0047"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach, as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE Handbook</a> ( <a href="./references#CD008309-bbs2-0079" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013 . Available from guidelinedevelopment.org/handbook.">Schünemann 2013</a> ), to assess the certainty of the evidence for the following critical (clinically relevant) outcomes. </p> <p> <ol id="CD008309-list-0020"> <li> <p>Death or BPD at 36 weeks' PMA</p> </li> <li> <p>Mechanical ventilation at any time</p> </li> <li> <p>Pulmonary air leak, any (during the first hospitalisation)</p> </li> <li> <p>BPD (clinical definition) among survivors to 36 weeks' PMA</p> </li> <li> <p>IVH grade III and IV</p> </li> <li> <p>Death (all causes) during the first hospitalisation</p> </li> <li> <p>Neurosensory disability in survivors; measured beyond one‐year PMA</p> </li> </ol> </p> <p>Two review authors (MEA and DAO) independently assessed the certainty of the evidence for each of the outcomes above. We considered evidence from RCTs as high certainty but downgraded the evidence one level for serious (or by two levels for very serious) limitations based upon the following: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates and presence of publication bias. </p> <p>We used the <a href="./references#CD008309-bbs2-0049" title="GRADEpro Guideline Development Tool . GRADEproGDT . Hamilton (ON) : GRADE Working Group, McMaster University and Evidence Prime , 2023 . Available from gradepro.org.">GRADEpro GDT</a> tool to create three summaries of findings tables to report the certainty of the evidence for the following comparisons. </p> <p> <ol id="CD008309-list-0021"> <li> <p>S‐LMA versus InSurE ( <a href="./full#CD008309-tbl-0001">summary of findings Table 1</a> ) </p> </li> <li> <p>S‐LMA versus S‐ETT ( <a href="./full#CD008309-tbl-0002">summary of findings Table 2</a> ) </p> </li> <li> <p>S‐LMA versus no surfactant administration ( <a href="./full#CD008309-tbl-0003">summary of findings Table 3</a> ) </p> </li> </ol> </p> <p>The GRADE approach results in an assessment of the certainty of a body of evidence as belonging to one of four grades. </p> <p> <ol id="CD008309-list-0022"> <li> <p>High certainty: further research is very unlikely to change our confidence in the estimate of effect. </p> </li> <li> <p>Moderate certainty: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> <li> <p>Low certainty: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> <li> <p>Very low certainty: we are very uncertain about the estimate.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD008309-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD008309-sec-0048"></div> <section id="CD008309-sec-0049"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> ; <a href="./references#CD008309-sec-0244" title="">Characteristics of excluded studies</a> ; and <a href="./references#CD008309-sec-0245" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD008309-sec-0050"> <h4 class="title">Results of the search</h4> <p>Searches identified 149 articles. After removing 56 duplicates, 93 articles were available for screening. We excluded 71 articles based on title/abstract and reviewed 22 full‐text articles. We excluded 12 articles with reasons, and classified two as ongoing ( <a href="./references#CD008309-bbs2-0021" title="ACTRN12619000995178. Surfactant administration by either supraglottic airway device (SAD) or direct laryngoscopy in late preterm and term newborns on nasal continuous positive airway pressure (nCPAP): a randomised, multi-centre, non-inferiority trial [The SAINT trial: Surfactant by supraglottic Airway versus direct laryngoscopy IN late preterm and Term newborns]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12619000995178 (first received 12 July 2019) . [CENTRAL: CN-01974801 ] ">ANZCTRN12619000995178</a> ; <a href="./references#CD008309-bbs2-0022" title="CTRI/2016/12/007540. Laryngeal mask airway versus endotracheal tube for surfactant administration in respiratory distress syndrome in preterm neonates more than 30 weeks of gestation – a randomized control trial [A clinical trial to study the effects of two methods of surfactant administration, through laryngeal mask airway and endotracheal tube in preterm babies with respiratory distress syndrome]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2016/12/007540 (first received 6 December 2016) . [CENTRAL: CN-01807424 ] ">CTRI/2016/12/007540</a> ). We included eight trials (23 references) in the quantitative analysis (one from the previous version of the review and seven new; <a href="./references#CD008309-bbs2-0100" title="Abdel-LatifME , OsbornDA . Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome . Cochrane Database of Systematic Reviews2011 , Issue 7 . Art. No: CD008309. [DOI: 10.1002/14651858.CD008309.pub2 ] ">Abdel‐Latif 2011b</a> ). The study flow diagram is shown in <a href="#CD008309-fig-0001">Figure 1</a> . </p> </section> <section id="CD008309-sec-0051"> <h4 class="title">Population</h4> <p>We included eight RCTs enrolling 510 newborn infants (260 in intervention groups) ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). The description of all included studies is displayed in the <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> table and is summarised in <a href="#CD008309-tbl-0004">Table 1</a> . Three studies were halted early before achieving their planned sample size ( <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> was halted because of slow enrolment, which was thought to be due to clinicians' hesitation at the study centre to intubate and administer surfactant by the endotracheal route. <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> was stopped early due to an interim analysis showing both groups were equivalent. <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> was stopped after a preliminary analysis needed towards the end of a co‐investigator fellowship training revealed essential differences between groups. </p> <p>The sample size of the studies ranged from 26 ( <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ), to 103 infants ( <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). Two studies were multicentre ( <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ), and six were single‐centre ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>No trial enrolled infants at less than 27 weeks' gestation or less than 800 g bodyweight. The smallest infant allocated LMA surfactant in the trials weighed 1025 g ( <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ). The enrolment criteria for weight in the included trials was greater than 800 g ( <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ), 1000 g or greater ( <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ), 1200 g or greater ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ), 1250 g or greater ( <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ), 1800 g or greater ( <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ), and 2000 g or greater ( <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>All studies were conducted in high‐income (USA) and upper‐middle‐income (Iran and Brazil) countries. </p> </section> <section id="CD008309-sec-0052"> <h4 class="title">Interventions and comparisons</h4> <p>See <a href="#CD008309-fig-0002">Figure 2</a> ; <a href="#CD008309-tbl-0004">Table 1</a> ; and <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD008309-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Studies included in the review categorised by comparison group.Abbreviations: ETT: endotracheal tube; nCPAP: nasal continuous positive airway pressure; LMA: laryngeal mask airway; S‐LMA: surfactant administration via laryngeal mask airway; S‐ETT: surfactant administration via an endotracheal tube with extubation at standard criteria; InSurE: intubate, surfactant and extubate." data-id="CD008309-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-02.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Studies included in the review categorised by comparison group.</p> <p>Abbreviations: ETT: endotracheal tube; nCPAP: nasal continuous positive airway pressure; LMA: laryngeal mask airway; S‐LMA: surfactant administration via laryngeal mask airway; S‐ETT: surfactant administration via an endotracheal tube with extubation at standard criteria; InSurE: intubate, surfactant and extubate. </p> </div> </div> </div> <p>All studies administered surfactant via LMA size 1. There was no analgesia sedation used in the LMA group except for oral sucrose in one study ( <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). All studies using InSurE ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ), or ETT ( <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ), in the control group used analgesia‐sedation except one study ( <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>We pooled the included studies in four separate comparisons based on the comparison group as follows ( <a href="#CD008309-fig-0002">Figure 2</a> ). </p> <p> <ol id="CD008309-list-0023"> <li> <p><b>Comparison 1: S‐LMA versus InSurE:</b> five studies (333 participants) with sample sizes ranging from 50 to 93 infants ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> </li> <li> <p><b>Comparison 2: S‐LMA versus S‐ETT:</b> one study involving 48 infants ( <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ). </p> </li> <li> <p><b>Comparison 3: S‐LMA versus LISA:</b> no studies compared S‐LMA versus LISA using thin catheters or other techniques (e.g. nebulised surfactant). </p> </li> <li> <p><b>Comparison 4: S‐LMA versus no surfactant administration:</b> two studies involving 129 participants ( <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> </li> </ol> </p> <p>Given the fundamental difference in the therapeutic approaches for control infants above (InSurE, S‐ETT, LISA and no surfactant administration), we analysed data from trials within these categories separately and did not pool data in a meta‐analysis. </p> </section> <section id="CD008309-sec-0053"> <h4 class="title">Outcomes</h4> <p>The included studies reported a wide range of outcomes, and the prevalence of these depended on the type of population studied. Since most of the included studies' population was preterm or borderline preterm infants, outcomes such as severe IVH and CLD were rare as these are more common among extremely preterm infants. No trial enrolled infants less than 27 weeks' gestation or less than 800 g. The mean GA and birth weight of each trial are summarised in <a href="#CD008309-tbl-0004">Table 1</a> . </p> <section id="CD008309-sec-0054"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD008309-list-0024"> <li> <p>Four studies reported the composite outcome of death or BPD, defined as the need for oxygen or respiratory support at 36 weeks' PMA ( <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> </li> </ol> </p> </section> <section id="CD008309-sec-0055"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD008309-list-0025"> <li> <p>Reporting of most secondary outcomes was incomplete.</p> </li> <li> <p>Continuous outcomes, including duration of respiratory support, oxygen therapy and hospitalisation, were incomplete and variably reported as means and SD, and non‐parametric data (medians and IQR or range). We converted non‐parametric data to parametric data where available for inclusion in the meta‐analysis. </p> </li> </ol> </p> </section> </section> <section id="CD008309-sec-0056"> <h4 class="title">Excluded studies</h4> <p>We excluded 12 studies, including seven observational studies, two reviews (all ineligible study types), one RCT comparing LISA with nCPAP versus LISA with LMA‐assisted ventilation (ineligible comparator), one case report and one animal study (see <a href="./references#CD008309-sec-0244" title="">Characteristics of excluded studies</a> table). </p> </section> <section id="CD008309-sec-0057"> <h4 class="title">Studies awaiting classification</h4> <p>No studies are awaiting classification.</p> </section> <section id="CD008309-sec-0058"> <h4 class="title">Ongoing studies</h4> <p>We identified two ongoing trials that are still recruiting. One trial is comparing surfactant administration by either a supraglottic airway device or direct laryngoscopy in late preterm and term newborns on nCPAP ( <a href="./references#CD008309-bbs2-0021" title="ACTRN12619000995178. Surfactant administration by either supraglottic airway device (SAD) or direct laryngoscopy in late preterm and term newborns on nasal continuous positive airway pressure (nCPAP): a randomised, multi-centre, non-inferiority trial [The SAINT trial: Surfactant by supraglottic Airway versus direct laryngoscopy IN late preterm and Term newborns]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12619000995178 (first received 12 July 2019) . [CENTRAL: CN-01974801 ] ">ANZCTRN12619000995178</a> ). One trial is comparing LMA versus ETT for surfactant administration in RDS in preterm neonates of more than 30 weeks' gestation ( <a href="./references#CD008309-bbs2-0022" title="CTRI/2016/12/007540. Laryngeal mask airway versus endotracheal tube for surfactant administration in respiratory distress syndrome in preterm neonates more than 30 weeks of gestation – a randomized control trial [A clinical trial to study the effects of two methods of surfactant administration, through laryngeal mask airway and endotracheal tube in preterm babies with respiratory distress syndrome]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2016/12/007540 (first received 6 December 2016) . [CENTRAL: CN-01807424 ] ">CTRI/2016/12/007540</a> ). </p> <p>See <a href="./references#CD008309-sec-0245" title="">Characteristics of ongoing studies</a> table. </p> </section> </section> <section id="CD008309-sec-0059"> <h3 class="title">Risk of bias in included studies</h3> <p>We completed a risk of bias summary for each eligible study ( <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> table; <a href="#CD008309-fig-0003">Figure 3</a> ). We presented our overall assessment of the risk of bias using the risk of bias graph ( <a href="#CD008309-fig-0004">Figure 4</a> ). We resolved disagreements among the review authors through discussion to achieve a consensus. Specific methodological issues are addressed below. </p> <div class="figure" id="CD008309-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008309-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD008309-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008309-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD008309-sec-0060"> <h4 class="title">Allocation</h4> <p>Seven studies performed and reported randomisation adequately (low risk of bias; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). One study was described as randomised but did not report on the randomisation method (unclear risk of bias; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>Seven studies performed and reported allocation concealment adequately (low risk of bias; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). One study did not report on allocation concealment ( <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> </section> <section id="CD008309-sec-0061"> <h4 class="title">Blinding</h4> <p>Seven studies did not blind the intervention to parents, caregivers or study personnel (high risk of bias; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> did not report blinding (unclear risk of bias). </p> <p>One study blinded the outcome assessors (low risk of detection bias; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). The other studies either did not blind assessors (high risk of detection bias; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> , <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ), or report on the outcome's blinding (unclear risk of detection bias; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> </section> <section id="CD008309-sec-0062"> <h4 class="title">Incomplete outcome data</h4> <p>Seven studies reported all enrolled infants (low risk of attrition bias; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). One study reported on analysed infants, and it is unclear whether all enrolled infants completed the study (unclear risk of attrition bias; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> </section> <section id="CD008309-sec-0063"> <h4 class="title">Selective reporting</h4> <p>Seven studies reported prespecified outcomes ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> , <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). Two of the seven studies were registered retrospectively, two years after first enrollment. For this reason, we judged them at unclear risk of reporting bias ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). We judged the other five studies at low risk of reporting bias. </p> <p>One study did not have a published protocol (unclear risk of reporting bias; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> </section> <section id="CD008309-sec-0064"> <h4 class="title">Other potential sources of bias</h4> <p>Three studies were stopped early and enrolled fewer participants than the projected sample size (unclear risk of bias; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). Three studies were stopped early and judged at high risk of bias because of loss of equipoise ( <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ); important differences between groups ( <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ); and reduction of the trial power and the true effect of the intervention was likely to have been smaller than the reported effect ( <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ) (see <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> table). One study had higher five‐minute Apgar scores in the LMA group (unclear risk of other bias; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). One study was judged at low risk of bias ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ). </p> </section> </section> <section id="CD008309-sec-0065"> <h3 class="title" id="CD008309-sec-0065">Effects of interventions</h3> <p>See: <a href="./full#CD008309-tbl-0001"><b>Summary of findings 1</b> Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE)</a>; <a href="./full#CD008309-tbl-0002"><b>Summary of findings 2</b> Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT)</a>; <a href="./full#CD008309-tbl-0003"><b>Summary of findings 3</b> Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration</a> </p> <p>See 'Outline of the analysis and summary of findings tables' ( <a href="#CD008309-tbl-0005">Table 2</a> ). </p> <div class="table" id="CD008309-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outline of the analysis and summary of findings tables</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Types of comparisons</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Effects of interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Summary of findings tables</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Tables of data and analyses</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1: S‐LMA vs surfactant administration via invasive methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1.1. S‐LMA vs InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Comparison 1: S‐LMA vs InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><a href="./full#CD008309-tbl-0001">summary of findings Table 1</a> : S‐LMA vs InSurE </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 1: S‐LMA vs InSurE – overall analysis ( <a href="./references#CD008309-fig-0005" title="">Analysis 1.1</a> ; <a href="./references#CD008309-fig-0006" title="">Analysis 1.2</a> ; <a href="./references#CD008309-fig-0007" title="">Analysis 1.3</a> ; <a href="./references#CD008309-fig-0008" title="">Analysis 1.4</a> ; <a href="./references#CD008309-fig-0009" title="">Analysis 1.5</a> ; <a href="./references#CD008309-fig-0010" title="">Analysis 1.6</a> ; <a href="./references#CD008309-fig-0011" title="">Analysis 1.7</a> ; <a href="./references#CD008309-fig-0012" title="">Analysis 1.8</a> ; <a href="./references#CD008309-fig-0013" title="">Analysis 1.9</a> ; <a href="./references#CD008309-fig-0014" title="">Analysis 1.10</a> ; <a href="./references#CD008309-fig-0015" title="">Analysis 1.11</a> ; <a href="./references#CD008309-fig-0016" title="">Analysis 1.12</a> ; <a href="./references#CD008309-fig-0017" title="">Analysis 1.13</a> ; <a href="./references#CD008309-fig-0018" title="">Analysis 1.14</a> ; <a href="./references#CD008309-fig-0019" title="">Analysis 1.15</a> ; <a href="./references#CD008309-fig-0020" title="">Analysis 1.16</a> ; <a href="./references#CD008309-fig-0021" title="">Analysis 1.17</a> ; <a href="./references#CD008309-fig-0022" title="">Analysis 1.18</a> ; <a href="./references#CD008309-fig-0023" title="">Analysis 1.19</a> ; <a href="./references#CD008309-fig-0024" title="">Analysis 1.20</a> ; <a href="./references#CD008309-fig-0025" title="">Analysis 1.21</a> ; <a href="./references#CD008309-fig-0026" title="">Analysis 1.22</a> ; <a href="./references#CD008309-fig-0027" title="">Analysis 1.23</a> ; <a href="./references#CD008309-fig-0028" title="">Analysis 1.24</a> ; <a href="./references#CD008309-fig-0029" title="">Analysis 1.25</a> ; <a href="./references#CD008309-fig-0030" title="">Analysis 1.26</a> ; <a href="./references#CD008309-fig-0031" title="">Analysis 1.27</a> ; <a href="./references#CD008309-fig-0032" title="">Analysis 1.28</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 2: S‐LMA vs InSurE – subgroup analyses: use of sedation and analgesia premedication ( <a href="./references#CD008309-fig-0033" title="">Analysis 2.1</a> ; <a href="./references#CD008309-fig-0034" title="">Analysis 2.2</a> ; <a href="./references#CD008309-fig-0035" title="">Analysis 2.3</a> ; <a href="./references#CD008309-fig-0036" title="">Analysis 2.4</a> ; <a href="./references#CD008309-fig-0037" title="">Analysis 2.5</a> ; <a href="./references#CD008309-fig-0038" title="">Analysis 2.6</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 3: S‐LMA vs InSurE – subgroup analyses: gestational age ( <a href="./references#CD008309-fig-0039" title="">Analysis 3.1</a> ; <a href="./references#CD008309-fig-0040" title="">Analysis 3.2</a> ; <a href="./references#CD008309-fig-0041" title="">Analysis 3.3</a> ; <a href="./references#CD008309-fig-0042" title="">Analysis 3.4</a> ; <a href="./references#CD008309-fig-0043" title="">Analysis 3.5</a> ; <a href="./references#CD008309-fig-0044" title="">Analysis 3.6</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 4: S‐LMA vs InSurE – sensitivity analysis ( <a href="./references#CD008309-fig-0008" title="">Analysis 1.4</a> ; <a href="./references#CD008309-fig-0045" title="">Analysis 4.1</a> ; <a href="./references#CD008309-fig-0046" title="">Analysis 4.2</a> ; <a href="./references#CD008309-fig-0047" title="">Analysis 4.3</a> ; <a href="./references#CD008309-fig-0048" title="">Analysis 4.4</a> ; <a href="./references#CD008309-fig-0049" title="">Analysis 4.5</a> ; <a href="./references#CD008309-fig-0050" title="">Analysis 4.6</a> ; <a href="./references#CD008309-fig-0051" title="">Analysis 4.7</a> ; <a href="./references#CD008309-fig-0052" title="">Analysis 4.8</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.2. S‐LMA vs S‐ETT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparison 2: S‐LMA vs S‐ETT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./full#CD008309-tbl-0002">summary of findings Table 2</a> : S‐LMA vs S‐ETT </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5: S‐LMA vs S‐ETT – overall analysis ( <a href="./references#CD008309-fig-0053" title="">Analysis 5.1</a> ; <a href="./references#CD008309-fig-0054" title="">Analysis 5.2</a> ; <a href="./references#CD008309-fig-0055" title="">Analysis 5.3</a> ; <a href="./references#CD008309-fig-0056" title="">Analysis 5.4</a> ; <a href="./references#CD008309-fig-0057" title="">Analysis 5.5</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2. S‐LMA vs with surfactant administration via less‐invasive methods (LISA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparison 3: S‐LMA vs surfactant administration via less‐invasive methods (LISA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3. S‐LMA vs no surfactant administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Comparison 4: S‐LMA vs no surfactant administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./full#CD008309-tbl-0003">summary of findings Table 3</a> : S‐LMA vs no surfactant administration </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 6: S‐LMA vs no surfactant administration – overall analysis ( <a href="./references#CD008309-fig-0058" title="">Analysis 6.1</a> ; <a href="./references#CD008309-fig-0059" title="">Analysis 6.2</a> ; <a href="./references#CD008309-fig-0060" title="">Analysis 6.3</a> ; <a href="./references#CD008309-fig-0061" title="">Analysis 6.4</a> ; <a href="./references#CD008309-fig-0062" title="">Analysis 6.5</a> ; <a href="./references#CD008309-fig-0063" title="">Analysis 6.6</a> ; <a href="./references#CD008309-fig-0064" title="">Analysis 6.7</a> ; <a href="./references#CD008309-fig-0065" title="">Analysis 6.8</a> ; <a href="./references#CD008309-fig-0066" title="">Analysis 6.9</a> ; <a href="./references#CD008309-fig-0067" title="">Analysis 6.10</a> ; <a href="./references#CD008309-fig-0068" title="">Analysis 6.11</a> ; <a href="./references#CD008309-fig-0069" title="">Analysis 6.12</a> ; <a href="./references#CD008309-fig-0070" title="">Analysis 6.13</a> ; <a href="./references#CD008309-fig-0071" title="">Analysis 6.14</a> ; <a href="./references#CD008309-fig-0072" title="">Analysis 6.15</a> ; <a href="./references#CD008309-fig-0073" title="">Analysis 6.16</a> ; <a href="./references#CD008309-fig-0074" title="">Analysis 6.17</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7: S‐LMA vs no surfactant administration – subgroup analyses: gestational age ( <a href="./references#CD008309-fig-0075" title="">Analysis 7.1</a> ; <a href="./references#CD008309-fig-0076" title="">Analysis 7.2</a> ; <a href="./references#CD008309-fig-0077" title="">Analysis 7.3</a> ; <a href="./references#CD008309-fig-0078" title="">Analysis 7.4</a> ; <a href="./references#CD008309-fig-0079" title="">Analysis 7.5</a> ; <a href="./references#CD008309-fig-0080" title="">Analysis 7.6</a> ; <a href="./references#CD008309-fig-0081" title="">Analysis 7.7</a> ) </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>InSurE: Intubate, Surfactant and Extubate; LMA: laryngeal mask airway; nCPAP: nasal continuous positive airway pressure; S‐ETT: surfactant administration via an endotracheal tube with extubation at standard criteria; S‐LMA: surfactant administration via laryngeal mask airway. </p> </div> </div> <section id="CD008309-sec-0066"> <h4 class="title">Comparison 1: surfactant administration via laryngeal mask airway versus surfactant administration via endotracheal tube with the intent to rapidly extubate </h4> <p>Five studies involving 333 infants compared S‐LMA versus InSurE ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ; <a href="./full#CD008309-tbl-0001">summary of findings Table 1</a> ). </p> <section id="CD008309-sec-0067"> <h5 class="title">Primary outcomes</h5> <section id="CD008309-sec-0068"> <h6 class="title">Death or bronchopulmonary dysplasia (composite outcome) defined as the need for oxygen or respiratory support at 36 weeks' postmenstrual age </h6> <p>S‐LMA may have little or no effect on the composite outcome of death or BPD at 36 weeks' PMA compared with InSurE (RR 1.50, 95% CI 0.27 to 8.34; I <sup>2</sup> = not applicable as 1 study (50 participants) had 0 events in both groups; 2 studies, 110 participants; low‐certainty evidence; <a href="./references#CD008309-fig-0005" title="">Analysis 1.1</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>Subgroup analysis by use of sedation and analgesia: four studies reported the use of sedation and analgesia in the InSurE group but not in the S‐LMA group ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). However, data for this outcome were only available from two studies ( <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). There may be little or no difference in this outcome (RR 1.50, 95% CI 0.27 to 8.34; I <sup>2</sup> = not applicable as 1 study (50 participants) had 0 events in both groups; 2 studies, 110 participants; <a href="./references#CD008309-fig-0033" title="">Analysis 2.1</a> ). </p> <p>Subgroup analysis by GA: one study reported no infants born at 32 to 36 weeks' gestation died or had BPD (50 participants; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). There may be little or no difference in death or BPD in infants born at 28 to 36 weeks' GA (RR 1.50, 95% CI 0.27 to 8.34; 1 study, 60 participants; <a href="./references#CD008309-fig-0039" title="">Analysis 3.1</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>The available data did not permit the other planned subgroup and sensitivity analyses.</p> </section> </section> <section id="CD008309-sec-0069"> <h5 class="title">Secondary outcomes</h5> <section id="CD008309-sec-0070"> <h6 class="title">Measures of the safety of the surfactant administration procedure</h6> <section id="CD008309-sec-0071"> <p><b>Failure to place laryngeal mask airway or endotracheal tube at the first attempt</b></p> <p>There may be little or no difference in failure to place LMA at the first attempt in the S‐LMA versus InSurE groups (RR 0.38, 95% CI 0.13 to 1.14; I <sup>2</sup> = 0%; 2 studies, 163 participants; <a href="./references#CD008309-fig-0006" title="">Analysis 1.2</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>The available data did not permit planned subgroup analyses.</p> <p>Sensitivity analysis using one study found similar results (RR 0.27, 95% CI 0.03 to 2.54; 1 study, 93 participants; <a href="./references#CD008309-fig-0045" title="">Analysis 4.1</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ). </p> </section> <section id="CD008309-sec-0072"> <p><b>Bradycardia during the intervention (heart rate less than 100 beats per minute or as defined by study authors)</b></p> <p>S‐LMA probably results in little or no difference in bradycardia during the procedure when compared to InSurE (RR 0.41, 95% CI 0.11 to 1.51; I <sup>2</sup> = 0%; 3 studies, 203 participants; <a href="./references#CD008309-fig-0007" title="">Analysis 1.3</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0073"> <p><b>Hypoxaemia during the intervention (oxygen saturation less than 80% or as defined by study authors)</b></p> <p>S‐LMA results in little or no difference in hypoxaemia during the procedure compared to InSurE (RR 2.88, 95% CI 0.63 to 13.15; I <sup>2</sup> = 0%; 3 studies, 203 participants; <a href="./references#CD008309-fig-0008" title="">Analysis 1.4</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0074"> <p><b>Apnoea (cessation of spontaneous breathing greater than 20 seconds) during the intervention</b></p> <p>There was little or no difference in apnoea during the procedure when comparing S‐LMA versus InSurE (RR 3.00, 95% CI 0.13 to 70.30; 1 study, 50 participants; <a href="./references#CD008309-fig-0009" title="">Analysis 1.5</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0075"> <p><b>Surfactant reflux during the intervention</b></p> <p>S‐LMA probably has little or no difference in surfactant reflux during the procedure when compared to InSurE (RR 0.71, 95% CI 0.41 to 1.24; I <sup>2</sup> = 56%; 3 studies, 223 participants; <a href="./references#CD008309-fig-0010" title="">Analysis 1.6</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>The available data did not permit the planned subgroup analysis.</p> <p>Sensitivity analysis using two studies found similar results (RR 0.49, 95% CI 0.24 to 1.01; I <sup>2</sup> = 71%; 2 studies, 153 participants; <a href="./references#CD008309-fig-0046" title="">Analysis 4.2</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> was excluded from the sensitivity analysis due to low quality, stemming from unclear randomisation, allocation concealment and loss to follow‐up. </p> </section> <section id="CD008309-sec-0076"> <p><b>Postintervention gastric surfactant aspirated greater than 10% of surfactant dose</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0077"> <p><b>Postintervention intratracheal surfactant received</b></p> <p>S‐LMA likely results in little or no difference in postintervention surfactant received when compared to InSurE (RR 1.55, 95% CI 0.88 to 2.73; I <sup>2</sup> = 0%; 4 studies, 240 participants; <a href="./references#CD008309-fig-0011" title="">Analysis 1.7</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>The available data did not permit planned subgroup analyses.</p> <p>Sensitivity analysis using three studies found similar results (RR 1.78, 95% CI 0.97 to 3.26; I <sup>2</sup> = 0%; 3 studies, 170 participants; <a href="./references#CD008309-fig-0047" title="">Analysis 4.3</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> was excluded from the sensitivity analysis due to low quality, stemming from unclear randomisation, allocation concealment and loss to follow‐up. </p> </section> <section id="CD008309-sec-0078"> <p><b>Number of doses of intratracheal surfactant received postintervention</b></p> <p>There was little or no difference in the number of doses of surfactant received when comparing S‐LMA with InSurE (MD 0.50, 95% CI −1.68 to 2.68; 1 study, 60 participants; <a href="./references#CD008309-fig-0012" title="">Analysis 1.8</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0079"> <p><b>Need for positive pressure ventilation during the intervention (for studies comparing laryngeal mask airway or other non‐invasive methods)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0080"> <p><b>Need for immediate intubation (within 15 minutes of intervention) (for studies comparing laryngeal mask airway or other non‐invasive methods)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> </section> <section id="CD008309-sec-0081"> <h6 class="title">Measures of respiratory support</h6> <section id="CD008309-sec-0082"> <p><b>Mechanical ventilation within the first 72 hours of life</b></p> <p>There may be little or no difference in mechanical ventilation within the first 72 hours when comparing S‐LMA versus InSurE (RR 0.25, 95% CI 0.03 to 2.08; 1 study, 50 participants; <a href="./references#CD008309-fig-0013" title="">Analysis 1.9</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0083"> <p><b>Mechanical ventilation within the first 72 hours or not ventilated but reached failure criteria</b></p> <p>S‐LMA probably results in a reduction in mechanical ventilation within the first 72 hours or not ventilated but reached failure criteria when compared to InSurE group (RR 0.39, 95% CI 0.22 to 0.70; 1 study, 60 participants; <a href="./references#CD008309-fig-0014" title="">Analysis 1.10</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0084"> <p><b>Mechanical ventilation at any time</b></p> <p>S‐LMA without sedation or analgesia may result in a reduction in mechanical ventilation at any time compared to InSurE (RR 0.53, 95% CI 0.36 to 0.78; I <sup>2</sup> = 27%; RD −0.14, 95% CI −0.22 to −0.06; I <sup>2</sup> = 89%; NNTB 7, 95% CI 5 to 17; 5 studies, 333 participants; low‐certainty evidence; <a href="./references#CD008309-fig-0015" title="">Analysis 1.11</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> <p>Subgroup analysis: there was a reduction in this outcome for S‐LMA versus InSurE for use of sedation and analgesia premedication in favour of S‐LMA (RR 0.53, 95% CI 0.36 to 0.78; I <sup>2</sup> = 27%; 4 studies, 263 participants; <a href="./references#CD008309-fig-0034" title="">Analysis 2.2</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). There was a reduction in this outcome for infants born at 28 to 36 weeks' GA in favour of S‐LMA (RR 0.56, 95% CI 0.38 to 0.82; I <sup>2</sup> = 46%; 3 studies, 213 participants; <a href="./references#CD008309-fig-0040" title="">Analysis 3.2</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). There was no evidence of a difference in this outcome for infants born at 32 to 36 weeks' gestation comparing S‐LMA versus InSurE (RR 0.25, 95% CI 0.03 to 2.08; I <sup>2</sup> = not applicable as 1 study (70 participants) had 0 events in both groups; 2 studies, 120 participants; <a href="./references#CD008309-fig-0040" title="">Analysis 3.2</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>The available data did not permit the other planned subgroup analyses.</p> <p>Sensitivity analysis using only high‐quality studies (i.e. by excluding <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> , which was at unclear risk of selection and attrition bias) found similar results (RR 0.53, 95% CI 0.36 to 0.78; I <sup>2</sup> = 27%; 4 studies, 263 participants; <a href="./references#CD008309-fig-0048" title="">Analysis 4.4</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> </section> <section id="CD008309-sec-0085"> <p><b>Pulmonary air leak, any (during the first hospitalisation)</b></p> <p>S‐LMA may result in little or no difference in pulmonary air leak (RR 1.39, 95% CI 0.65 to 2.98; I <sup>2</sup> = 0%; 5 studies, 333 participants; low‐certainty evidence; <a href="./references#CD008309-fig-0016" title="">Analysis 1.12</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>Subgroup analysis: there were similar results for use of sedation and analgesia premedication (RR 1.39, 95% CI 0.65 to 2.98; I <sup>2</sup> = 0%; 4 studies, 263 participants; <a href="./references#CD008309-fig-0035" title="">Analysis 2.3</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). There was little or no difference in pulmonary air leak for infants born at 28 to 36 weeks' gestation comparing S‐LMA versus InSurE (RR 1.39, 95% CI 0.65 to 2.98; I <sup>2</sup> = 0%; 3 studies, 213 participants; <a href="./references#CD008309-fig-0041" title="">Analysis 3.3</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). The available data did not permit the other planned subgroup analyses. </p> <p>Sensitivity analysis using high‐quality studies (i.e. by excluding <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> , which was at unclear risk of selection and attrition bias) showed similar results (RR 1.39, 95% CI 0.65 to 2.98; I <sup>2</sup> = 0%; 4 studies, 263 participants; <a href="./references#CD008309-fig-0049" title="">Analysis 4.5</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> </section> <section id="CD008309-sec-0086"> <p><b>Pulmonary air leak requiring drainage (during the first hospitalisation)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0087"> <p><b>Duration of mechanical ventilation via endotracheal tube (days; in survivors)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0088"> <p><b>Duration of any respiratory support (mechanical ventilation, nasal continuous positive airway pressure, high flow) (days; in survivors)</b></p> <p>S‐LMA versus InSurE resulted in little or no difference in the duration of any respiratory support (MD −0.41 days, 95% CI −0.92 to 0.10; I <sup>2</sup> = 0%; 2 studies, 130 participants; <a href="./references#CD008309-fig-0017" title="">Analysis 1.13</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>The available data did not permit planned subgroup analyses.</p> <p>Sensitivity analysis showed similar results (MD −0.23 days, 95% CI −1.07 to 0.61; 1 study, 60 participants; <a href="./references#CD008309-fig-0050" title="">Analysis 4.6</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ). </p> </section> <section id="CD008309-sec-0089"> <p><b>Duration of oxygen therapy (days; in survivors)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0090"> <p><b>Postnatal systemic corticosteroid therapy for bronchopulmonary dysplasia prevention</b></p> <p>One study reported no infants received postnatal corticosteroid therapy for BPD prevention (50 participants; <a href="./references#CD008309-fig-0018" title="">Analysis 1.14</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> </section> <section id="CD008309-sec-0091"> <h6 class="title">Outcomes during hospitalisation</h6> <section id="CD008309-sec-0092"> <p><b>Bronchopulmonary dysplasia (physiological definition), evaluated where necessary by a room‐air challenge at 36 weeks' postmenstrual age for infants with borderline oxygen requirements</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0093"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors to 36 weeks' postmenstrual age</b></p> <p>S‐LMA may result in little or no difference in BPD (clinical definition) among survivors to 36 weeks' PMA when compared to InSurE (RR 1.28, 95% CI 0.47 to 3.52; I <sup>2</sup> = 0%; 4 studies, 264 participants; low‐certainty‐evidence; <a href="./references#CD008309-fig-0019" title="">Analysis 1.15</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>Subgroup analysis: the four studies reporting BPD (clinical definition) all used sedation or analgesia in InSurE but not in S‐LMA (RR 1.28, 95% CI 0.47 to 3.52; I <sup>2</sup> = 0%; 4 studies, 264 participants; <a href="./references#CD008309-fig-0036" title="">Analysis 2.4</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). There was no difference in this outcome for infants born between 28 and 36 weeks' gestation (RR 1.28, 95% CI 0.47 to 3.52; I <sup>2</sup> = 0%; 3 studies, 214 participants; <a href="./references#CD008309-fig-0042" title="">Analysis 3.4</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>The available data did not permit the other planned subgroup analyses.</p> <p>Sensitivity analysis was not applicable as all included studies were high quality.</p> </section> <section id="CD008309-sec-0094"> <p><b>Intraventricular haemorrhage, any grade</b></p> <p>S‐LMA may result in little or no difference in IVH, any grade when compared to InSurE (RR 1.00, 95% CI 0.22 to 4.56; I <sup>2</sup> = not applicable as 1 study (50 participants) had 0 events in both groups; 2 studies, 110 participants; <a href="./references#CD008309-fig-0020" title="">Analysis 1.16</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0095"> <p><b>Intraventricular haemorrhage, grade III and IV</b></p> <p>One study reported no infants had IVH, grade III and IV (50 participants; <a href="./references#CD008309-fig-0021" title="">Analysis 1.17</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0096"> <p><b>Cystic periventricular leukomalacia</b></p> <p>One study reported no infants had cystic PVL (50 participants; <a href="./references#CD008309-fig-0022" title="">Analysis 1.18</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0097"> <p><b>Patent ductus arteriosus requiring medical therapy</b></p> <p>There may be little or no difference in PDA requiring medical therapy (RR 3.00, 95% CI 0.13 to 70.30; 1 study, 50 participants; <a href="./references#CD008309-fig-0023" title="">Analysis 1.19</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0098"> <p><b>Necrotising enterocolitis, modified Bell stage 2 or greater</b></p> <p>One study reported no infants had NEC, modified Bell stage 2 or greater (50 participants; <a href="./references#CD008309-fig-0024" title="">Analysis 1.20</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0099"> <p><b>Spontaneous intestinal perforation</b></p> <p>One study reported no infants had spontaneous intestinal perforation (50 participants; <a href="./references#CD008309-fig-0025" title="">Analysis 1.21</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0100"> <p><b>Retinopathy of prematurity, any grade</b></p> <p>One study reported no infants with ROP, any grade (50 participants; <a href="./references#CD008309-fig-0026" title="">Analysis 1.22</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0101"> <p><b>Retinopathy of prematurity, stage 3 or greater</b></p> <p>One study reported no infants with ROP, stage 3 or greater (50 participants; <a href="./references#CD008309-fig-0027" title="">Analysis 1.23</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0102"> <p><b>Duration of hospitalisation (days)</b></p> <p>S‐LMA may result in little or no difference in duration of hospitalisation compared to InSurE (MD −0.98, 95% CI −2.43 to 0.47; I <sup>2</sup> = 30%; 4 studies, 283 participants; <a href="./references#CD008309-fig-0028" title="">Analysis 1.24</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). </p> <p>The available data did not permit planned subgroup analyses.</p> <p>Sensitivity analysis showed a reduction in duration of hospitalisation in favour of S‐LMA (MD −2.88 days, 95% CI −6.44 to −0.68; I <sup>2</sup> = 32%; 3 studies, 213 participants; <a href="./references#CD008309-fig-0051" title="">Analysis 4.7</a> ; <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> </section> <section id="CD008309-sec-0103"> <p><b>Neonatal death (all causes) during the first 28 days</b></p> <p>One study reported no infants had a neonatal death (60 participants; <a href="./references#CD008309-fig-0029" title="">Analysis 1.25</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0104"> <p><b>Death (all causes) during the first hospitalisation</b></p> <p><a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> reported one death before hospital discharge in the InSurE group (93 participants), while the other two studies reported no events. S‐LMA may have little or no effect on mortality before hospital discharge (RR 0.28, 95% CI 0.01 to 6.60; I <sup>2</sup> = not applicable as 2 studies (130 participants) had 0 events in both groups; 3 studies, 203 participants; low‐certainty evidence; <a href="./references#CD008309-fig-0030" title="">Analysis 1.26</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>Subgroup analysis: the three studies reporting death (all causes) all used sedation or analgesia in InSurE but not in S‐LMA (RR 0.28, 95% CI 0.01 to 6.60; I <sup>2</sup> = 0%; 3 studies, 203 participants; <a href="./references#CD008309-fig-0038" title="">Analysis 2.6</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). There was no difference in death (all causes) for infants born at 28 to 36 weeks' gestation (RR 0.28, 95% CI 0.01 to 6.60; I <sup>2</sup> = not applicable as 1 study (60 participants) had 0 events in both groups; 2 studies, 153 participants; <a href="./references#CD008309-fig-0044" title="">Analysis 3.6</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>The available data did not permit the other planned subgroup or sensitivity analyses.</p> </section> </section> <section id="CD008309-sec-0105"> <h6 class="title">Postdischarge outcomes</h6> <section id="CD008309-sec-0106"> <p><b>Oxygen therapy at home</b></p> <p>There may be little or no difference in home oxygen use (RR 3.00, 95% CI 0.33 to 27.23; 1 study, 60 participants; <a href="./references#CD008309-fig-0031" title="">Analysis 1.27</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0107"> <p><b>Number of hospital readmissions with respiratory illness in the first two years</b></p> <p>Two studies reported no hospital readmissions with respiratory illness in the first two years (130 participants; <a href="./references#CD008309-fig-0032" title="">Analysis 1.28</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit planned subgroup and sensitivity analyses.</p> </section> <section id="CD008309-sec-0108"> <p><b>Parent‐reported wheeze in the first two years</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0109"> <p><b>Bronchodilator use in the first two years</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0110"> <p><b>Neurosensory disability in survivors; measured beyond one year' PMA</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> </section> </section> </section> <section id="CD008309-sec-0111"> <h4 class="title">Comparison 2: surfactant administration via laryngeal mask airway versus surfactant administration via an endotracheal tube with extubation at standard criteria </h4> <p>One study involving 48 infants compared S‐LMA versus S‐ETT ( <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./full#CD008309-tbl-0002">summary of findings Table 2</a> ). </p> <section id="CD008309-sec-0112"> <h5 class="title">Primary outcomes</h5> <section id="CD008309-sec-0113"> <h6 class="title">Death or bronchopulmonary dysplasia (composite outcome) at 36 weeks' postmenstrual age </h6> <p>The study in this comparison did not report on this outcome.</p> </section> </section> <section id="CD008309-sec-0114"> <h5 class="title">Secondary outcomes</h5> <section id="CD008309-sec-0115"> <h6 class="title">Measures of the safety of the surfactant administration procedure</h6> <section id="CD008309-sec-0116"> <p><b>Failure to place laryngeal mask airway or endotracheal tube at the first attempt</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0117"> <p><b>Bradycardia during the intervention (heart rate less than 100 beats per minute or as defined by study authors)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0118"> <p><b>Hypoxaemia during the intervention (oxygen saturation less than 80% or as defined by study authors)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0119"> <p><b>Apnoea (cessation of spontaneous breathing greater than 20 seconds) during the intervention</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0120"> <p><b>Surfactant reflux during the intervention</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0121"> <p><b>Postintervention gastric surfactant aspirated greater than 10% of surfactant dose</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0122"> <p><b>Postintervention intratracheal surfactant received</b></p> <p>There may be little or no difference in postintervention intratracheal surfactant received (RR 1.27, 95% CI 0.41 to 3.93; 1 study, 48 participants; <a href="./references#CD008309-fig-0053" title="">Analysis 5.1</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ). </p> </section> <section id="CD008309-sec-0123"> <p><b>Number of doses of intratracheal surfactant received postintervention</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0124"> <p><b>Need for positive pressure ventilation during the intervention (for studies comparing laryngeal mask airway or other non‐invasive methods)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0125"> <p><b>Need for immediate intubation (within 15 minutes of intervention) (for studies comparing laryngeal mask airway or other non‐invasive methods)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> </section> <section id="CD008309-sec-0126"> <h6 class="title">Measures of respiratory support</h6> <section id="CD008309-sec-0127"> <p><b>Mechanical ventilation within the first 72 hours of life</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0128"> <p><b>Mechanical ventilation within the first 72 hours or not ventilated but reached failure criteria</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0129"> <p><b>Mechanical ventilation at any time</b></p> <p>S‐LMA without sedation or analgesia compared to S‐ETT group with sedation and analgesia may result in a reduction in mechanical ventilation at any time (RR 0.47, 95% CI 0.31 to 0.71; RD −0.54, 95% CI −0.74 to −0.34; NNTB 2, 95% CI 2 to 3; 1 study, 48 participants; low‐certainty evidence; <a href="./references#CD008309-fig-0054" title="">Analysis 5.2</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ). </p> </section> <section id="CD008309-sec-0130"> <p><b>Pulmonary air leak, any (during the first hospitalisation)</b></p> <p>There may be little or no difference in pulmonary air leak during first hospitalisation (RR 2.56, 95% CI 0.11 to 59.75; 1 study, 48 participants; very low‐certainty evidence; <a href="./references#CD008309-fig-0055" title="">Analysis 5.3</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ). </p> </section> <section id="CD008309-sec-0131"> <p><b>Pulmonary air leak requiring drainage (during the first hospitalisation)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0132"> <p><b>Duration of mechanical ventilation via endotracheal tube (days; in survivors)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0133"> <p><b>Duration of any respiratory support (mechanical ventilation, nasal continuous positive airway pressure, high flow) (days; in survivors)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0134"> <p><b>Duration of oxygen therapy (days; in survivors)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0135"> <p><b>Postnatal systemic corticosteroid therapy for BPD prevention</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> </section> <section id="CD008309-sec-0136"> <h6 class="title">Outcomes during hospitalisation</h6> <section id="CD008309-sec-0137"> <p><b>Bronchopulmonary dysplasia (physiological definition), evaluated where necessary by a room‐air challenge at 36 weeks' postmenstrual age for infants with borderline oxygen requirements</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0138"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors to 36 weeks' postmenstrual age</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0139"> <p><b>Intraventricular haemorrhage, any grade</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0140"> <p><b>Intraventricular haemorrhage, grade III and IV</b></p> <p>There may be little or no difference in IVH grade III and IV (RR 2.56, 95% CI 0.11 to 59.75; 1 study, 48 participants; very low‐certainty evidence; <a href="./references#CD008309-fig-0056" title="">Analysis 5.4</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ). </p> </section> <section id="CD008309-sec-0141"> <p><b>Cystic periventricular leukomalacia</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0142"> <p><b>Patent ductus arteriosus requiring medical therapy</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0143"> <p><b>Necrotising enterocolitis, modified Bell stage 2 or greater</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0144"> <p><b>Spontaneous intestinal perforation</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0145"> <p><b>Retinopathy of prematurity, any grade</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0146"> <p><b>Retinopathy of prematurity, stage 3 or greater</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0147"> <p><b>Duration of hospitalisation (days)</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0148"> <p><b>Neonatal death (all causes) during the first 28 days</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0149"> <p><b>Death (all causes) during the first hospitalisation</b></p> <p>There may be little or no difference in death during the first hospitalisation (RR 0.17, 95% CI 0.01 to 3.37; 1 study, 48 participants; very low‐certainty evidence; <a href="./references#CD008309-fig-0057" title="">Analysis 5.5</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ). </p> </section> </section> <section id="CD008309-sec-0150"> <h6 class="title">Postdischarge outcomes</h6> <section id="CD008309-sec-0151"> <p><b>Oxygen therapy at home</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0152"> <p><b>Number of hospital readmissions with respiratory illness in the first two years</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0153"> <p><b>Parent‐reported wheeze in the first two years</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0154"> <p><b>Bronchodilator use in the first two years</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> <section id="CD008309-sec-0155"> <p><b>Neurosensory disability in survivors; measured beyond one year' postmenstrual age</b></p> <p>The study in this comparison did not report on this outcome.</p> </section> </section> </section> </section> <section id="CD008309-sec-0156"> <h4 class="title">Comparison 3: surfactant administration via laryngeal mask airway versus surfactant administration via less‐invasive methods </h4> <p>We identified no studies comparing S‐LMA versus LISA using thin catheters or other techniques (e.g. nebulised surfactant). </p> </section> <section id="CD008309-sec-0157"> <h4 class="title">Comparison 4: surfactant administration via laryngeal mask airway versus no surfactant administration </h4> <p>Two studies involving 129 participants compared S‐LMA versus no surfactant ( <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ; <a href="./full#CD008309-tbl-0003">summary of findings Table 3</a> ). </p> <section id="CD008309-sec-0158"> <h5 class="title">Primary outcomes</h5> <section id="CD008309-sec-0159"> <h6 class="title">Death or bronchopulmonary dysplasia (composite outcome) defined as the need for oxygen or respiratory support at 36 weeks' postmenstrual age </h6> <p>There may be no difference between the S‐LMA and no surfactant groups on death or BPD (composite outcome) (RR 1.65, 95% CI 0.85 to 3.22; I <sup>2</sup> = 58%; 2 studies, 129 participants; low‐certainty evidence; <a href="./references#CD008309-fig-0058" title="">Analysis 6.1</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>Subgroup analysis: there was no difference in the composite outcome of death or BPD for infants born at 32 to 36 weeks' gestation for S‐LMA compared to no surfactant group (RR 1.14, 95% CI 0.59 to 2.22; 1 study, 26 participants; <a href="./references#CD008309-fig-0075" title="">Analysis 7.1</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). There was no difference between groups for infants born between 28 to 36 weeks' gestation (RR 5.30, 95% CI 0.64 to 43.80; 1 study, 103 participants; <a href="./references#CD008309-fig-0075" title="">Analysis 7.1</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the other planned subgroup analyses.</p> </section> </section> <section id="CD008309-sec-0160"> <h5 class="title">Secondary outcomes</h5> <section id="CD008309-sec-0161"> <h6 class="title">Measures of the safety of the surfactant administration procedure</h6> <section id="CD008309-sec-0162"> <p><b>Failure to place laryngeal mask airway or endotracheal tube at first attempt</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0163"> <p><b>Bradycardia during the intervention (heart rate less than 100 beats per minute or as defined by study authors)</b></p> <p>One study reported no infants had bradycardia (26 participants; <a href="./references#CD008309-fig-0059" title="">Analysis 6.2</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0164"> <p><b>Hypoxaemia during the intervention (oxygen saturation less than 80% or as defined by study authors)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0165"> <p><b>Apnoea (cessation of spontaneous breathing greater than 20 seconds) during the intervention</b></p> <p>One study reported no infants had apnoea during the intervention (26 participants; <a href="./references#CD008309-fig-0060" title="">Analysis 6.3</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0166"> <p><b>Surfactant reflux during the intervention</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0167"> <p><b>Postintervention gastric surfactant aspirated greater than 10% of surfactant dose</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0168"> <p><b>Postintervention intratracheal surfactant received</b></p> <p>S‐LMA may reduce the need for postintervention intratracheal surfactant received when compared to no surfactant group (RR 0.55, 95% CI 0.37 to 0.83; I <sup>2</sup> = 0%; RD −0.26, 95% CI −0.41 to −0.10; I <sup>2</sup> = 0%; NNTB 4, 95% CI 3 to 10; 2 studies, 129 participants; <a href="./references#CD008309-fig-0061" title="">Analysis 6.4</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>Subgroup analysis: there was no difference in postintervention intratracheal surfactant received for infants born at 32 to 36 weeks' gestation between groups (RR 0.14, 95% CI 0.01 to 2.52; 1 study, 26 participants; <a href="./references#CD008309-fig-0076" title="">Analysis 7.2</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). There was a reduction in postintervention intratracheal surfactant received for infants born at 28 to 36 weeks' gestation in favour of S‐LMA (RR 0.59, 95% CI 0.39 to 0.89; 1 study, 103 participants; <a href="./references#CD008309-fig-0076" title="">Analysis 7.2</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the other planned subgroup analyses.</p> </section> <section id="CD008309-sec-0169"> <p><b>Number of doses of intratracheal surfactant received postintervention</b></p> <p>There was little or no difference in the number of doses of surfactant received when comparing S‐LMA with no surfactant group (MD −0.30, 95% CI −0.64 to 0.04; 1 study, 103 participants; <a href="./references#CD008309-fig-0062" title="">Analysis 6.5</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0170"> <p><b>Need for positive pressure ventilation during the intervention (for studies comparing laryngeal mask airway or other non‐invasive methods)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0171"> <p><b>Need for immediate intubation (within 15 minutes of intervention) (for studies comparing laryngeal mask airway or other non‐invasive methods)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> </section> <section id="CD008309-sec-0172"> <h6 class="title">Measures of respiratory support</h6> <section id="CD008309-sec-0173"> <p><b>Mechanical ventilation within the first 72 hours of life</b></p> <p>There may be a difference in mechanical ventilation within the first 72 hours when comparing S‐LMA versus no surfactant group favouring S‐LMA (RR 0.60, 95% CI 0.39 to 0.92; 1 study, 103 participants; <a href="./references#CD008309-fig-0063" title="">Analysis 6.6</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0174"> <p><b>Mechanical ventilation within the first 72 hours or not ventilated but reached failure criteria</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0175"> <p><b>Mechanical ventilation at any time</b></p> <p>S‐LMA probably results in a reduction in mechanical ventilation at any time when compared to the no surfactant group (RR 0.57, 95% CI 0.38 to 0.85; I <sup>2</sup> = 0%; RD −0.24, 95% CI −0.40 to −0.08; I <sup>2</sup> = 0%; NNTB 4, 95% CI 3 to 13; 2 studies, 129 participants; moderate‐certainty evidence; <a href="./references#CD008309-fig-0064" title="">Analysis 6.7</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>Subgroup analysis: there was no difference in mechanical ventilation at any time for infants born at 32 to 36 weeks' gestation (RR 0.33, 95% CI 0.04 to 2.80; 1 study, 26 participants; <a href="./references#CD008309-fig-0077" title="">Analysis 7.3</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). There was a reduction in mechanical ventilation at any time for infants born at 28 to 36 weeks' gestation (RR 0.59, 95% CI 0.39 to 0.89; 1 study, 103 participants; <a href="./references#CD008309-fig-0077" title="">Analysis 7.3</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). The available data did not permit the other planned subgroup analyses. </p> </section> <section id="CD008309-sec-0176"> <p><b>Pulmonary air leak, any (during the first hospitalisation)</b></p> <p>S‐LMA may result in little or no difference in pulmonary air leak (RR 0.65, 95% CI 0.23 to 1.88; I <sup>2</sup> = 0%; 2 studies, 129 participants; low‐certainty evidence; <a href="./references#CD008309-fig-0065" title="">Analysis 6.8</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>Subgroup analysis: there was no difference in pulmonary air leak for infants born at 32 to 36 weeks' gestation (RR 0.33, 95% CI 0.04 to 2.80; 1 study, 26 participants; <a href="./references#CD008309-fig-0078" title="">Analysis 7.4</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). There was no difference in pulmonary air leak for infants born at 28 to 36 weeks' gestation (RR 0.85, 95% CI 0.24 to 2.98; 1 study, 103 participants; <a href="./references#CD008309-fig-0078" title="">Analysis 7.4</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the other planned subgroup analyses.</p> </section> <section id="CD008309-sec-0177"> <p><b>Pulmonary air leak requiring drainage (during the first hospitalisation)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0178"> <p><b>Duration of mechanical ventilation via endotracheal tube (days; in survivors)</b></p> <p>S‐LMA versus no surfactant resulted in little or no difference in duration of mechanical ventilation via ETT (MD −0.17 days, 95% CI −0.54 to 0.21; I <sup>2</sup> = 0%; 2 studies, 129 participants; <a href="./references#CD008309-fig-0066" title="">Analysis 6.9</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>Subgroup analysis: there was no difference in duration of mechanical ventilation via ETT for infants born at 32 to 36 weeks' gestation (MD −1.00 days, 95% CI −2.71 to 0.71; 1 study, 26 participants; <a href="./references#CD008309-fig-0079" title="">Analysis 7.5</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). There was no difference in duration of mechanical ventilation via ETT for infants born at 28 to 36 weeks' gestation (MD −0.13 days, 95% CI −0.51 to 0.26; 1 study, 103 participants; <a href="./references#CD008309-fig-0079" title="">Analysis 7.5</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the other planned subgroup analyses.</p> </section> <section id="CD008309-sec-0179"> <p><b>Duration of any respiratory support (mechanical ventilation, laryngeal mask airway, high flow) (days; in survivors)</b></p> <p>S‐LMA versus no surfactant resulted in little or no difference in the duration of any respiratory support (MD 0.10 days, 95% CI −0.76 to 0.95; I <sup>2</sup> = 0%; 2 studies, 129 participants; <a href="./references#CD008309-fig-0067" title="">Analysis 6.10</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>Subgroup analysis: there was no difference in duration of any respiratory support for infants born at 32 to 36 weeks' gestation (MD 0 days, 95% CI −1.80 to 1.80; 1 study, 26 participants; <a href="./references#CD008309-fig-0080" title="">Analysis 7.6</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). There was no difference in duration of any respiratory support for infants born at 28 to 36 weeks' gestation (MD 0.13 days, 95% CI −0.85 to 1.10; 1 study, 103 participants; <a href="./references#CD008309-fig-0080" title="">Analysis 7.6</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the other planned subgroup analyses.</p> </section> <section id="CD008309-sec-0180"> <p><b>Duration of oxygen therapy (days; in survivors)</b></p> <p>There was little or no difference in the duration of oxygen therapy when comparing S‐LMA with no surfactant group (MD 1.00, 95% CI −0.73 to 2.73; 1 study, 103 participants; <a href="./references#CD008309-fig-0068" title="">Analysis 6.11</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0181"> <p><b>Postnatal systemic corticosteroid therapy for bronchopulmonary dysplasia prevention</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> </section> <section id="CD008309-sec-0182"> <h6 class="title">Outcomes during hospitalisation</h6> <section id="CD008309-sec-0183"> <p><b>Bronchopulmonary dysplasia (physiological definition), evaluated where necessary by a room‐air challenge at 36 weeks' postmenstrual age for infants with borderline oxygen requirements</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0184"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors to 36 weeks' postmenstrual age</b></p> <p>S‐LMA may result in little or no difference in BPD (clinical definition) among survivors to 36 weeks' PMA when compared to no surfactant (RR 1.65, 95% CI 0.85 to 3.22; I <sup>2</sup> = 58%; 2 studies, 129 participants; low‐certainty evidence; <a href="./references#CD008309-fig-0069" title="">Analysis 6.12</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>Subgroup analysis: there was no difference in BPD (clinical definition) between groups for infants born at 32 to 36 weeks' gestation (RR 1.14, 95% CI 0.59 to 2.22; 1 study, 26 participants; <a href="./references#CD008309-fig-0081" title="">Analysis 7.7</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ). There was no difference in BPD (clinical definition) for infants born at 28 to 36 weeks' gestation (RR 5.30, 95% CI 0.64 to 43.80; 1 study, 103 participants; <a href="./references#CD008309-fig-0081" title="">Analysis 7.7</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). </p> <p>The available data did not permit the other planned subgroup analyses.</p> </section> <section id="CD008309-sec-0185"> <p><b>Intraventricular haemorrhage, any grade</b></p> <p>One study reported no infants had IVH, any grade (103 participants; <a href="./references#CD008309-fig-0070" title="">Analysis 6.13</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0186"> <p><b>Intraventricular haemorrhage, grade III and IV</b></p> <p>One study reported no infants had IVH grade III and IV (103 participants; <a href="./references#CD008309-fig-0071" title="">Analysis 6.14</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0187"> <p><b>Cystic periventricular leukomalacia</b></p> <p>One study reported no infants had cystic PVL (103 participants; <a href="./references#CD008309-fig-0072" title="">Analysis 6.15</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0188"> <p><b>Patent ductus arteriosus requiring medical therapy</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0189"> <p><b>Necrotising enterocolitis, modified Bell stage 2 or greater</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0190"> <p><b>Spontaneous intestinal perforation</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0191"> <p><b>Retinopathy of prematurity, any grade</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0192"> <p><b>Retinopathy of prematurity, stage 3 or greater</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0193"> <p><b>Duration of hospitalisation (days)</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0194"> <p><b>Neonatal death (all causes) during the first 28 days</b></p> <p>One study reported no infants died during the first 28 days (103 participants; <a href="./references#CD008309-fig-0073" title="">Analysis 6.16</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> <section id="CD008309-sec-0195"> <p><b>Death (all causes) during the first hospitalisation</b></p> <p>One study reported no infants died during the first hospitalisation (103 participants; <a href="./references#CD008309-fig-0074" title="">Analysis 6.17</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). Meta‐analysis was not applicable. </p> <p>The available data did not permit the planned subgroup analyses.</p> </section> </section> <section id="CD008309-sec-0196"> <h6 class="title">Postdischarge outcomes</h6> <section id="CD008309-sec-0197"> <p><b>Oxygen therapy at home</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0198"> <p><b>Number of hospital readmissions with respiratory illness in the first two years</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0199"> <p><b>Parent‐reported wheeze in the first two years</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0200"> <p><b>Bronchodilator use in the first two years</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> <section id="CD008309-sec-0201"> <p><b>Neurosensory disability in survivors; measured beyond one year postmenstrual age</b></p> <p>None of the studies in this comparison reported this outcome.</p> </section> </section> </section> </section> <section id="CD008309-sec-0202"> <h4 class="title">Subgroup analysis</h4> <p>We performed subgroup analysis by:</p> <p> <ol id="CD008309-list-0026"> <li> <p>use of sedation and analgesia premedication (i.e. sedation and analgesia used versus none) (see <a href="./references#CD008309-fig-0033" title="">Analysis 2.1</a> ; <a href="./references#CD008309-fig-0034" title="">Analysis 2.2</a> ; <a href="./references#CD008309-fig-0035" title="">Analysis 2.3</a> ; <a href="./references#CD008309-fig-0036" title="">Analysis 2.4</a> ; <a href="./references#CD008309-fig-0037" title="">Analysis 2.5</a> ; <a href="./references#CD008309-fig-0038" title="">Analysis 2.6</a> ); </p> </li> <li> <p>GA (28 weeks or less (extremely preterm), 29 to 32 weeks (very preterm), 33 to 36 weeks (preterm)), (see <a href="./references#CD008309-fig-0039" title="">Analysis 3.1</a> ; <a href="./references#CD008309-fig-0040" title="">Analysis 3.2</a> ; <a href="./references#CD008309-fig-0041" title="">Analysis 3.3</a> ; <a href="./references#CD008309-fig-0042" title="">Analysis 3.4</a> ; <a href="./references#CD008309-fig-0043" title="">Analysis 3.5</a> ; <a href="./references#CD008309-fig-0044" title="">Analysis 3.6</a> ; <a href="./references#CD008309-fig-0075" title="">Analysis 7.1</a> ; <a href="./references#CD008309-fig-0076" title="">Analysis 7.2</a> ; <a href="./references#CD008309-fig-0077" title="">Analysis 7.3</a> ; <a href="./references#CD008309-fig-0078" title="">Analysis 7.4</a> ; <a href="./references#CD008309-fig-0079" title="">Analysis 7.5</a> ; <a href="./references#CD008309-fig-0080" title="">Analysis 7.6</a> ; <a href="./references#CD008309-fig-0081" title="">Analysis 7.7</a> ). </p> </li> </ol> </p> <p>However, the available data did not permit planned subgroup analysis by the timing of surfactant administration (i.e. prophylaxis versus rescue) as all included studies used rescue surfactant. </p> <p>We did not perform subgroup analysis for comparison two (S‐LMA versus S‐ETT) as there was a single trial ( <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ), which included infants at 28 to 35 weeks' gestation and used sedation and analgesia premedication in the S‐ETT group. We did not perform subgroup analysis for comparison three (S‐LMA versus LISA) as no trial assessed this comparison. </p> <p>Regarding comparison four (S‐LMA versus no surfactant administration), there were limited data on the GA subgroup. One trial included in comparison four used 24% oral sucrose solution as analgesia for the S‐LMA group ( <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ). As sucrose has no sedative effect, we considered this equivalent to no use of analgesia sedation, and hence, no subgroup analysis based on analgesia sedation premedication was conducted. </p> </section> <section id="CD008309-sec-0203"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analysis by trial quality for comparison one (S‐LMA versus InSurE) (see <a href="./references#CD008309-fig-0045" title="">Analysis 4.1</a> ; <a href="./references#CD008309-fig-0046" title="">Analysis 4.2</a> ; <a href="./references#CD008309-fig-0047" title="">Analysis 4.3</a> ; <a href="./references#CD008309-fig-0048" title="">Analysis 4.4</a> ; <a href="./references#CD008309-fig-0049" title="">Analysis 4.5</a> ; <a href="./references#CD008309-fig-0050" title="">Analysis 4.6</a> ; <a href="./references#CD008309-fig-0051" title="">Analysis 4.7</a> ; <a href="./references#CD008309-fig-0052" title="">Analysis 4.8</a> ). For this analysis, we excluded <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> based on unclear allocation concealment, randomisation and loss to follow‐up. The sensitivity analyses are included under the relevant outcomes. </p> <p>We did not perform sensitivity analysis for comparison two (S‐LMA versus S‐ETT) and four (S‐LMA versus no surfactant administration) as all included trials were of either of high quality, or there was only one trial included. Furthermore, we did not perform sensitivity analysis for comparison three (S‐LMA versus LISA) as there were no trials. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD008309-sec-0204" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD008309-sec-0204"></div> <section id="CD008309-sec-0205"> <h3 class="title" id="CD008309-sec-0205">Summary of main results</h3> <p>We included eight RCTs (510 newborn infants). We found no studies of prophylactic or early S‐LMA or studies comparing S‐LMA to LISA. Seven studies were considered at low risk of selection and attrition bias, but seven studies were unblinded. </p> <section id="CD008309-sec-0206"> <h4 class="title">Comparison 1: surfactant administration via laryngeal mask airway versus surfactant administration via endotracheal tube with the intent to rapidly extubate </h4> <p>Five studies reporting outcomes for 333 infants compared S‐LMA versus InSurE. We found low‐certainty evidence that there may be little or no difference in the primary outcome of death or BPD at 36 weeks' PMA. There may be a reduction in mechanical ventilation at any time with S‐LMA compared with InSurE (low‐certainty evidence). In subgroup analysis, the reduction in mechanical ventilation at any time was restricted to four studies enrolling 236 infants that used analgesia or sedation for the InSurE technique. No trial reported the use of analgesia or sedation for S‐LMA except for the use of sucrose. There may be little or no difference in air leak and BPD (clinical definition) among survivors to 36 weeks' PMA (low‐certainty evidence). One study reported no infants had an IVH grade III or IV, and no infant had cystic PVL, NEC, spontaneous intestinal perforation or ROP (50 participants). There was one death before hospital discharge in the InSurE group (3 studies, 203 participants). No study reported neurosensory disability in survivors measured beyond one year' PMA. </p> <p>The measures of safety of the surfactant administration procedure found there may be little or no difference in failure to place LMA/ETT at the first attempt, bradycardia, hypoxaemia (oxygen saturation less than 80%), apnoea and surfactant reflux during the procedure with S‐LMA compared to InSurE techniques. </p> </section> <section id="CD008309-sec-0207"> <h4 class="title">Comparison 2: surfactant administration via laryngeal mask airway versus surfactant administration via endotracheal tube with extubation at standard criteria </h4> <p>One study enrolling 48 infants compared S‐LMA versus S‐ETT ( <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ). The study did not report the primary outcome of death or BPD at 36 weeks' PMA. There is low‐certainty evidence that S‐LMA may reduce the use of mechanical ventilation at any time compared to S‐ETT. For other morbidities and mortality, there were either too few events, or the morbidities were not reported, to assess effectiveness or safety. Postdischarge outcomes were not reported. </p> <p>The measures of safety of the surfactant administration procedure were not reported. Comparing S‐LMA and S‐ETT, there may be little or no difference in postintervention intratracheal surfactant received. The number of doses of intratracheal surfactant received postintervention was not reported. </p> </section> <section id="CD008309-sec-0208"> <h4 class="title">Comparison 3: surfactant administration via laryngeal mask airway versus surfactant administration via less‐invasive methods </h4> <p>We did not identify any study for this comparison. With the increasing move towards gentle and non‐invasive ventilatory strategies, comparing these strategies is paramount. </p> </section> <section id="CD008309-sec-0209"> <h4 class="title">Comparison 4: surfactant administration via laryngeal mask airway versus no surfactant administration </h4> <p>Two studies enrolling 129 infants compared S‐LMA versus no surfactant administration. Rescue surfactant could be used in both groups in both trials. There is low‐certainty evidence that there may be little or no difference in death or BPD at 36 weeks' PMA. There is probably a reduction in mechanical ventilation at any time in the S‐LMA group compared to no surfactant. There is low‐certainty evidence that there may be little or no difference in BPD (clinical definition) among survivors to 36 weeks' PMA in the S‐LMA group compared to no surfactant. One study reported no infants in either group with any IVH, IVH grade III or IV, cystic PVL or died. PDA, NEC, spontaneous intestinal perforation, ROP and duration of hospitalisation were not reported. Postdischarge outcomes were not reported. </p> <p>Data on the safety measures of the surfactant administration procedure were limited. One study reported failure to place LMA at the first attempt in 30% of infants in the S‐LMA group. There were limited data on hypoxaemia, bradycardia and apnoea during the procedure. Postintervention gastric surfactant aspirated greater than 10% of surfactant dose was reported in 8% and 28% of infants in the S‐LMA groups in the two studies. S‐LMA may reduce the need for postintervention intratracheal surfactant compared to no surfactant. </p> <p>Currently, there are two ongoing registered trials. One trial is comparing surfactant administration by either a supraglottic airway device or direct laryngoscopy in late preterm and term newborns on nCPAP ( <a href="./references#CD008309-bbs2-0021" title="ACTRN12619000995178. Surfactant administration by either supraglottic airway device (SAD) or direct laryngoscopy in late preterm and term newborns on nasal continuous positive airway pressure (nCPAP): a randomised, multi-centre, non-inferiority trial [The SAINT trial: Surfactant by supraglottic Airway versus direct laryngoscopy IN late preterm and Term newborns]. trialsearch.who.int/Trial2.aspx?TrialID=ACTRN12619000995178 (first received 12 July 2019) . [CENTRAL: CN-01974801 ] ">ANZCTRN12619000995178</a> ). One trial is comparing LMA versus ETT for surfactant administration in RDS in preterm neonates of more than 30 weeks' gestation ( <a href="./references#CD008309-bbs2-0022" title="CTRI/2016/12/007540. Laryngeal mask airway versus endotracheal tube for surfactant administration in respiratory distress syndrome in preterm neonates more than 30 weeks of gestation – a randomized control trial [A clinical trial to study the effects of two methods of surfactant administration, through laryngeal mask airway and endotracheal tube in preterm babies with respiratory distress syndrome]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2016/12/007540 (first received 6 December 2016) . [CENTRAL: CN-01807424 ] ">CTRI/2016/12/007540</a> ). </p> </section> </section> <section id="CD008309-sec-0210"> <h3 class="title" id="CD008309-sec-0210">Overall completeness and applicability of evidence</h3> <p>We included eight RCTs (enrolling 510 newborn infants) in this review. For specific comparisons, no studies evaluated prophylactic S‐LMA; S‐LMA was not compared to other LISA techniques, including thin catheter surfactant or nebulised surfactant for infants on non‐invasive respiratory support. </p> <p>Five trials enrolling 333 infants compared rescue S‐LMA with InSurE technique in very preterm or preterm infants ranging from 800 g to 2000 g birth weight and from 27 weeks up to 37 weeks' gestation, or both. Most outcomes were incompletely reported except for mechanical ventilation at any time. Long‐term neurodevelopmental outcomes were also not reported. </p> <p>One trial enrolling 48 infants born at 28 to 35 weeks' gestation with birth weight of 1000 g or greater compared rescue S‐LMA versus S‐ETT. The primary outcome of death or BPD was not reported. Most outcomes were incompletely reported, or there were too few events to assess safety and efficacy. Long‐term neurodevelopmental outcomes were also not reported. </p> <p>Two studies enrolling 129 infants with birth weights greater than 1200 g and GAs 28 to 35 weeks compared rescue S‐LMA versus no surfactant administration. Rescue surfactant could be used in both groups in both trials. The primary outcome of death or BPD was not reported. Most outcomes were incompletely reported, or there were too few events to assess safety and efficacy. Long‐term neurodevelopmental outcomes were also not reported. </p> <p>No trial enrolled infants at less than 27 weeks' gestation or less than 800 g. Furthermore, subgroup data on very low birth weight infants (between 1000 g and 1500 g), and preterm infants (28 to 32 weeks' gestation) were unavailable. Only a few infants at less than 32 weeks' gestation or less than 1500 g were likely recruited in the studies included in this review. Given this limitation, the results of this review do not apply to very low birth weight or preterm infants. </p> <p>The scarcity of data in very preterm and extremely preterm infants may be related to the unavailability of suitably small LMA devices. LMA size 1.0 is generally recommended for preterm infants at 1500 g birth weight ( <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ). Although they have been used in infants as low as 800 g birth weight ( <a href="./references#CD008309-bbs2-0036" title="BrimacombeJ , GandiniD . Airway rescue and drug delivery in an 800 g neonate with the laryngeal mask airway . Paediatric Anaesthesia1999 ; 9 ( 2 ): 178 . [DOI: 10.1046/j.1460-9592.1999.00385.x ] [PMID: 10189665 ] ">Brimacombe 1999</a> ), data supporting their use is lacking. Size 0.5 LMA is currently unavailable for routine clinical use. Technological improvement in this area may encourage studies using LMA in infants of less than 1500 g. </p> <p>Various LMA devices were used. This review has not assessed the efficacy or safety of specific devices in subgroup analysis. </p> <p>Dosaging and specifics of surfactant administration are documented in the <a href="./references#CD008309-sec-0243" title="">Characteristics of included studies</a> table with trials administering 100 mg/kg to 200 mg/kg of surfactant, most commonly via a thin catheter inserted through the LMA and most commonly in several aliquots with or without intermittent positive pressure ventilation (IPPV) after aliquots, with device removal after administration then reinstitution of non‐invasive ventilation. The risk of surfactant leakage and non‐optimal fitting of LMA were not reported. </p> <p>Sedation or opioid analgesia, or both, was not used in the S‐LMA group but was used in four trials for the InSurE procedure. The analysis that found S‐LMA reduced mechanical ventilation at any time is restricted to trials that used sedation or opioid analgesia for the InSurE procedure. </p> <p>There was also incomplete reporting of measures of safety of surfactant administration, including failure rates of insertion on the first attempt, surfactant reflux, hypoxaemia, bradycardia and apnoea during the procedure, and postintervention gastric surfactant aspirated greater than 10% of surfactant dose indicating failure to administer some or all of the dose intratracheal. </p> </section> <section id="CD008309-sec-0211"> <h3 class="title" id="CD008309-sec-0211">Quality of the evidence</h3> <p>The risk of bias in the studies included in this review varied ( <a href="#CD008309-fig-0003">Figure 3</a> ), with seven trials assessed at low risk of selection and attrition bias ( <a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> ; <a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> ; <a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> ; <a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> ; <a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> ; <a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> ; <a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> ), and with one trial having an unknown risk of bias ( <a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> ) ( <a href="#CD008309-fig-0004">Figure 4</a> ). Given the interventions included in this review are difficult to blind, we did not assess blinding as a potential source of bias in this review. However, most of the reported outcomes were objective, so at a lower risk of reporting bias. </p> <p>The certainty of the evidence, assessed according to GRADE, was moderate to very low. We downgraded the certainty of the evidence as shown in the summary of findings tables due to serious study limitations in many trials ( <a href="./full#CD008309-tbl-0001">summary of findings Table 1</a> ; <a href="./full#CD008309-tbl-0002">summary of findings Table 2</a> ; <a href="./full#CD008309-tbl-0003">summary of findings Table 3</a> ). </p> <p>We did not perform all planned subgroup analyses, as subgroup data were limited or unavailable. As no trial enrolled infants at less than 27 weeks' gestation or less than 800 g birth weight and limited data were available for very low birth weight (1000 g to 1500 g birth weight) or preterm infants (28 to 32 weeks' gestation), the results may not apply to very low birth weight or very preterm infants. </p> <p>Given only eight RCTs enrolling 510 newborn infants were included in this review, with many outcomes under‐reported or reported in a small number of infants, often with few events, the review is underpowered to detect important differences for most outcomes studied. </p> </section> <section id="CD008309-sec-0212"> <h3 class="title" id="CD008309-sec-0212">Potential biases in the review process</h3> <p>The protocol was first published in 2010 ( <a href="./references#CD008309-bbs2-0099" title="Abdel-LatifME , OsbornDA . Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome . Cochrane Database of Systematic Reviews2010 , Issue 1 . Art. No: CD008309. [DOI: 10.1002/14651858.CD008309 ] ">Abdel‐Latif 2010b</a> ), and the review in 2011 ( <a href="./references#CD008309-bbs2-0100" title="Abdel-LatifME , OsbornDA . Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome . Cochrane Database of Systematic Reviews2011 , Issue 7 . Art. No: CD008309. [DOI: 10.1002/14651858.CD008309.pub2 ] ">Abdel‐Latif 2011b</a> ); since then, both the research questions about the use of S‐LMA and the methods used for Cochrane reviews have changed, and we have, therefore, updated our methods substantially. In addition, due to changes in the research questions about S‐LMA, we have subsequently had to change the comparison groups ( <a href="#CD008309-fig-0002">Figure 2</a> ). We separated comparison 1 (invasive surfactant administration) into two distinct methods of invasive surfactant administration: InSurE and S‐ETT. </p> <p>Furthermore, we added a new comparison for S‐LMA versus surfactant administration via less‐invasive methods (LISA) such as thin catheters. </p> <p>We also removed the subgroup analyses: type of LMA surfactant (animal‐derived, synthetic). We removed blinding as a criterion in the sensitivity analysis as the intervention is unlikely to be able to be adequately blinded. </p> <p>These post hoc changes might be considered potential biases in the review process.</p> <p>For the 2023 update, we searched additional databases: Epistemonikos and the Chinese language articles from China/Asia On Demand (CAOD). </p> <p>We included subgroup analyses even when only one study was available because weight and gestation groups are commonly used in guideline development. </p> <p>Some outcomes may only be relevant for certain groups within the study population. For instance, BPD is more relevant for extremely preterm infants (28 weeks' gestation or less) than preterm (33 to 36 weeks' gestation). Subgroup analyses were performed only for GRADE outcomes. Data was limited, particularly for infants under 32 weeks' gestation and 1500 g. </p> </section> <section id="CD008309-sec-0213"> <h3 class="title" id="CD008309-sec-0213">Agreements and disagreements with other studies or reviews</h3> <p>One recent systematic review including six RCTs enrolling 357 infants assessed the efficacy of S‐LMA versus 'standard methods of surfactant delivery' ( <a href="./references#CD008309-bbs2-0027" title="Al AliRA , GautamB , MillerMR , CoulsonS , YuenD . Laryngeal mask airway for surfactant administration versus standard treatment methods in preterm neonates with respiratory distress syndrome: a systematic review and meta-analysis . American Journal of Perinatology2022 ; 39 ( 13 ): 1433-40 . [PMID: 33517565 ] ">Al Ali 2022</a> ). <a href="./references#CD008309-bbs2-0027" title="Al AliRA , GautamB , MillerMR , CoulsonS , YuenD . Laryngeal mask airway for surfactant administration versus standard treatment methods in preterm neonates with respiratory distress syndrome: a systematic review and meta-analysis . American Journal of Perinatology2022 ; 39 ( 13 ): 1433-40 . [PMID: 33517565 ] ">Al Ali 2022</a> reported that S‐LMA was associated with decreased oxygen requirement, reduced intubation and mechanical ventilation. They reported no differences between groups for death, BPD or pneumothorax. The review concluded LMA might be an effective alternative method of surfactant delivery. However, further high‐quality RCTs with larger sample sizes and including extreme preterm infants are needed to establish LMA as an alternative technique for surfactant delivery. </p> <p>Another review compared S‐LMA, pharyngeal instillation and aerosolisation methods, and broadly supports the findings of our review ( <a href="./references#CD008309-bbs2-0042" title="DeviU , RobertsKD , PanditaA . A systematic review of surfactant delivery via laryngeal mask airway, pharyngeal instillation, and aerosolization: methods, limitations, and outcomes . Pediatric Pulmonology2022 ; 57 ( 1 ): 9-19 . [PMID: 34559459 ] ">Devi 2022</a> ). </p> <p>In one network meta‐analysis, <a href="./references#CD008309-bbs2-0033" title="BellosI , FitrouG , PanzaR , PanditaA . Comparative efficacy of methods for surfactant administration: a network meta-analysis . Archives of Disease in Childhood – Fetal and Neonatal Edition2021 ; 106 ( 5 ): 474 . [DOI: 10.1136/archdischild-2020-319763 ] [PMID: 33452218 ] ">Bellos 2021</a> compared surfactant administration via thin catheters, laryngeal mask, nebulisation, pharyngeal instillation, intubation and surfactant administration followed by immediate extubation (InSurE) and no surfactant administration. <a href="./references#CD008309-bbs2-0033" title="BellosI , FitrouG , PanzaR , PanditaA . Comparative efficacy of methods for surfactant administration: a network meta-analysis . Archives of Disease in Childhood – Fetal and Neonatal Edition2021 ; 106 ( 5 ): 474 . [DOI: 10.1136/archdischild-2020-319763 ] [PMID: 33452218 ] ">Bellos 2021</a> included 16 RCTs and 20 observational studies (13,234 participants). Compared with InSurE, administration via a thin catheter was associated with significantly lower mortality rates, mechanical ventilation, BPD and PVL with moderate certainty of evidence and NEC with low certainty of evidence. There were no differences observed by comparing InSurE with the administration via a laryngeal mask, nebulisation or pharyngeal instillation. </p> <p>One Cochrane review of surfactant therapy via a thin catheter (S‐TC) in preterm infants with or at risk of RDS concluded that S‐TC compared with S‐ETT is associated with reduced risk of death or BPD, less intubation in the first 72 hours, and reduced incidence of major complications and in‐hospital mortality ( <a href="./references#CD008309-bbs2-0026" title="Abdel-LatifME , WheelerKI , DavisPG , De PaoliAG , DargavillePA . Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome . Cochrane Database of Systematic Reviews2021 , Issue 5 . Art. No: CD011672. [DOI: 10.1002/14651858.CD011672.pub2 ] ">Abdel‐Latif 2021</a> ). S‐LMA was not a comparator in this review. </p> <p>Given there are no comparisons between S‐LMA and other non‐invasive methods of surfactant delivery, and the findings of our review and the other reviews above, further evaluation of S‐LMA to standard methods of surfactant delivery (particularly other non‐invasive methods) in high‐quality RCTs with larger sample size are indicated. </p> <p>As the placement of LMA can be learned more quickly and easily than intubation and has a higher success rate on the first attempt without the need for laryngoscopy ( <a href="./references#CD008309-bbs2-0072" title="PejovicNJ , Myrnerts HöökS , ByamugishaJ , AlfvénT , LubulwaC , CavallinF , et al. A randomized trial of laryngeal mask airway in neonatal resuscitation . New England Journal of Medicine2020 ; 383 ( 22 ): 2138-47 . [DOI: 10.1056/NEJMoa2005333 ] [PMID: 33252870 ] ">Pejovic 2020</a> ; <a href="./references#CD008309-bbs2-0096" title="WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2017 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Wanous 2017</a> ), S‐LMA has been proposed as an ideal method for administering surfactants in lower‐ and middle‐income countries (LMIC) ( <a href="./references#CD008309-bbs2-0098" title="ZapataHA , FortP , RobertsKD , KaluarachchiDC , GuthrieSO . Surfactant administration through laryngeal or supraglottic airways (SALSA): a viable method for low-income and middle-income countries . Frontiers in Pediatrics2022 ; 10 : 853831 . [DOI: 10.3389/fped.2022.853831 ] [PMID: 35372140 ] ">Zapata 2022</a> ). Three studies included in the review were from upper‐middle or middle‐income countries (Brazil, Iran). A quality improvement initiative in Jordan (LMIC country) showed that surfactant administration through laryngeal or supraglottic airways (SALSA) was feasible and more effective than matched retrospective control of InSurE ( <a href="./references#CD008309-bbs2-0009" title="Abu LeyahNA , HasanAA , JuneauJN , Al JammalMA , JaberGA , WildingGE , et al. Implementation of surfactant administration through laryngeal or supraglottic airways (SALSA): a Jordanian NICU's journey to improve surfactant administration . Children2022 ; 9 ( 8 ): 1147 . [DOI: 10.3390/children9081147 ] [PMID: 36010038 ] ">Abu Leyah 2022</a> ). Larger trials are necessary to establish the safety and efficacy of SALSA in LMIC. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD008309-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram. Updated search December 2022." data-id="CD008309-fig-0001" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram. Updated search December 2022.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Studies included in the review categorised by comparison group.Abbreviations: ETT: endotracheal tube; nCPAP: nasal continuous positive airway pressure; LMA: laryngeal mask airway; S‐LMA: surfactant administration via laryngeal mask airway; S‐ETT: surfactant administration via an endotracheal tube with extubation at standard criteria; InSurE: intubate, surfactant and extubate." data-id="CD008309-fig-0002" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-02.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Studies included in the review categorised by comparison group.</p> <p>Abbreviations: ETT: endotracheal tube; nCPAP: nasal continuous positive airway pressure; LMA: laryngeal mask airway; S‐LMA: surfactant administration via laryngeal mask airway; S‐ETT: surfactant administration via an endotracheal tube with extubation at standard criteria; InSurE: intubate, surfactant and extubate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-02.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD008309-fig-0003" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD008309-fig-0004" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA)" data-id="CD008309-fig-0005" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 2: Failure to place LMA or ETT at first attempt" data-id="CD008309-fig-0006" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 2: Failure to place LMA or ETT at first attempt </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 3: Bradycardia (heart rate &lt; 100 beats per minute) during the intervention" data-id="CD008309-fig-0007" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 3: Bradycardia (heart rate &lt; 100 beats per minute) during the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 4: Hypoxaemia (oxygen saturation &lt; 80%) during the intervention" data-id="CD008309-fig-0008" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 4: Hypoxaemia (oxygen saturation &lt; 80%) during the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 5: Apnoea (cessation of spontaneous breathing &gt; 20 seconds) during the intervention" data-id="CD008309-fig-0009" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 5: Apnoea (cessation of spontaneous breathing &gt; 20 seconds) during the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 6: Surfactant reflux during the intervention" data-id="CD008309-fig-0010" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 6: Surfactant reflux during the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 7: Postintervention intratracheal surfactant received" data-id="CD008309-fig-0011" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 7: Postintervention intratracheal surfactant received </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 8: Number of doses of intratracheal surfactant received postintervention" data-id="CD008309-fig-0012" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 8: Number of doses of intratracheal surfactant received postintervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 9: Mechanical ventilation within first 72 hours" data-id="CD008309-fig-0013" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 9: Mechanical ventilation within first 72 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 10: Mechanical ventilation within first 72 hours or not ventilated but reached failure criteria as defined by the study authors" data-id="CD008309-fig-0014" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 10: Mechanical ventilation within first 72 hours or not ventilated but reached failure criteria as defined by the study authors </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 11: Mechanical ventilation at any time" data-id="CD008309-fig-0015" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 11: Mechanical ventilation at any time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 12: Pulmonary air leak, any (during first hospitalisation)" data-id="CD008309-fig-0016" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 12: Pulmonary air leak, any (during first hospitalisation) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 13: Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors)" data-id="CD008309-fig-0017" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 13: Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 14: Postnatal systemic corticosteroid therapy for BPD prevention" data-id="CD008309-fig-0018" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 14: Postnatal systemic corticosteroid therapy for BPD prevention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 15: BPD (clinical definition) among survivors to 36 weeks' PMA" data-id="CD008309-fig-0019" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 15: BPD (clinical definition) among survivors to 36 weeks' PMA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 16: Any intraventricular haemorrhage" data-id="CD008309-fig-0020" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 16: Any intraventricular haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 17: Intraventricular haemorrhage grade III and IV" data-id="CD008309-fig-0021" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 17: Intraventricular haemorrhage grade III and IV </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 18: Cystic periventricular leukomalacia" data-id="CD008309-fig-0022" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 18: Cystic periventricular leukomalacia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 19: Patent ductus arteriosus requiring medical therapy" data-id="CD008309-fig-0023" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 19: Patent ductus arteriosus requiring medical therapy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 20: Necrotising enterocolitis, modified Bell stage 2 or greater" data-id="CD008309-fig-0024" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 20: Necrotising enterocolitis, modified Bell stage 2 or greater </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 21: Spontaneous intestinal perforation" data-id="CD008309-fig-0025" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 21: Spontaneous intestinal perforation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 22: Retinopathy of prematurity (ROP), any grade" data-id="CD008309-fig-0026" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 22: Retinopathy of prematurity (ROP), any grade </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 23: ROP, stage 3 or greater" data-id="CD008309-fig-0027" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 23: ROP, stage 3 or greater </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 24: Duration of hospitalisation (days)" data-id="CD008309-fig-0028" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 24: Duration of hospitalisation (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 25: Neonatal death (all causes) during the first 28 days" data-id="CD008309-fig-0029" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 25: Neonatal death (all causes) during the first 28 days </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.26" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 26: Death (all causes) during the first hospitalisation" data-id="CD008309-fig-0030" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.26.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.26.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 26: Death (all causes) during the first hospitalisation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.26.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.27" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 27: Use of home oxygen" data-id="CD008309-fig-0031" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.27.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.27.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 27: Use of home oxygen </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.27.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-001.28" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 28: Number of hospital readmissions with respiratory illness in the first two years" data-id="CD008309-fig-0032" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.28.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-001.28.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis, Outcome 28: Number of hospital readmissions with respiratory illness in the first two years </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-001.28.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA)" data-id="CD008309-fig-0033" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 2: Mechanical ventilation at any time" data-id="CD008309-fig-0034" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 2: Mechanical ventilation at any time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 3: Pulmonary air leak, any (during first hospitalisation)" data-id="CD008309-fig-0035" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 3: Pulmonary air leak, any (during first hospitalisation) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 4: BPD (clinical definition) among survivors to 36 weeks' PMA" data-id="CD008309-fig-0036" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 4: BPD (clinical definition) among survivors to 36 weeks' PMA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 5: Intraventricular haemorrhage grade III and IV" data-id="CD008309-fig-0037" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 5: Intraventricular haemorrhage grade III and IV </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 6: Death (all causes) during the first hospitalisation" data-id="CD008309-fig-0038" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication, Outcome 6: Death (all causes) during the first hospitalisation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA)" data-id="CD008309-fig-0039" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 2: Mechanical ventilation at any time" data-id="CD008309-fig-0040" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 2: Mechanical ventilation at any time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 3: Pulmonary air leak, any (during first hospitalisation)" data-id="CD008309-fig-0041" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 3: Pulmonary air leak, any (during first hospitalisation) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 4: BPD (clinical definition) among survivors to 36 weeks' PMA" data-id="CD008309-fig-0042" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 4: BPD (clinical definition) among survivors to 36 weeks' PMA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 5: Intraventricular haemorrhage grade III and IV" data-id="CD008309-fig-0043" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 5: Intraventricular haemorrhage grade III and IV </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 6: Death (all causes) during the first hospitalisation" data-id="CD008309-fig-0044" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age, Outcome 6: Death (all causes) during the first hospitalisation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 1: Failure to place LMA or ETT at first attempt" data-id="CD008309-fig-0045" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 1: Failure to place LMA or ETT at first attempt </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 2: Surfactant reflux during the intervention" data-id="CD008309-fig-0046" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 2: Surfactant reflux during the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 3: Postintervention intratracheal surfactant received" data-id="CD008309-fig-0047" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 3: Postintervention intratracheal surfactant received </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 4: Mechanical ventilation at any time" data-id="CD008309-fig-0048" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 4: Mechanical ventilation at any time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 5: Pulmonary air leak, any (during first hospitalisation)" data-id="CD008309-fig-0049" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 5: Pulmonary air leak, any (during first hospitalisation) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 6: Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors)" data-id="CD008309-fig-0050" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 6: Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-004.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 7: Duration of hospitalisation (days)" data-id="CD008309-fig-0051" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-004.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 7: Duration of hospitalisation (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-004.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 8: Number of hospital readmissions with respiratory illness in the first two years" data-id="CD008309-fig-0052" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-004.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis, Outcome 8: Number of hospital readmissions with respiratory illness in the first two years </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-004.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 1: Postintervention intratracheal surfactant received" data-id="CD008309-fig-0053" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 1: Postintervention intratracheal surfactant received </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 2: Mechanical ventilation at any time" data-id="CD008309-fig-0054" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 2: Mechanical ventilation at any time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 3: Pulmonary air leak, any (during first hospitalisation)" data-id="CD008309-fig-0055" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 3: Pulmonary air leak, any (during first hospitalisation) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 4: Intraventricular haemorrhage grade III and IV" data-id="CD008309-fig-0056" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 4: Intraventricular haemorrhage grade III and IV </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 5: Death (all causes) during the first hospitalisation" data-id="CD008309-fig-0057" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis, Outcome 5: Death (all causes) during the first hospitalisation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA)" data-id="CD008309-fig-0058" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 2: Bradycardia (heart rate &lt; 100 beats per minute) during the intervention" data-id="CD008309-fig-0059" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 2: Bradycardia (heart rate &lt; 100 beats per minute) during the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 3: Apnoea (cessation of spontaneous breathing &gt; 20 seconds) during the intervention" data-id="CD008309-fig-0060" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 3: Apnoea (cessation of spontaneous breathing &gt; 20 seconds) during the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 4: Postintervention intratracheal surfactant received" data-id="CD008309-fig-0061" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 4: Postintervention intratracheal surfactant received </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 5: Number of doses of intratracheal surfactant received postintervention" data-id="CD008309-fig-0062" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 5: Number of doses of intratracheal surfactant received postintervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 6: Mechanical ventilation within first 72 hours" data-id="CD008309-fig-0063" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 6: Mechanical ventilation within first 72 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 7: Mechanical ventilation at any time" data-id="CD008309-fig-0064" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 7: Mechanical ventilation at any time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 8: Pulmonary air leak, any (during first hospitalisation)" data-id="CD008309-fig-0065" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 8: Pulmonary air leak, any (during first hospitalisation) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 9: Duration of mechanical ventilation via ETT (days; in survivors)" data-id="CD008309-fig-0066" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 9: Duration of mechanical ventilation via ETT (days; in survivors) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 10: Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors)" data-id="CD008309-fig-0067" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 10: Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 11: Duration of oxygen therapy (days; in survivors)" data-id="CD008309-fig-0068" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 11: Duration of oxygen therapy (days; in survivors) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 12: Bronchopulmonary dysplasia (clinical definition) among survivors to 36 weeks' PMA" data-id="CD008309-fig-0069" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 12: Bronchopulmonary dysplasia (clinical definition) among survivors to 36 weeks' PMA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 13: Any intraventricular haemorrhage" data-id="CD008309-fig-0070" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 13: Any intraventricular haemorrhage </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 14: Intraventricular haemorrhage grade III and IV" data-id="CD008309-fig-0071" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.14</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 14: Intraventricular haemorrhage grade III and IV </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 15: Cystic periventricular leukomalacia" data-id="CD008309-fig-0072" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.15</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 15: Cystic periventricular leukomalacia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 16: Neonatal death (all causes) during the first 28 days" data-id="CD008309-fig-0073" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.16</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 16: Neonatal death (all causes) during the first 28 days </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-006.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 17: Death (all causes) during the first hospitalisation" data-id="CD008309-fig-0074" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-006.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.17</div> <div class="figure-caption"> <p>Comparison 6: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis, Outcome 17: Death (all causes) during the first hospitalisation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-006.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' PMA" data-id="CD008309-fig-0075" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 1: Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' PMA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 2: Postintervention intratracheal surfactant received" data-id="CD008309-fig-0076" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 2: Postintervention intratracheal surfactant received </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 3: Mechanical ventilation at any time" data-id="CD008309-fig-0077" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 3: Mechanical ventilation at any time </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 4: Pulmonary air leak, any (during first hospitalisation)" data-id="CD008309-fig-0078" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 4: Pulmonary air leak, any (during first hospitalisation) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-007.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 5: Duration of mechanical ventilation via ETT (days; in survivors)" data-id="CD008309-fig-0079" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-007.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 5: Duration of mechanical ventilation via ETT (days; in survivors) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-007.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 6: Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors)" data-id="CD008309-fig-0080" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-007.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 6: Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD008309-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/urn:x-wiley:14651858:media:CD008309:CD008309-CMP-007.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 7: BPD (clinical definition) among survivors to 36 weeks' PMA" data-id="CD008309-fig-0081" src="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_t/tCD008309-CMP-007.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7: Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age, Outcome 7: BPD (clinical definition) among survivors to 36 weeks' PMA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/media/CDSR/CD008309/image_n/nCD008309-CMP-007.07.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD008309-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants with or at risk of respiratory distress syndrome<br/><b>Settings:</b> NICU<br/><b>Intervention:</b> S‐LMA<br/><b>Comparator:</b> InSurE </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With InSurE</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With S‐LMA</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or bronchopulmonary dysplasia</b> <br/>Follow‐up at 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>55 per 1000</b> <br/>(10 to 303) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.50</b> <br/>(0.27 to 8.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mechanical ventilation at any time</b> </p> <p>Any time to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>302 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>160 per 1000</b> <br/>(109 to 236) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.53</b> <br/>(0.36 to 0.78) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Subgroup analyses: there may be a reduction for infants born at 28–36 weeks' gestation (RR 0.56, 95% CI 0.38 to 0.82; 3 studies, 213 participants; I <sup>2</sup> = 46%). </p> <p>Comparing S‐LMA without sedation or analgesia vs InSurE with analgesia or sedation, there may be a reduction in mechanical ventilation at any time (RR 0.53, 95% CI 0.36 to 0.78; 4 studies, 263 participants; I <sup>2</sup> = 27%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pulmonary air leak, any (during first hospitalisation)</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> <br/>(36 to 166) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.39</b> <br/>(0.65 to 2.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>333<br/>(5 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors</b> <br/>Follow‐up at 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>47 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>60 per 1000</b> <br/>(22 to 165) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.28</b> <br/>(0.47 to 3.52) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>264<br/>(4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraventricular haemorrhage grade III and IV</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death (all causes) during the first hospitalisation</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b> <br/>(0 to 68) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.28</b> <br/>(0.01 to 6.60) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>203<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurosensory disability in survivors</b> <br/>Follow‐up: &gt; 1 years </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>NICU:</b> neonatal intensive care unit; <b>PMA:</b> postmenstrual age; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded two levels for severe imprecision (wide confidence intervals and few events).<br/><sup>b</sup> Downgraded one level for imprecision (wide confidence intervals) and one level for inconsistency (low heterogeneity).<br/><sup>c</sup> Downgraded one level for inconsistency (single small study so not able to be assessed) and two levels for severe imprecision (no events). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008309-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants with or at risk of respiratory distress syndrome<br/><b>Settings:</b> NICU<br/><b>Intervention:</b> S‐LMA<br/><b>Comparator:</b> S‐ETT </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With S‐ETT</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>With S‐LMA</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or bronchopulmonary dysplasia</b> <br/>Follow‐up to 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mechanical ventilation at any time</b> </p> <p>Any time to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1000 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>470 per 1000</b> <br/>(310 to 710) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.47</b> <br/>(0.31 to 0.71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA without sedation or analgesia vs S‐ETT with sedation and analgesia may reduce the use of mechanical ventilation at any time. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pulmonary air leak, any (during first hospitalisation)</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.56</b> <br/>(0.11 to 59.75) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors</b> <br/>Follow‐up at 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraventricular haemorrhage grade III and IV</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.56</b> <br/>(0.11 to 59.75) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death (all causes) during the first hospitalisation</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>91 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/>(1 to 306) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.17</b> <br/>(0.01 to 3.37) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurosensory disability in survivors</b> <br/>Follow‐up at &gt; 1 year </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>NICU:</b> neonatal intensive care unit; <b>PMA:</b> postmenstrual age; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for inconsistency (single small study so not able to be assessed) and one level for imprecision (wide confidence intervals).<br/><sup>b</sup> Downgraded one level for inconsistency (single small study so not able to be assessed) and two levels for imprecision (wide confidence intervals and few events). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD008309-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants with or at risk of respiratory distress syndrome<br/><b>Settings:</b> NICU<br/><b>Intervention:</b> S‐LMA </p> <p><b>Comparator:</b> no surfactant administration </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With nCPAP and no surfactant administration</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With S‐LMA</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death or bronchopulmonary dysplasia</b> <br/>Follow‐up at 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>200 per 1000</b> <br/>(103 to 390) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.65</b> <br/>(0.85 to 3.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mechanical ventilation at any time</b> </p> <p>At any time to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>561 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>320 per 1000</b> <br/>(213 to 477) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.57</b> <br/>(0.38 to 0.85) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pulmonary air leak, any (during first hospitalisation)</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b> <br/>(28 to 228) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.65</b> <br/>(0.23 to 1.88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Bronchopulmonary dysplasia (clinical definition) among survivors</b> <br/>Follow‐up: 36 weeks' PMA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>200 per 1000</b> <br/>(103 to 390) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.65</b> <br/>(0.85 to 3.22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intraventricular haemorrhage grade III and IV</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death (all causes) during the first hospitalisation</b> </p> <p>Anytime to discharge</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Neurosensory disability in survivors</b> <br/>Follow‐up at &gt; 1 year </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>nCPAP:</b> nasal continuous positive airway pressure; <b>NICU:</b> neonatal intensive care unit; <b>PMA:</b> postmenstrual age; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for inconsistency (moderate heterogeneity) and one level for imprecision (wide confidence intervals).<br/><sup>b</sup> Downgraded one level for imprecision (wide confidence intervals).<br/><sup>c</sup> Downgraded two levels for severe imprecision (wide confidence intervals and few events).<br/><sup>d</sup> Downgraded one level for inconsistency (single small study so not able to be assessed) and two levels for imprecision (wide confidence intervals and few events). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008309-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of characteristics of included studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Multicentre study/total number of infants recruited</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Country</b> </p> </th> <th align="center" class="headercell" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Birth weight (g) and gestational age (weeks)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Intervention group (LMA)</b><sup>a</sup> </p> <p><b>(LMA type and size)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Control group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Surfactant dose</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Sedation or analgesia</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Eligibility criteria</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>S‐LMA group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control group</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0001" title="AminiE , SheikhM , ShariatM , DaliliH , AzadiN , NourollahiS . Surfactant administration in preterm neonates using laryngeal mask airway: a randomized clinical trial . Acta Medica Iranica2019 ; 57 ( 6 ): 348-54 . [pISSN: 0044-6025] IRCT201602019568N14. Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201602019568N14 (first received 10 March 2016) . [CENTRAL: CN-01882974 ] ">Amini 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 37 weeks' GA</p> <p>Birth weight ≥ 1200 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32.6 SD 2.3</p> <p>Mean 1970, SD 520 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32.4, SD 2.3</p> <p>Mean 1850, SD 496 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Classic</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>InSurE group single‐dose morphine 0.1 mg/kg.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0002" title="AttridgeJT , StewartC , StukenborgGJ , KattwinkelJ . Administration of rescue surfactant by laryngeal mask airway: lessons from a pilot trial . American Journal of Perinatology Reports2013 ; 30 ( 3 ): 201-6 . [DOI: 10.1055/s-0032-1323592 ] [PMID: 22893557 ] NCT00599651. Randomized controlled trial of surfactant administration by laryngeal mask airway (LMA) . clinicaltrials.gov/ct2/show/NCT00599651 (first received 24 January 2008) . [CENTRAL: CN-01516614 ] StewartC , AttridgeJ , KattwinkelJ . Randomised controlled trial of surfactant administration by laryngeal mask airway (LMA) . In: American Pediatric Society / Society for Pediatric Research Abstract . 2008 . ">Attridge 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Birth weight &gt; 1200 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA median 33+5/7 (IQR 31–34+6/7)</p> <p>Median 2001 (IQR 1670–2820) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA median 32 (IQR 31+3/7–35)</p> <p>Median 2130 (IQR 1799–2570) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>North America LMA</p> <p>Not stated.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nCPAP without surfactant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>nCPAP group no analgesia‐sedation.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0003" title="BarbosaRF , SimoesES , SilvaYP . A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates . Jornal de Pediatria2017 ; 93 ( 4 ): 343-50 . [DOI: 10.1016/j.jped.2016.08.007 ] [PMID: 28130967 ] NCT01173237. Efficacy evaluation of surfactant administration for respiratory distress syndrome treatment via laryngeal mask airway. A randomized controlled trial . clinicaltrials.gov/ct2/show/NCT01173237 (first received 2 August 2010) . [CENTRAL: CN-01530800 ] ">Barbosa 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brazil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28–35 weeks' GA</p> <p>Birth weight ≥ 1000 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 31 (range 28–34)</p> <p>Mean 1515 (range 1025–2295) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32 (range 28–35)</p> <p>Mean 1495 (range 1005–2515) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ProSeal</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ETT with extubation at standard criteria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>S‐ETT group remifentanil and midazolam bolus.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0004" title="GallupJA , NdakorSM , PezzanoC , PinheiroJM . Randomized trial of surfactant therapy via laryngeal mask airway versus brief tracheal intubation in preterm neonates . Journal of Pediatrics2022 ; S0022-3476 ( 22 ): 00891-5 . [DOI: 10.1016/j.jpeds.2022.10.009 ] [PMID: 36241051 ] GallupJA , PinheiroJM , NdakorSM , PezzanoC . Randomized trial of surfactant therapy via laryngeal mask airway vs brief tracheal intubation . Pediatrics2021 ; 147 ( 3 ): 755-6 . [DOI: 10.1542/peds.147.3MA8.755 ] NCT02164734. Efficacy of rescue surfactant delivery via endotracheal intubation (InSurE technique) versus laryngeal mask airway (LMA) for respiratory distress syndrome (RDS) in preterm neonates [Surfactant via endotracheal tube vs. laryngeal mask airway (LMA) in preterm neonates with respiratory distress syndrome]. clinicaltrials.gov/ct2/show/NCT02164734 (first received 17 June 2014) . [CENTRAL: CN-01546455 ] ">Gallup 2022</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27–36 weeks' GA</p> <p>Birth weight &gt; 800 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA range 27–36</p> <p>Mean 1848 (range 810–3560) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA range 27–36</p> <p>Mean 1926 (range 1050–3288) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unique</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group atropine and no analgesia‐sedation.</p> <p>InSurE group atropine 0.01 mg/kg and remifentanil 2 μg/kg.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0005" title="GharehbaghiM , MoghaddamYJ , RadfarR . Comparing the efficacy of surfactant administration by laryngeal mask airway and endotracheal intubation in neonatal respiratory distress syndrome . Crescent Journal of Medical and Biological Sciences2018 ; 5 ( 3 ): 222-7 . [ISSN: 2148-9696] IRCT201411183915N12. Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubation in neonatal respiratory distress syndrome . trialsearch.who.int/Trial2.aspx?TrialID=IRCT201411183915N12 (first received 28 November 2014) . [CENTRAL: CN-01855189 ] ">Gharehbaghi 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>33–37 weeks' GA</p> <p>Birth weight ≥ 1200 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32.88, SD 1.32</p> <p>Mean 2078, SD 669 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 33.76, SD 2.12</p> <p>Mean 2198, SD 669 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hangzhou LMA</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>InSurE group fentanyl 1–2 µg/kg/dose.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0006" title="NCT01042600. Rescue surfactant for respiratory distress syndrome (RDS) in newborns: comparing efficacy of delivery via laryngeal mask airway to delivery by endotracheal intubation [Randomized controlled trial of surfactant delivery via laryngeal mask airway (LMA) versus endotracheal Intubation]. clinicaltrials.gov/ct2/show/NCT01042600 (first received 5 January 2010) . [CENTRAL: CN-01527465 ] PinheiroJM , Santana-RivasQ , PezzanoC . Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery . Journal of Perinatology2016 ; 36 ( 3 ): 196-201 . [DOI: 10.1038/jp.2015.177 ] [PMID: 26633145 ] Santana-RivasQ , PinheiroJ , PezzanoC . Trial of surfactant administration via laryngeal mask airway (LMA) vs. endotracheal intubation with premedication in neonatal respiratory distress syndrome (RDS) . In: Pediatric Academic Societies Annual Meeting . 2013 . ">Pinheiro 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No</p> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29–36 weeks' GA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA &lt; 33 weeks (n = 11)</p> <p>GA ≥ 33 weeks (n = 19)</p> <p>Mean 2118 (range 1150–3984) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA &lt; 33 weeks (n = 18)</p> <p>GA ≥ 33 weeks (n = 12)</p> <p>Mean 1945 (range 1015–3700) g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Classic</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group atropine 0.01 mg/kg and no analgesia‐sedation.</p> <p>InSurE group premedication with atropine 0.01 mg/kg plus morphine 0.1 mg/kg.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0007" title="GrobergA , DintamanJ . Can laryngeal mask airway be used for surfactant administration in neonates?Journal of Perinatology2019 ; 39 ( 1 ): 8-10 . [DOI: 10.1038/s41372-018-0238-0 ] [PMID: 30305714 ] NCT01116921. Laryngeal mask airway (LMA) for surfactant administration in neonates . clinicaltrials.gov/ct2/show/NCT01116921 (first received 5 May 2010) . [CENTRAL: CN-01576428 ] RobertsK , LamplandA , LeoneT , TipnisJ , StepkaE , KesselJ , et al. Laryngeal mask airway for surfactant administration in neonates . European Journal of Pediatrics2016 ; 175 ( 11 ): 1491 . RobertsKD , BrownR , LamplandAL , LeoneTA , RudserKD , FinerNN , et al. Laryngeal mask airway for surfactant administration in neonates: a randomized, controlled trial . Journal of Pediatrics2018 ; 193 : 40-6.e1 . [DOI: 10.1016/j.jpeds.2017.09.068 ] [PMID: 29174079 ] RobertsKD , FinerN , LamplandA , LeoneT , TipnisJ , MerrittT , et al. Laryngeal mask airway for surfactant administration in neonates . Journal of Investigative Medicine2016 ; 64 ( 1 ): 157 . WanouA , RudserK , RobertK . Comparison of laryngeal mask airway and endotracheal tube placement in neonates (Abstract) . European Journal of Pediatrics2017 ; 176 ( 11 ): 1526 . WanousAA , WeyA , RudserKD , RobertsKD . Feasibility of laryngeal mask airway device placement in neonates . Neonatology2016 ; 111 ( 3 ): 222-7 . [DOI: 10.1159/000450691 ] [PMID: 27866188 ] ">Roberts 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28–35 weeks' GA</p> <p>Birth weight ≥ 1250 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32+5/7, SD 1+6/7</p> <p>Mean 1968, SD 506 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 32+5/7, SD 1+6/7</p> <p>Mean 1982, SD 492 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unique</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>nCPAP without surfactant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group 24% oral sucrose solution and atropine 0.02 mg/kg.</p> <p>nCPAP group no analgesia‐sedation.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD008309-bbs2-0008" title="SadeghniaA , TanhaeiM , MohammadizadehM , NematiM . A comparison of surfactant administration through i-Gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams . Advanced Biomedical Research2014 ; 3 : 160 . [DOI: 10.4103/2277-9175.137875 ] [PMID: 25221763 ] ">Sadeghnia 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Iran</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Birth weight ≥ 2000 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 34.9, SD 1.6</p> <p>Mean 2352, SD 318 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GA mean 35.07, SD 1.04</p> <p>Mean 2999, SD 523 g</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>i‐Gel SA</p> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 mg/kg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>S‐LMA group no analgesia‐sedation.</p> <p>InSurE group no analgesia‐sedation.</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>ETT: endotracheal tube; GA: gestational age; IQR: interquartile range; InSurE: intubate, surfactant and extubate; LMA: laryngeal mask airway; nCPAP: nasal continuous positive airway pressure; S‐LMA: surfactant administration via laryngeal mask airway; S‐ETT: surfactant administration via an endotracheal tube with extubation at standard criteria; SD: standard deviation. </p> <p><sup>a</sup> Manufacturer details: Classic LMA, Unique LMA and ProSeal LMA, Teleflex Medical, Wayne, Pennsylvania, USA; Hangzhou LMA, Hangzhou Shanyou Co Ltd, Hangzhou, Zhejiang, China; i‐Gel SA, Wokingham, Berkshire, UK; North America LMA, San Diego, California, USA. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of characteristics of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD008309-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outline of the analysis and summary of findings tables</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Types of comparisons</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Effects of interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Summary of findings tables</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Tables of data and analyses</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1: S‐LMA vs surfactant administration via invasive methods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1.1. S‐LMA vs InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Comparison 1: S‐LMA vs InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><a href="./full#CD008309-tbl-0001">summary of findings Table 1</a> : S‐LMA vs InSurE </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 1: S‐LMA vs InSurE – overall analysis ( <a href="./references#CD008309-fig-0005" title="">Analysis 1.1</a> ; <a href="./references#CD008309-fig-0006" title="">Analysis 1.2</a> ; <a href="./references#CD008309-fig-0007" title="">Analysis 1.3</a> ; <a href="./references#CD008309-fig-0008" title="">Analysis 1.4</a> ; <a href="./references#CD008309-fig-0009" title="">Analysis 1.5</a> ; <a href="./references#CD008309-fig-0010" title="">Analysis 1.6</a> ; <a href="./references#CD008309-fig-0011" title="">Analysis 1.7</a> ; <a href="./references#CD008309-fig-0012" title="">Analysis 1.8</a> ; <a href="./references#CD008309-fig-0013" title="">Analysis 1.9</a> ; <a href="./references#CD008309-fig-0014" title="">Analysis 1.10</a> ; <a href="./references#CD008309-fig-0015" title="">Analysis 1.11</a> ; <a href="./references#CD008309-fig-0016" title="">Analysis 1.12</a> ; <a href="./references#CD008309-fig-0017" title="">Analysis 1.13</a> ; <a href="./references#CD008309-fig-0018" title="">Analysis 1.14</a> ; <a href="./references#CD008309-fig-0019" title="">Analysis 1.15</a> ; <a href="./references#CD008309-fig-0020" title="">Analysis 1.16</a> ; <a href="./references#CD008309-fig-0021" title="">Analysis 1.17</a> ; <a href="./references#CD008309-fig-0022" title="">Analysis 1.18</a> ; <a href="./references#CD008309-fig-0023" title="">Analysis 1.19</a> ; <a href="./references#CD008309-fig-0024" title="">Analysis 1.20</a> ; <a href="./references#CD008309-fig-0025" title="">Analysis 1.21</a> ; <a href="./references#CD008309-fig-0026" title="">Analysis 1.22</a> ; <a href="./references#CD008309-fig-0027" title="">Analysis 1.23</a> ; <a href="./references#CD008309-fig-0028" title="">Analysis 1.24</a> ; <a href="./references#CD008309-fig-0029" title="">Analysis 1.25</a> ; <a href="./references#CD008309-fig-0030" title="">Analysis 1.26</a> ; <a href="./references#CD008309-fig-0031" title="">Analysis 1.27</a> ; <a href="./references#CD008309-fig-0032" title="">Analysis 1.28</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 2: S‐LMA vs InSurE – subgroup analyses: use of sedation and analgesia premedication ( <a href="./references#CD008309-fig-0033" title="">Analysis 2.1</a> ; <a href="./references#CD008309-fig-0034" title="">Analysis 2.2</a> ; <a href="./references#CD008309-fig-0035" title="">Analysis 2.3</a> ; <a href="./references#CD008309-fig-0036" title="">Analysis 2.4</a> ; <a href="./references#CD008309-fig-0037" title="">Analysis 2.5</a> ; <a href="./references#CD008309-fig-0038" title="">Analysis 2.6</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 3: S‐LMA vs InSurE – subgroup analyses: gestational age ( <a href="./references#CD008309-fig-0039" title="">Analysis 3.1</a> ; <a href="./references#CD008309-fig-0040" title="">Analysis 3.2</a> ; <a href="./references#CD008309-fig-0041" title="">Analysis 3.3</a> ; <a href="./references#CD008309-fig-0042" title="">Analysis 3.4</a> ; <a href="./references#CD008309-fig-0043" title="">Analysis 3.5</a> ; <a href="./references#CD008309-fig-0044" title="">Analysis 3.6</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 4: S‐LMA vs InSurE – sensitivity analysis ( <a href="./references#CD008309-fig-0008" title="">Analysis 1.4</a> ; <a href="./references#CD008309-fig-0045" title="">Analysis 4.1</a> ; <a href="./references#CD008309-fig-0046" title="">Analysis 4.2</a> ; <a href="./references#CD008309-fig-0047" title="">Analysis 4.3</a> ; <a href="./references#CD008309-fig-0048" title="">Analysis 4.4</a> ; <a href="./references#CD008309-fig-0049" title="">Analysis 4.5</a> ; <a href="./references#CD008309-fig-0050" title="">Analysis 4.6</a> ; <a href="./references#CD008309-fig-0051" title="">Analysis 4.7</a> ; <a href="./references#CD008309-fig-0052" title="">Analysis 4.8</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.2. S‐LMA vs S‐ETT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparison 2: S‐LMA vs S‐ETT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./full#CD008309-tbl-0002">summary of findings Table 2</a> : S‐LMA vs S‐ETT </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 5: S‐LMA vs S‐ETT – overall analysis ( <a href="./references#CD008309-fig-0053" title="">Analysis 5.1</a> ; <a href="./references#CD008309-fig-0054" title="">Analysis 5.2</a> ; <a href="./references#CD008309-fig-0055" title="">Analysis 5.3</a> ; <a href="./references#CD008309-fig-0056" title="">Analysis 5.4</a> ; <a href="./references#CD008309-fig-0057" title="">Analysis 5.5</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2. S‐LMA vs with surfactant administration via less‐invasive methods (LISA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparison 3: S‐LMA vs surfactant administration via less‐invasive methods (LISA)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3. S‐LMA vs no surfactant administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Comparison 4: S‐LMA vs no surfactant administration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./full#CD008309-tbl-0003">summary of findings Table 3</a> : S‐LMA vs no surfactant administration </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 6: S‐LMA vs no surfactant administration – overall analysis ( <a href="./references#CD008309-fig-0058" title="">Analysis 6.1</a> ; <a href="./references#CD008309-fig-0059" title="">Analysis 6.2</a> ; <a href="./references#CD008309-fig-0060" title="">Analysis 6.3</a> ; <a href="./references#CD008309-fig-0061" title="">Analysis 6.4</a> ; <a href="./references#CD008309-fig-0062" title="">Analysis 6.5</a> ; <a href="./references#CD008309-fig-0063" title="">Analysis 6.6</a> ; <a href="./references#CD008309-fig-0064" title="">Analysis 6.7</a> ; <a href="./references#CD008309-fig-0065" title="">Analysis 6.8</a> ; <a href="./references#CD008309-fig-0066" title="">Analysis 6.9</a> ; <a href="./references#CD008309-fig-0067" title="">Analysis 6.10</a> ; <a href="./references#CD008309-fig-0068" title="">Analysis 6.11</a> ; <a href="./references#CD008309-fig-0069" title="">Analysis 6.12</a> ; <a href="./references#CD008309-fig-0070" title="">Analysis 6.13</a> ; <a href="./references#CD008309-fig-0071" title="">Analysis 6.14</a> ; <a href="./references#CD008309-fig-0072" title="">Analysis 6.15</a> ; <a href="./references#CD008309-fig-0073" title="">Analysis 6.16</a> ; <a href="./references#CD008309-fig-0074" title="">Analysis 6.17</a> ) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis 7: S‐LMA vs no surfactant administration – subgroup analyses: gestational age ( <a href="./references#CD008309-fig-0075" title="">Analysis 7.1</a> ; <a href="./references#CD008309-fig-0076" title="">Analysis 7.2</a> ; <a href="./references#CD008309-fig-0077" title="">Analysis 7.3</a> ; <a href="./references#CD008309-fig-0078" title="">Analysis 7.4</a> ; <a href="./references#CD008309-fig-0079" title="">Analysis 7.5</a> ; <a href="./references#CD008309-fig-0080" title="">Analysis 7.6</a> ; <a href="./references#CD008309-fig-0081" title="">Analysis 7.7</a> ) </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>InSurE: Intubate, Surfactant and Extubate; LMA: laryngeal mask airway; nCPAP: nasal continuous positive airway pressure; S‐ETT: surfactant administration via an endotracheal tube with extubation at standard criteria; S‐LMA: surfactant administration via laryngeal mask airway. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outline of the analysis and summary of findings tables</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/full#CD008309-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008309-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.27, 8.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Failure to place LMA or ETT at first attempt <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.13, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Bradycardia (heart rate &lt; 100 beats per minute) during the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.11, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Hypoxaemia (oxygen saturation &lt; 80%) during the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [0.63, 13.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Apnoea (cessation of spontaneous breathing &gt; 20 seconds) during the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.13, 70.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Surfactant reflux during the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.41, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Postintervention intratracheal surfactant received <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.88, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Number of doses of intratracheal surfactant received postintervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐1.68, 2.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Mechanical ventilation within first 72 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Mechanical ventilation within first 72 hours or not ventilated but reached failure criteria as defined by the study authors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.22, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Mechanical ventilation at any time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.36, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Pulmonary air leak, any (during first hospitalisation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.65, 2.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐0.92, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Postnatal systemic corticosteroid therapy for BPD prevention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 BPD (clinical definition) among survivors to 36 weeks' PMA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.47, 3.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Any intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.22, 4.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Intraventricular haemorrhage grade III and IV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 Cystic periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 Patent ductus arteriosus requiring medical therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.13, 70.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 Necrotising enterocolitis, modified Bell stage 2 or greater <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 Spontaneous intestinal perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.22 Retinopathy of prematurity (ROP), any grade <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.23 ROP, stage 3 or greater <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.24 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.98 [‐2.43, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.25 Neonatal death (all causes) during the first 28 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.26 Death (all causes) during the first hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.01, 6.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.27 Use of home oxygen <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.33, 27.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.28 Number of hospital readmissions with respiratory illness in the first two years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – overall analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008309-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.27, 8.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Sedation or analgesia for InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.27, 8.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Mechanical ventilation at any time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.36, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 No sedation or analgesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Sedation or analgesia for InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.36, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Pulmonary air leak, any (during first hospitalisation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.65, 2.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 No sedation or analgesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Sedation or analgesia for InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.65, 2.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 BPD (clinical definition) among survivors to 36 weeks' PMA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.47, 3.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Sedation or analgesia for InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.47, 3.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Intraventricular haemorrhage grade III and IV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Sedation or analgesia for InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Death (all causes) during the first hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.01, 6.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Sedation or analgesia for InSurE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.01, 6.60]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: use of sedation and analgesia premedication</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008309-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.27, 8.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.27, 8.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Mechanical ventilation at any time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.36, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.38, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Pulmonary air leak, any (during first hospitalisation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.65, 2.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.65, 2.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 BPD (clinical definition) among survivors to 36 weeks' PMA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.47, 3.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.47, 3.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Intraventricular haemorrhage grade III and IV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Death (all causes) during the first hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.01, 6.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.01, 6.60]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – subgroup analyses: gestational age</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008309-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Failure to place LMA or ETT at first attempt <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.03, 2.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Surfactant reflux during the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>153</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.24, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Postintervention intratracheal surfactant received <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [0.97, 3.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Mechanical ventilation at any time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.36, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Pulmonary air leak, any (during first hospitalisation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.39 [0.65, 2.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐1.07, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.7 Duration of hospitalisation (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.88 [‐6.44, 0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.8 Number of hospital readmissions with respiratory illness in the first two years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) – sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008309-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Postintervention intratracheal surfactant received <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.41, 3.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Mechanical ventilation at any time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.31, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Pulmonary air leak, any (during first hospitalisation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.56 [0.11, 59.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Intraventricular haemorrhage grade III and IV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.56 [0.11, 59.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 Death (all causes) during the first hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 3.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus surfactant administration via endotracheal tube (ETT) with extubation at standard criteria (S‐ETT) – overall analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008309-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.85, 3.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Bradycardia (heart rate &lt; 100 beats per minute) during the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Apnoea (cessation of spontaneous breathing &gt; 20 seconds) during the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Postintervention intratracheal surfactant received <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.37, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Number of doses of intratracheal surfactant received postintervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.64, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 Mechanical ventilation within first 72 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.39, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.7 Mechanical ventilation at any time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.38, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.8 Pulmonary air leak, any (during first hospitalisation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.23, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.9 Duration of mechanical ventilation via ETT (days; in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.54, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.10 Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.76, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.11 Duration of oxygen therapy (days; in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐0.73, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.12 Bronchopulmonary dysplasia (clinical definition) among survivors to 36 weeks' PMA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.85, 3.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.13 Any intraventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.14 Intraventricular haemorrhage grade III and IV <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.15 Cystic periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.16 Neonatal death (all causes) during the first 28 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.17 Death (all causes) during the first hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – overall analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD008309-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Composite outcome of death or bronchopulmonary dysplasia (BPD) at 36 weeks' PMA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.85, 3.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.59, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.30 [0.64, 43.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Postintervention intratracheal surfactant received <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.37, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.39, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Mechanical ventilation at any time <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.38, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 2.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.39, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 Pulmonary air leak, any (during first hospitalisation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.23, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 2.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.24, 2.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.5 Duration of mechanical ventilation via ETT (days; in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.54, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐2.71, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.51, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.6 Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.76, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐1.80, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.85, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.7 BPD (clinical definition) among survivors to 36 weeks' PMA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.85, 3.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7.1 32 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.59, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7.2 28 to 36 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.30 [0.64, 43.80]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Surfactant administration via laryngeal mask airway (S‐LMA) versus no surfactant administration – subgroup analyses: gestational age</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD008309.pub3/references#CD008309-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD008309.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD008309-note-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD008309-note-0016">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD008309-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD008309-note-0014">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD008309-note-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD008309-note-0015">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD008309-note-0010">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD008309-note-0011">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008309\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008309\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008309\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD008309\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD008309\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008309.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD008309.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD008309.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD008309.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD008309.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717770934"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008309.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717770938"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD008309.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc00c8e88936b',t:'MTc0MDcxNzc3MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 